Processing 00000000.tx.1: Crystal Structure of Human Thimet Oligopeptidase Provides Insight into Substrate Recognition, Regulation, and Localization* Kallol Ray, Christina S. 

Phrase: "Crystal Structure of Human Thimet Oligopeptidase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   753   C0427896:Crystal [Body Substance]
   753   C0678594:Structure [Spatial Concept]
   753   C1533132:Crystal [Body Substance]
   753   C1704641:Crystal [Manufactured Object]

Phrase: "Provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "Insight into Substrate Recognition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0233820:Insight [Mental Process]

Phrase: "Regulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "Localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "* Kallol Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086894:ray [Fish]
   861   C0851346:ray [Natural Phenomenon or Process]
   861   C2314876:ray [Fish]

Phrase: "Christina S."
Processing 00000000.tx.2: Hines, Jerry Coll-Rodriguez, and David W. 

Phrase: "Hines,"

Phrase: "Jerry Coll-Rodriguez,"

Phrase: "and"

Phrase: "David W."
Processing 00000000.tx.3: Rodgers From the Department of Molecular and Cellular Biochemistry and Center for Structural Biology, University of Kentucky, Lexington, Kentucky 40536 Received for publication, January 23, 2004 , and in revised form, February 27, 2004.  

Phrase: "Rodgers From the Department of Molecular"

Phrase: "and"

Phrase: "Cellular Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Center for Structural Biology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "University of Kentucky,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Lexington,"

Phrase: "Kentucky 40536"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022557:Kentucky [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "January 23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "February 27,"

Phrase: "2004."
Processing 00000000.tx.4: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES  Thimet oligopeptidase (TOP) is a zinc metallopeptidase that metabolizes a number of bioactive peptides and degrades peptides released by the proteasome, limiting antigenic presentation by MHC class I molecules. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2825142:Experimental Result [Finding]
           Result
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Thimet oligopeptidase (TOP)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a zinc metallopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025543:Metallopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "metabolizes"

Phrase: "a number of bioactive peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "degrades"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "released by the proteasome,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "limiting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0439801:limiting [Functional Concept]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "antigenic presentation by MHC class I molecules."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449450:Presentation [Idea or Concept]
   743   C0206431:Antigen Presentation [Cell Function]
Processing 00000000.tx.5: We present the crystal structure of human TOP at 2.0- resolution. 

Phrase: "We"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "the crystal structure of human TOP at 2.0- resolution."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   738   C0427896:Crystal [Body Substance]
   738   C0678594:Structure [Spatial Concept]
   738   C1533132:Crystal [Body Substance]
   738   C1704641:Crystal [Manufactured Object]
Processing 00000000.tx.6: The active site is located at the base of a deep channel that runs the length of the elongated molecule, an overall fold first seen in the closely related metallopeptidase neurolysin. 

Phrase: "The active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "located at the base of a deep channel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0002055:base [Inorganic Chemical]
   744   C0178499:Base [Chemical Viewed Functionally]
   744   C0205125:Deep [Spatial Concept]
   744   C0439799:Channel [Spatial Concept]
   744   C1706095:Channel [Conceptual Entity]
   744   C1880279:Base [Biomedical or Dental Material]

Phrase: "that"

Phrase: "runs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:Runs [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "the length of the elongated molecule,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]

Phrase: "an overall fold first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "seen in the closely related metallopeptidase neurolysin."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0025543:Metallopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205397:Seen [Qualitative Concept]
   748   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1423943:NEUROLYSIN [Gene or Genome]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]
Processing 00000000.tx.7: Comparison of the two related structures indicates hinge-like flexibility and identifies elements near one end of the channel that adopt different conformations. 

Phrase: "Comparison of the two related structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "indicates"

Phrase: "hinge-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0457406:Hinge [Medical Device]
  1000   C1706053:Hinge [Medical Device]

Phrase: "like flexibility"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0242808:Flexibility [Qualitative Concept]
   928 E C0443220:Flexible [Qualitative Concept]

Phrase: "and"

Phrase: "identifies"

Phrase: "elements near one end of the channel"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0013879:Elements [Element, Ion, or Isotope]
   714 E C1705248:Element [Conceptual Entity]

Phrase: "that"

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "different conformations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.8: Relatively few of the sequence differences between TOP and neurolysin map to the proposed substrate-binding site, and four of these variable residues may account for differences in substrate specificity. 

Phrase: "Relatively"

Phrase: "few of the sequence differences"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0205388:Few [Quantitative Concept]
   760   C1519249:Sequence [Functional Concept]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "between TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin map to the proposed substrate-binding site,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0024779:Map [Manufactured Object]
   744   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "four of these variable residues"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205450:Four [Quantitative Concept]
   760   C0439828:Variable [Qualitative Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "may"

Phrase: "account for differences"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1551359:account [Idea or Concept]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in substrate specificity."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0038592:Substrate Specificity [Quantitative Concept]
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   861   C1710236:Substrate [Manufactured Object]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.9: In addition, a loop segment (residues 599-611) in TOP differs in conformation and degree of order from the corresponding neurolysin loop, suggesting it may also play a role in activity differences. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a loop segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441635:Segment [Spatial Concept]
   789 E C0205122:Segmental [Spatial Concept]

Phrase: "(residues 599-611"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "in TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "differs in conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0026377:Conformation [Spatial Concept]

Phrase: "and"

Phrase: "degree of order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0441889:Degree [Qualitative Concept]
   790   C0449286:Degree [Quantitative Concept]
   790   C0542560:Degree [Intellectual Product]
   790   C1561545:degree [Quantitative Concept]
   790   C2348088:Degree [Quantitative Concept]

Phrase: "from the corresponding neurolysin loop,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "it"

Phrase: "may"

Phrase: "also"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in activity differences."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.10: Cysteines thought to mediate covalent oligomerization of rat TOP, which can inactivate the enzyme, are found to be surface-accessible in the human enzyme, and additional cysteines (residues 321,350, and 644) may also mediate multimerization in the human homolog. 

Phrase: "Cysteines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "covalent oligomerization of rat TOP,"

Phrase: "which"

Phrase: "can"

Phrase: "inactivate"

Phrase: "the enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "surface-accessible in the human enzyme,"

Phrase: "and"

Phrase: "additional cysteines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(residues 321,350,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "644"

Phrase: ")"

Phrase: "may"

Phrase: "also"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "multimerization in the human homolog."
Processing 00000000.tx.11: Disorder in the N terminus of TOP indicates it may be involved in subcellular localization, but a potential nuclear import element is found to be part of a helix and, therefore, unlikely to be involved in transport. 

Phrase: "Disorder in the N terminus of TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0012634:Disorder [Disease or Syndrome]

Phrase: "indicates"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "involved in subcellular localization,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0475264:Localisation [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "but"

Phrase: "a potential nuclear import element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C1705248:Element [Conceptual Entity]

Phrase: "is"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "part of a helix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1292711:Part of [Spatial Concept]
   770   C0449719:Part [Spatial Concept]
   770   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "therefore,"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "be"

Phrase: "involved in transport."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0005528:Transport, NOS [Cell Function]
   790   C1314939:Involved [Functional Concept]
   790   C1317949:Transport [Manufactured Object]
   790   C3495449:transport [Medical Device]
Processing 00000000.tx.12: A large acidic patch on the surface could potentially mediate a protein-protein interaction, possibly through formation of a covalent linkage.  

Phrase: "A large acidic patch on the surface"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0332461:Patch [Finding]
   748   C0445403:Patch [Biomedical or Dental Material]
   748   C0991556:Patch [Medical Device]
   748   C1305400:Patch [Medical Device]
   748   C1533128:Patch [Biomedical or Dental Material]
   748   C1706366:{Patch} [Quantitative Concept]
   748   C1707974:Patch [Biomedical or Dental Material]

Phrase: "could"

Phrase: "potentially"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "a protein-protein interaction,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1704675:Interaction [Functional Concept]

Phrase: "possibly through formation of a covalent linkage."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0023745:linkage [Molecular Function]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1511539:Covalent [Molecular Function]
   748   C1522492:Formation [Functional Concept]
   748   C2362652:Possibly [Qualitative Concept]
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES  Thimet oligopeptidase (TOP,1 3.4.24.15 [EC] ) is a 77-kDa zinc metalloendopeptidase that bears the His-Glu-Xaa-Xaa-His (HEXXH) active site sequence motif characteristic of a large superfamily of metallopeptidases (1-4). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2825142:Experimental Result [Finding]
           Result
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Thimet oligopeptidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(TOP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "1 3.4.24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0442766:1/24 [Finding]
   804   C2827734:1+ [Quantitative Concept]
   804   C2981698:1+ [Classification]

Phrase: "[EC] )"

Phrase: "is"

Phrase: "a 77-kDa zinc metalloendopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442934:Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "bears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004897:Bear [Mammal]

Phrase: "the His-Glu-Xaa-Xaa-"

Phrase: "His"

Phrase: "(HEXXH"

Phrase: ")"

Phrase: "active site sequence motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514562:Motif [Amino Acid Sequence]

Phrase: "characteristic of a large superfamily of metallopeptidases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521970:Characteristic [Qualitative Concept]

Phrase: "(1-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: It is widely distributed in mammalian tissues with the highest expression levels in the brain, pituitary gland, and testis (5-8). 

Phrase: "It"

Phrase: "is"

Phrase: "widely"

Phrase: "distributed in mammalian tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0024660:Mammalian [Mammal]
   770   C0040300:Tissues [Tissue]
   770   C1704711:Distributed [Functional Concept]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "with the highest expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C3244092:expression level [Idea or Concept]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "pituitary gland,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032005:Pituitary Gland [Body Part, Organ, or Organ Component]
           Pituitary, NOS
  1000   C1278880:Pituitary gland [Body Part, Organ, or Organ Component]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "testis"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039597:Testis [Body Part, Organ, or Organ Component]
  1000   C1278981:Testis [Body Part, Organ, or Organ Component]
   916 E C0021358:Testes [Body Part, Organ, or Organ Component]
   907 E C0205070:Testicular [Spatial Concept]
   888 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: "(5-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.15: TOP is present in different subcellular locations depending on cell type, with reports of secreted and cytosolic forms (5-16), membrane association (5-7, 17, 18), and nuclear localization (7, 12, 14). 

Phrase: "TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "present in different subcellular locations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "depending on cell type,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0007634:Cell Type [Cell]
           Cell
   833   C0449475:cell type [Intellectual Product]
   770   C0332307:Type [Qualitative Concept]
   770   C1269647:Cell [Cell]
   770   C1547052:*Type [Quantitative Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737   C0725813:depend [Medical Device]

Phrase: "with reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "of secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "and"

Phrase: "cytosolic forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "(5-16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "membrane association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "(5-7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "17,"

Phrase: "18"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "nuclear localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "(7,"

Phrase: "12,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.16: Consistent with its broad tissue and subcellular compartment distribution, TOP appears to play a variety of physiological roles. 

Phrase: "Consistent with its broad tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "subcellular compartment distribution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]

Phrase: "TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a variety of physiological roles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]
Processing 00000000.tx.17: It has been implicated in the metabolism of a number of small peptides active in the central nervous system and the periphery including neurotensin, bradykinin, somatostatin, opioids, and angiotensin I (4, 6, 9, 16, 19-26). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the metabolism of a number of small peptides"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   741   C1158921:Peptide Metabolism [Molecular Function]
   739   C0025519:Metabolism [Organism Function]
   739   C0025520:metabolism [Functional Concept]
   739   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   739   C0237753:*Number [Quantitative Concept]
   739   C0449788:Number [Quantitative Concept]
   739   C0700321:Small [Quantitative Concept]

Phrase: "active in the central nervous system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205177:Active [Functional Concept]

Phrase: "and"

Phrase: "the periphery"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "neurotensin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "bradykinin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "somatostatin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "opioids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242402:Opioids [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "angiotensin I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(4,"

Phrase: "6,"

Phrase: "9,"

Phrase: "16,"

Phrase: "19-26"

Phrase: ")."
Processing 00000000.tx.18: In addition, recent reports demonstrate that TOP is primarily responsible for degrading peptides released from proteasomes, thereby limiting the extent of antigen presentation by MHC class I molecules (27-29). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "demonstrate"

Phrase: "that TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "primarily responsible for degrading peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "released from proteasomes,"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   790   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1325620:proteasome [Cell Component]
   756 E C1752727:Proteasome [Molecular Function]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "thereby"

Phrase: "limiting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0439801:limiting [Functional Concept]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "the extent of antigen presentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "by MHC class I molecules"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0019629:MHC Class I Molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0567416:molecules [Substance]
   756   C0017355:MHC Class I [Gene or Genome]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "(27-29"

Phrase: ")."
Processing 00000000.tx.19: TOP has also been linked to amyloid precursor protein processing (30), and it promotes increased degradation of the A peptide, a key component of amyloid plaques in Alzheimer's disease (31). 

Phrase: "TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "linked to amyloid precursor protein processing"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033666:protein processing [Molecular Function]
   783   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
   753   C1709694:Processing [Activity]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "increased degradation of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "A peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "a key component of amyloid plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C1440087:Amyloid A component [Immunologic Factor]
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.20: Expression of TOP activity is regulated at the level of transcription (32-34), but activity may also be regulated by posttranslational modification. 

Phrase: "Expression of TOP activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "regulated at the level of transcription"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0040649:Transcription [Genetic Function]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "(32-34"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "regulated by posttranslational modification."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0033666:Post-Translational Modification [Molecular Function]
   770   C0392747:Modification [Functional Concept]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.21: TOP oligomerizes by intermolecular disulfide bond formation in the absence of reductant, resulting in a decrease or loss of activity, and this modulation by multimerization may be a physiological regulatory mechanism (35-37). 

Phrase: "TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "oligomerizes by intermolecular disulfide bond formation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1150347:disulphide bond formation [Molecular Function]
   790   C1511997:Disulfide Bond [Amino Acid Sequence]
   783   C2338018:Intermolecular bond [Intellectual Product]
   753   C0012771:disulfide [Chemical Viewed Structurally]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of reductant,"

Phrase: "resulting in a decrease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0332294:Resulting in [Functional Concept]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "or"

Phrase: "loss of activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "this modulation by multimerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443264:Modulation [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "a physiological regulatory mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "(35-37"

Phrase: ")."
Processing 00000000.tx.22: The activity of rat TOP can also be modulated by phosphorylation, and phosphorylated forms of the enzymes have been isolated from cultured cells (38, 39). 

Phrase: "The activity of rat TOP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C2610629:oligopeptidase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "modulated by phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C0443264:Modulated [Spatial Concept]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "phosphorylated forms of the enzymes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "isolated from cultured cells"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737 E C0370215:Isolate [Substance]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.23: TOP belongs to the M3 family of metallopeptidases (2), which has eight other known members that all share some sequence similarity with TOP. 

Phrase: "TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "belongs to the M3 family of metallopeptidases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0015576:Family [Family Group]
   748   C0025543:Metallopeptidases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1300554:m3 [Quantitative Concept]
   748   C1704727:Family [Conceptual Entity]
   748   C3484373:M3 [Intellectual Product]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "has"

Phrase: "eight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205454:Eight [Quantitative Concept]

Phrase: "other known members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680022:members [Population Group]
   827 E C2698041:Member [Professional or Occupational Group]

Phrase: "that"

Phrase: "all"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "some sequence similarity with TOP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1710052:Sequence Similarity [Quantitative Concept]
   753   C2348205:Similarity [Qualitative Concept]
Processing 00000000.tx.24: The member of this family most closely related to TOP, the peptidase neurolysin, has more than 60% sequence identity and a similar tissue distribution (1, 40, 41). 

Phrase: "The member of this family most closely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0086282:Family member [Family Group]
   774   C1611821:Family Member [Intellectual Product]
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]

Phrase: "related to TOP,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "the peptidase neurolysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "has"

Phrase: "more than 60% sequence identity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0205172:More [Functional Concept]
   760   C0424215:Identity [Mental Process]
   760   C1519249:Sequence [Functional Concept]
   760   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "a similar tissue distribution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0040287:Tissue Distribution [Quantitative Concept]
   901   C0220927:tissue distribution [Functional Concept]
   827   C0040300:Tissue [Tissue]
   827   C0520511:distribution [Idea or Concept]
   827   C1547928:Tissue [Intellectual Product]
   827   C1704711:Distribution [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.25: Both TOP and neurolysin hydrolyze only short peptides, generally less than 20 residues in length, and they recognize cleavage sequences that vary widely, with no consistent preferences at any position relative to the site of hydrolysis (1, 19, 20, 40, 42). 

Phrase: "Both TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "hydrolyze"

Phrase: "only short peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "generally less than 20 residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "in length,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "they"

Phrase: "recognize"

Phrase: "cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "vary"

Phrase: "widely,"

Phrase: "with no consistent preferences"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0558295:Preferences [Idea or Concept]
   827 E C1549513:Preference [Idea or Concept]

Phrase: "at any position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]
   928 E C0240795:POSITIONAL [Finding]

Phrase: "relative to the site of hydrolysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "19,"

Phrase: "20,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.26: TOP and neurolysin cleave most bioactive or synthetic peptides at the same peptide bond, as might be expected from their high level of sequence similarity. 

Phrase: "TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "cleave"

Phrase: "most bioactive"

Phrase: "or"

Phrase: "synthetic peptides at the same peptide bond,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0678595:peptide bond [Natural Phenomenon or Process]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C1883254:synthetic [Activity]
   745   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]

Phrase: "as"

Phrase: "might"

Phrase: "be"

Phrase: "expected from their high level of sequence similarity."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C1710052:Sequence Similarity [Quantitative Concept]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0205250:High [Qualitative Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1299351:High [Qualitative Concept]
   744   C1517001:Expected [Idea or Concept]
   744   C1519249:Sequence [Functional Concept]
   744   C1547707:Level [Geographic Area]
   744   C2348205:Similarity [Qualitative Concept]
   744   C2700149:HIGH [Intellectual Product]
   744   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.27: Interestingly though, the two peptidases hydrolyze some peptides at different sites (1, 19, 20, 40), and systematic studies of sequence preferences show considerable differences at positions close to the cleavage site (43-48). 

Phrase: "Interestingly"

Phrase: "though"

Phrase: ","

Phrase: "the two peptidases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0030940:Peptidases [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C1947941:Peptidase [Enzyme]

Phrase: "hydrolyze"

Phrase: "some peptides at different sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "19,"

Phrase: "20,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "systematic studies of sequence preferences"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "considerable differences at positions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "close to the cleavage site"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0010813:cleavage [Cell Function]
   760   C0205145:Site [Spatial Concept]
   760   C0587267:Close [Functional Concept]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "(43-48"

Phrase: ")."
Processing 00000000.tx.28: For example, although both enzymes play an important role in metabolizing the 13-residue neuropeptide neurotensin, TOP cleaves between Arg-8 and Arg-9, whereas neurolysin cleaves between Pro-10 and Tyr-11. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "although"

Phrase: "both enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in metabolizing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "the 13-residue neuropeptide neurotensin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   812   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaves between Arg-8"

Phrase: "and"

Phrase: "Arg-9,"

Phrase: "whereas"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "cleaves between Pro-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2987124:PRO [Intellectual Product]

Phrase: "and"

Phrase: "Tyr-11."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]
Processing 00000000.tx.29: Comparing TOP and neurolysin will, therefore, provide insight into the mechanisms for the complex substrate specificity in these enzymes, which is frequently found in other enzymes that metabolize bioactive peptides, the neuropeptidases. 

Phrase: "Comparing TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "will"

Phrase: ","

Phrase: "therefore,"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insight into the mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0233820:Insight [Mental Process]

Phrase: "for the complex substrate specificity"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0038592:Substrate Specificity [Quantitative Concept]
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   827   C1710236:Substrate [Manufactured Object]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "in these enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "found in other enzymes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0014442:Enzymes [Enzyme,Organic Chemical]
   770   C0014445:enzymes [Functional Concept]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "metabolize"

Phrase: "bioactive peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "the neuropeptidases."
Processing 00000000.tx.30: The neurolysin crystal structure (49) showed that the enzyme active site is at the bottom of a deep, narrow channel, explaining why the M3 family members are restricted to unstructured peptide substrates. 

Phrase: "The neurolysin crystal structure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   827   C0427896:Crystal [Body Substance]
   827   C0678594:Structure [Spatial Concept]
   827   C1533132:Crystal [Body Substance]
   827   C1704641:Crystal [Manufactured Object]

Phrase: "(49"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the enzyme active site"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0205681:Active Site [Functional Concept]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0205145:Site [Spatial Concept]
   827   C0205177:Active [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "is at the bottom of a deep, narrow channel,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0205125:Deep [Spatial Concept]
   742   C0205168:Narrow [Qualitative Concept]
   742   C0332463:Narrow [Spatial Concept]
   742   C0333164:Narrow [Quantitative Concept]
   742   C0439799:Channel [Spatial Concept]
   742   C1511276:Bottom [Spatial Concept]
   742   C1552825:bottom [Idea or Concept]
   742   C1706095:Channel [Conceptual Entity]

Phrase: "explaining"

Phrase: "why"

Phrase: "the M3 family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "are"

Phrase: "restricted to unstructured peptide substrates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0443288:Restricted [Functional Concept]
   726   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.31: Subsequent modeling indicated that relatively few of the residue changes between TOP and neurolysin mapped to the walls and floor of the channel, allowing identification of a small number of positions that likely mediate differences in specificity (50). 

Phrase: "Subsequent modeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0870071:Modeling [Intellectual Product,Research Activity]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that relatively"

Phrase: "few of the residue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205388:Few [Quantitative Concept]
   770   C1709915:Residue [Conceptual Entity]
   770   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "changes between TOP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "mapped to the walls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0677535:Walls [Manufactured Object]
   737   C0024779:Map [Manufactured Object]
   737   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "floor of the channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0016249:Floor [Manufactured Object]
   770   C1547707:Floor [Geographic Area]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "identification of a small number of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1300638:Identification number [Intellectual Product]
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "positions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]

Phrase: "that likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "differences in specificity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.32: Here, we present a 2.0- crystal structure of human thimet oligopeptidase. 

Phrase: "Here,"

Phrase: "we"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "a 2.0- crystal structure of human thimet oligopeptidase."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   742   C0427896:Crystal [Body Substance]
   742   C0678594:Structure [Spatial Concept]
   742   C1533132:Crystal [Body Substance]
   742   C1704641:Crystal [Manufactured Object]
Processing 00000000.tx.33: This structure validates the specificity model and provides additional insights into the basis for differences between TOP and neurolysin. 

Phrase: "This structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "validates"

Phrase: "the specificity model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "additional insights into the basis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0233820:insights [Mental Process]

Phrase: "for differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "between TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.34: The structure also allows us to evaluate biochemical data concerning regulatory modification and subcellular localization of TOP, providing a framework for further study of this important enzyme.  

Phrase: "The structure also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "biochemical data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "regulatory modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "subcellular localization of TOP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "a framework for further study of this important enzyme."
Processing 00000000.tx.35: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES  Preparation of Overexpression ConstructsThe cDNA for human thimet oligopeptidase (TOP) was obtained from an expressed sequence tag clone (clone ID 2507774, Research Genetics) and subcloned into the pET32 (Novagen) expression vector. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   874   C2825142:Experimental Result [Finding]
           Result
   758   C1274040:Result [Functional Concept]
   758   C1546471:Result [Idea or Concept]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Preparation of Overexpression ConstructsThe cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]

Phrase: "for human thimet oligopeptidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "was"

Phrase: "obtained from an expressed sequence tag clone"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   814   C0600510:Expressed Sequence Tag [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0009013:Clone [Cell]
   748   C0037293:Tag [Neoplastic Process]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0181496:Tag [Manufactured Object]
   748   C1301820:Obtained [Functional Concept]
   748   C1519249:Sequence [Functional Concept]
   748   C1522642:Clone [Tissue]
   748   C1710492:TAG [Gene or Genome]
   714 E C1706701:Obtain [Activity]

Phrase: "(clone ID 2507774,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0009013:Clone [Cell]
   827   C0600091:ID [Intellectual Product]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "Research Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: ")"

Phrase: "and"

Phrase: "subcloned into the pET32"

Phrase: "(Novagen"

Phrase: ")"

Phrase: "expression vector."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.36: A construct for expressing TOP missing the first 15 residues, disordered in the related peptidase neurolysin, was produced by PCR amplification of the full-length clone using site-specific primers. 

Phrase: "A construct for expressing TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2827421:Construct [Classification]

Phrase: "missing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1551393:Missing [Idea or Concept]
  1000   C1705492:Missing [Qualitative Concept]
  1000   C3272743:MISSING [Qualitative Concept]
   966 E C2349206:Miss [Conceptual Entity]

Phrase: "the first 15 residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "disordered in the related peptidase neurolysin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C1423943:NEUROLYSIN [Gene or Genome]
   753   C1947941:Peptidase [Enzyme]
   719   C0012634:Disorder [Disease or Syndrome]

Phrase: "was"

Phrase: "produced by PCR amplification of the full-length clone"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0009013:Clone [Cell]
   742   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0443225:Full [Qualitative Concept]
   742   C0677874:pCR [Finding]
   742   C1444754:Length [Quantitative Concept]
   742   C1517480:Amplification [Molecular Biology Research Technique]
   742   C1521871:Amplification [Phenomenon or Process]
   742   C1522642:Clone [Tissue]
   742   C1705759:Amplification [Cell or Molecular Dysfunction]
   742   C1706316:LENGTH [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "site-specific primers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0449604:site specific [Spatial Concept]
Processing 00000000.tx.37: The PCR product was subcloned into pET32a vector (TOP-N15). 

Phrase: "The PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "subcloned into pET32a vector"

Phrase: "(TOP-N15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.38: The construct was further modified (vector TOP-N15-C2S) by PCR-based mutagenesis (QuikChange, Stratagene) to produce a version of TOP with cysteines 246 and 253 replaced by serines to prevent covalent aggregation of the protein. 

Phrase: "The construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "(vector TOP-N15-C2S"

Phrase: ")"

Phrase: "by PCR-based mutagenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079866:Mutagenesis [Molecular Function]
   827   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "(QuikChange,"

Phrase: "Stratagene"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "a version of TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333052:Version [Functional Concept]
   760   C2607870:Version [Spatial Concept]

Phrase: "with cysteines 246"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "253"

Phrase: "replaced by serines to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C1299987:Replaced by [Functional Concept]
           replaced
   770   C0559956:Replaced [Functional Concept]
   737   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   737 E C1554078:Replace [Idea or Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "covalent aggregation of the protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.39: Expression and Purification of Native Human Thimet Oligopeptidase ConstructsAll TOP variants were expressed in Escherichia coli BL21(DE3)RP cells (Stratagene) to overcome poor protein production caused by differences in codon usage. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Purification of Native Human Thimet Oligopeptidase ConstructsAll TOP variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0243114:purification [Functional Concept]
   739   C1998793:Purification [Functional Concept]

Phrase: "were"

Phrase: "expressed in Escherichia coli BL21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0014834:Escherichia coli [Bacterium]
   760   C0014833:Escherichia [Bacterium]
   760   C0450615:BL21 [Body Location or Region]

Phrase: "(DE3"

Phrase: ")"

Phrase: "RP cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "poor protein production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "caused by differences"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in codon usage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457083:Usage [Functional Concept]
Processing 00000000.tx.40: Cells were grown in Terrific Broth media at 37 C to an A600 of 0.6, and transcription was induced by adding 1 mM isopropyl-1-thio--D-galactopyranoside to the culture after lowering the growth temperature to 16 C to maintain protein solubility. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in Terrific Broth media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "at 37 C"

Phrase: "to an A600"

Phrase: "of 0.6,"

Phrase: "and"

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "was"

Phrase: "induced by adding 1 mM isopropyl-1-thio"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1418486:MM-1 [Gene or Genome]
   754   C0945818:Add 1 [Quantitative Concept]
   744   C0205263:Induced [Functional Concept]
   744   C1412102:THIO [Gene or Genome]
   744   C2945717:isopropyl [Chemical Viewed Structurally]
   711   C1883712:Add [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "galactopyranoside to the culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016945:Galactopyranoside [Biologically Active Substance,Carbohydrate]

Phrase: "after lowering"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441994:lowering [Spatial Concept]
  1000   C2003888:Lowering [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "the growth temperature to 16 C to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0005903:temperature [Organism Attribute]
   748   C0039476:*Temperature [Quantitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "protein solubility."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0037628:Solubility [Qualitative Concept]
   789 E C1749467:soluble [Cell Component]
   789 E C1948047:Soluble [Qualitative Concept]
Processing 00000000.tx.41: After 6 h, cells were centrifuged and lysed, and TOP was purified by metal affinity chromatography using nickel nitrilotriacetic acid beads (Qiagen). 

Phrase: "After 6 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "and"

Phrase: "lysed,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "purified by metal affinity chromatography"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0008551:Chromatography, Affinity [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0025552:Metal [Inorganic Chemical]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1998793:Purified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nickel nitrilotriacetic acid beads"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]
   756   C0256984:nickel nitrilotriacetic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Qiagen"

Phrase: ")."
Processing 00000000.tx.42: The protein was eluted from the beads by incubation with enterokinase (Invitrogen) to cleave it from the polyhistidine-containing N-terminal fusion sequence. 

Phrase: "The protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "eluted from the beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0991566:Beads [Biomedical or Dental Material]
   737 E C2346972:Bead [Spatial Concept]

Phrase: "by incubation"

Phrase: "with enterokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014366:Enterokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418973:ENTEROKINASE [Gene or Genome]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "it from the polyhistidine-containing N-terminal fusion sequence."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0071590:poly-histidine [Amino Acid, Peptide, or Protein]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C0205088:Terminal [Temporal Concept]
   742   C0332256:Containing [Functional Concept]
   742   C0332466:Fusion [Functional Concept]
   742   C1293131:Fusion [Therapeutic or Preventive Procedure]
   742   C1519249:Sequence [Functional Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C2700400:Containing [Activity]
Processing 00000000.tx.43: Purified TOP constructs were dialyzed against 50 mM Tris, pH 8.0, containing 1 mM -mercaptoethanol and 1% glycerol and then concentrated for crystallization trials. 

Phrase: "Purified TOP constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "dialyzed against 50 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mM -mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "and"

Phrase: "1% glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "concentrated for crystallization trials."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0010423:Crystallization [Natural Phenomenon or Process]
   770   C1880165:Concentrated [Biomedical or Dental Material]
   737   C0008976:Trial [Research Activity]
   737 E C1880310:Concentrate [Manufactured Object]
   737 E C2003864:Concentrate [Substance]
Processing 00000000.tx.44: The activities of the purified constructs were determined by monitoring cleavage of a fluorogenic peptide substrate with the sequence of the 13-residue peptide neurotensin. 

Phrase: "The activities of the purified constructs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "determined by monitoring cleavage of a fluorogenic peptide substrate"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C0016349:Fluorogenic Substrate [Indicator, Reagent, or Diagnostic Aid]
   742   C0010813:cleavage [Cell Function]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0150369:Monitoring [Health Care Activity]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]
   742   C1516647:monitoring [Research Activity]
   742   C1710236:Substrate [Manufactured Object]

Phrase: "with the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "of the 13-residue peptide neurotensin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   812   C1417869:NEUROTENSIN [Gene or Genome]
Processing 00000000.tx.45: Crystallization of Thimet OligopeptidaseModified human thimet oligopeptidase was crystallized by hanging drop vapor diffusion (51) at 4 C. 

Phrase: "Crystallization of Thimet OligopeptidaseModified human thimet oligopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0010423:Crystallization [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "crystallized by hanging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444626:Crystallized [Chemical Viewed Structurally]
   790   C0544691:Hanging [Injury or Poisoning]

Phrase: "drop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1321095:Drop [Quantitative Concept]
  1000   C1705648:Drop [Activity]
  1000   C2347093:Drop [Quantitative Concept]
  1000   C2348338:Drop [Quantitative Concept]

Phrase: "vapor diffusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012222:Diffusion [Natural Phenomenon or Process]
   861   C1696141:Diffusion [Functional Concept]

Phrase: "(51"

Phrase: ")"

Phrase: "at 4 C."
Processing 00000000.tx.46: The best crystals were grown in 13% polyethylene glycol 6000, 100 mM sodium cacodylate, pH 6.5, and 25 mM magnesium acetate beginning with protein at a concentration of 10 mg/ml. 

Phrase: "The best crystals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0427896:Crystals [Body Substance]
   861   C0444626:Crystals [Chemical Viewed Structurally]
   861   C1378554:Crystals [Biomedical or Dental Material]
   861   C1533132:Crystals [Body Substance]
   861   C2699477:Crystals [Laboratory Procedure]
   827 E C1704641:Crystal [Manufactured Object]

Phrase: "were"

Phrase: "grown in 13% polyethylene glycol 6000,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0030775:Polyethylene Glycol 6000 [Organic Chemical,Pharmacologic Substance]
   790   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   753   C0017945:Glycol [Organic Chemical]
   753   C0017951:Glycol [Organic Chemical]
   753   C0032487:polyethylene [Biomedical or Dental Material,Organic Chemical]
   753   C0137914:Polyethylene [Biomedical or Dental Material,Organic Chemical]
   753   C0752345:Polyethylene [Biomedical or Dental Material,Organic Chemical]

Phrase: "100 mM sodium cacodylate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0300984:Sodium cacodylate [Organic Chemical]
   812   C0282083:Cacodylate [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "pH 6.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "25 mM magnesium acetate beginning with protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439659:Beginning [Temporal Concept]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 10 mg/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.47: Crystals typically grew to 0.25 x 0.1 x 0.03 mm. 

Phrase: "Crystals typically"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0427896:Crystals [Body Substance]
   861   C0444626:Crystals [Chemical Viewed Structurally]
   861   C1378554:Crystals [Biomedical or Dental Material]
   861   C1533132:Crystals [Body Substance]
   861   C2699477:Crystals [Laboratory Procedure]
   827 E C1704641:Crystal [Manufactured Object]

Phrase: "grew"

Phrase: "to 0.25 x 0.1 x 0.03 mm."
Processing 00000000.tx.48: They were prepared for data collection by transfer to a solution containing 25% glycerol, 20% polyethylene glycol 6000, 100 mM sodium cacodylate, pH 6.5, and 25 mM magnesium acetate for 10 s, mounting in a nylon loop, and plunging into liquid nitrogen (52). 

Phrase: "They"

Phrase: "were"

Phrase: "prepared for data collection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0010995:Data Collection [Research Activity]
   770   C1511726:Data [Idea or Concept]
   770   C1516698:Collection [Functional Concept]
   770   C1704814:Collection [Idea or Concept]
   770   C3245479:data [Medical Device]
   737   C1521827:Prepare [Functional Concept]

Phrase: "by transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]

Phrase: "to a solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "25% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "20% polyethylene glycol 6000,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0030775:Polyethylene Glycol 6000 [Organic Chemical,Pharmacologic Substance]
   861   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   812   C0017945:Glycol [Organic Chemical]
   812   C0017951:Glycol [Organic Chemical]
   812   C0032487:polyethylene [Biomedical or Dental Material,Organic Chemical]
   812   C0137914:Polyethylene [Biomedical or Dental Material,Organic Chemical]
   812   C0752345:Polyethylene [Biomedical or Dental Material,Organic Chemical]

Phrase: "100 mM sodium cacodylate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0300984:Sodium cacodylate [Organic Chemical]
   812   C0282083:Cacodylate [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "pH 6.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "25 mM magnesium acetate for 10 s,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0982266:magnesium acetate [Organic Chemical,Pharmacologic Substance]
   748   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "mounting in a nylon loop,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   760   C0419518:Loop [Medical Device]
   760   C0445022:Loop [Spatial Concept]
   760   C0740034:Nylon [Biomedical or Dental Material]
   726   C0181909:Mount [Medical Device]
   726   C0449878:mount [Finding]

Phrase: "and"

Phrase: "plunging into liquid nitrogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1882408:PLUNGE [Phenomenon or Process]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.49: Data Collection and Structure DeterminationX-ray data were collected at the Advanced Photon Source beamline 22-ID (Southeast Regional Collaborative Access Team), Argonne National Laboratory. 

Phrase: "Data Collection"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0010995:Data Collection [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   861   C3245479:data [Medical Device]
   789 E C1516695:Collected [Idea or Concept]

Phrase: "and"

Phrase: "Structure DeterminationX-ray data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "at the Advanced Photon Source beamline 22-ID (Southeast Regional Collaborative Access Team"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0871489:Team [Group]

Phrase: ")"

Phrase: ","

Phrase: "Argonne National Laboratory."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022877:Laboratory [Manufactured Object,Organization]
   827   C3244292:laboratory [Functional Concept]
Processing 00000000.tx.50: Data were reduced with HKL2000 (53). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "reduced with HKL2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.51: The space group of the crystals is P212121 with unit cell dimensions of a = 77.17 , b = 99.1 , c = 105.5 . Initial phases were determined by molecular replacement with the CNS software package (54) using neurolysin (Protein Data Bank code 1I1I [PDB] ) as a search object. 

Phrase: "The space group of the crystals"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1883067:Space [Spatial Concept]

Phrase: "is"

Phrase: "P212121 with unit cell dimensions of a = 77.17 ,"

Phrase: "b = 99.1 ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347469:/B [Quantitative Concept]

Phrase: "c = 105.5 . Initial phases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0585064:Phases [Temporal Concept]
   804   C1067936:Phasis [Eukaryote]
   771 E C0205390:Phase [Temporal Concept]

Phrase: "were"

Phrase: "determined by molecular replacement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035139:Replacement [Therapeutic or Preventive Procedure]
   770   C0559956:Replacement [Functional Concept]
   770   C1521991:Molecular [Qualitative Concept]
   770   C1555302:Replacement [Idea or Concept]

Phrase: "with the CNS software package"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013194:Package [Medical Device]
   827   C2700580:Package [Manufactured Object]

Phrase: "(54"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "(Protein Data Bank code 1I1I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C1705318:Protein Data Bank [Intellectual Product]

Phrase: "[PDB] ) as a search object."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0029401:PDB [Disease or Syndrome]
   760   C0048243:PDB [Hazardous or Poisonous Substance,Organic Chemical]
   760   C1705318:PDB [Intellectual Product]
Processing 00000000.tx.52: Model building and analysis were done using the program O (55), and structure refinements was carried out in CNS.  

Phrase: "Model building"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547706:Building [Functional Concept]
   861   C1999269:Building [Manufactured Object]

Phrase: "and"

Phrase: "analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "done"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the program O (55"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0450382:55 [Intellectual Product]
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "structure refinements"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in CNS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.53: RESULTS AND DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES  Overview of the Structure and Comparison with NeurolysinWe have determined the crystal structure of recombinant human TOP at 2.0- resolution (Table I). 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2825142:Experimental Result [Finding]
           Result
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Overview of the Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0814812:overview [Intellectual Product]

Phrase: "and"

Phrase: "Comparison with NeurolysinWe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "have"

Phrase: "determined"

Phrase: "the crystal structure of recombinant human TOP at 2.0- resolution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   736   C0427896:Crystal [Body Substance]
   736   C0678594:Structure [Spatial Concept]
   736   C1533132:Crystal [Body Substance]
   736   C1704641:Crystal [Manufactured Object]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.54: To obtain crystals, we used a modified version of thimet oligopeptidase, which begins at residue 16 and has residues 246 and 253 mutated from cysteine to serine. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "crystals,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0427896:Crystals [Body Substance]
  1000   C0444626:Crystals [Chemical Viewed Structurally]
  1000   C1378554:Crystals [Biomedical or Dental Material]
  1000   C1533132:Crystals [Body Substance]
  1000   C2699477:Crystals [Laboratory Procedure]
   966 E C1704641:Crystal [Manufactured Object]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a modified version of thimet oligopeptidase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "which"

Phrase: "begins at residue 16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439659:Begin [Temporal Concept]
   770   C1709915:Residue [Conceptual Entity]
   770   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "has"

Phrase: "residues 246"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "253"

Phrase: "mutated from cysteine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]

Phrase: "to serine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.55: The N terminus was removed because the corresponding residues of the closely related neurolysin were disordered in the crystal structure (49), and the cysteines were mutated to prevent covalent oligomerization of the enzyme (35). 

Phrase: "The N terminus"

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "because"

Phrase: "the corresponding residues of the closely related neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "were"

Phrase: "disordered in the crystal structure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   760   C0427896:Crystal [Body Substance]
   760   C0678594:Structure [Spatial Concept]
   760   C1533132:Crystal [Body Substance]
   760   C1704641:Crystal [Manufactured Object]
   726   C0012634:Disorder [Disease or Syndrome]

Phrase: "(49"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the cysteines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "covalent oligomerization of the enzyme"

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.56: Full-length native thimet oligopeptidase (both human and rat orthologs) did not crystallize despite extensive screening. 

Phrase: "Full-length native thimet oligopeptidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "both human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "rat orthologs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1335144:Ortholog [Gene or Genome]
   777 E C1709346:Orthologous [Qualitative Concept]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "crystallize despite extensive screening."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205231:Extensive [Qualitative Concept]
   770   C0220908:Screening [Health Care Activity]
   770   C0220909:screening [Functional Concept]
   770   C1698960:screening [Intellectual Product]
   770   C1710031:Screening [Diagnostic Procedure]
   770   C1710477:SCREENING [Research Activity]
Processing 00000000.tx.57: As expected, the modified recombinant thimet oligopeptidase had activity similar to native full-length enzyme (data not shown). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the modified recombinant thimet oligopeptidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "had"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "similar to native full-length enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.58: View this table: [in this window] [in a new window]  TABLE I Summary of crystallographic data and refinement  TOP is composed of 24 helices and 9 short strands (Fig. 1A). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE I Summary of crystallographic data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552616:summary [Intellectual Product]
   753   C1706244:Summary [Intellectual Product]

Phrase: "and"

Phrase: "refinement  TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "composed of 24 helices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0018882:Helix [Eukaryote]
   770   C0229304:Helix [Body Part, Organ, or Organ Component]
   770   C1017315:helices [Eukaryote]
   770   C1704821:Helix [Spatial Concept]
   770   C1705682:Helix [Anatomical Structure]

Phrase: "and"

Phrase: "9 short strands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1704972:Strand [Spatial Concept]
   793   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.59: A deep narrow channel, open at one end but closed off by helices 3-6 at the other, runs the length of the enzyme, dividing it into two distinct domains (I and II). 

Phrase: "A deep narrow channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "open at one end"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0175566:Open [Spatial Concept]
   770   C0205447:One [Quantitative Concept]
   770   C0444930:End [Spatial Concept]
   770   C2746065:End [Temporal Concept]
   715 E C0205088:Terminal [Temporal Concept]
   715 E C1705314:Terminal [Manufactured Object]
   715 E C1705315:Terminal [Spatial Concept]

Phrase: "but"

Phrase: "closed off"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0587267:Closed [Functional Concept]

Phrase: "by helices 3-6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0018882:Helix [Eukaryote]
   827   C0229304:Helix [Body Part, Organ, or Organ Component]
   827   C1017315:helices [Eukaryote]
   827   C1704821:Helix [Spatial Concept]
   827   C1705682:Helix [Anatomical Structure]

Phrase: "at the"

Phrase: "other,"

Phrase: "runs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:Runs [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "the length of the enzyme,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1444754:Length [Quantitative Concept]
   760   C1706316:LENGTH [Research Activity]

Phrase: "dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:dividing [Functional Concept]

Phrase: "it into two distinct domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205448:Two [Quantitative Concept]
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "(I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II"

Phrase: ")."
Processing 00000000.tx.60: The active site is located at the bottom of the channel about midway along its length, and the zinc ion cofactor is present at high occupancy (refined at full occupancy with a final thermal factor of 16.98 2) in the crystal structure. 

Phrase: "The active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "located at the bottom of the channel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439799:Channel [Spatial Concept]
   748   C1511276:Bottom [Spatial Concept]
   748   C1552825:bottom [Idea or Concept]
   748   C1706095:Channel [Conceptual Entity]

Phrase: "about midway"

Phrase: "along its length,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "the zinc ion cofactor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0178555:Cofactor [Biologically Active Substance]

Phrase: "is"

Phrase: "present at high occupancy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "("

Phrase: "refined at full occupancy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0443225:Full [Qualitative Concept]
   770   C2827063:Occupancy [Qualitative Concept]

Phrase: "with a final thermal factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "of 16.98 2"

Phrase: ")"

Phrase: "in the crystal structure."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   861   C0427896:Crystal [Body Substance]
   861   C0678594:Structure [Spatial Concept]
   861   C1533132:Crystal [Body Substance]
   861   C1704641:Crystal [Manufactured Object]
Processing 00000000.tx.61: This overall fold was first seen in neurolysin (49) and is likely conserved within the entire M3 metallopeptidase family (2), which has a total of nine members including TOP and neurolysin. 

Phrase: "This overall fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "seen in neurolysin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1423943:NEUROLYSIN [Gene or Genome]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "(49"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "conserved within the entire M3 metallopeptidase family"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0015576:Family [Family Group]
   748   C0025543:Metallopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439751:Entire [Quantitative Concept]
   748   C0444667:Entire [Quantitative Concept]
   748   C1300554:m3 [Quantitative Concept]
   748   C1704727:Family [Conceptual Entity]
   748   C3484373:M3 [Intellectual Product]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "has"

Phrase: "a total of nine members"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.62: Surprisingly, however, this fold has also been found recently in angiotensin-converting enzyme (56, 57) and Pyrococcus furiosus carboxypeptidase (58), metallopeptidases that were not thought to be closely related to the M3 family based on sequence comparisons. 

Phrase: "Surprisingly,"

Phrase: "however,"

Phrase: "this fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Fold [Spatial Concept]
  1000   C1880834:FOLD [Phenomenon or Process]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "recently in angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   760   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0332185:Recently [Temporal Concept]

Phrase: "(56,"

Phrase: "57"

Phrase: ")"

Phrase: "and"

Phrase: "Pyrococcus furiosus carboxypeptidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0007075:Carboxypeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3265462:Carboxypeptidase [Pharmacologic Substance]
   734   C0600435:Pyrococcus furiosus [Archaeon]

Phrase: "(58"

Phrase: ")"

Phrase: ","

Phrase: "metallopeptidases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metallopeptidases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "closely"

Phrase: "related to the M3 family"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0015576:Family [Family Group]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1300554:m3 [Quantitative Concept]
   760   C1704727:Family [Conceptual Entity]
   760   C3484373:M3 [Intellectual Product]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "based on sequence comparisons."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   802   C0004793:Base Sequence [Nucleotide Sequence]
           Sequence
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1707455:Comparison [Activity]
   737 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.63: Residues 16-24 of the TOP construct are disordered in the crystals, with no identifiable electron density, suggesting that even more of the N terminus than in neurolysin is disordered or that removing the first 16 residues caused adjacent residues to lose conformational stability. 

Phrase: "Residues 16-24 of the TOP construct"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C2827421:Construct [Classification]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "are"

Phrase: "disordered in the crystals,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0427896:Crystals [Body Substance]
   770   C0444626:Crystals [Chemical Viewed Structurally]
   770   C1378554:Crystals [Biomedical or Dental Material]
   770   C1533132:Crystals [Body Substance]
   770   C2699477:Crystals [Laboratory Procedure]
   737   C0012634:Disorder [Disease or Syndrome]
   737 E C1704641:Crystal [Manufactured Object]

Phrase: "with no identifiable electron density,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0596488:electron density [Molecular Sequence]
   827   C0013852:Electron [Quantitative Concept]
   827   C0178587:density [Quantitative Concept]
   827   C3463986:Electron [Bird]
   755 E C0013850:Electronic [Manufactured Object]
   755 E C0439794:Dense [Qualitative Concept]
   755 E C1547561:Electronic [Idea or Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that even more of the N terminus"

Phrase: "than"

Phrase: "in neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "is"

Phrase: "disordered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0012634:Disorder [Disease or Syndrome]

Phrase: "or"

Phrase: "that removing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0849355:remove [Qualitative Concept]
   966   C1883720:Remove [Activity]
   966   C3244314:remove [Functional Concept]

Phrase: "the first 16 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "adjacent residues to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   746   C0205117:Adjacent to [Spatial Concept]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "lose"

Phrase: "conformational stability."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]
Processing 00000000.tx.64: View larger version (88K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(88K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.65: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.66: Overview of the thimet oligopeptidase structure and active site density. 

Phrase: "Overview of the thimet oligopeptidase structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0814812:overview [Intellectual Product]

Phrase: "and"

Phrase: "active site density."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0178587:density [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]
   734   C0205681:Active Site [Functional Concept]
Processing 00000000.tx.67: A, stereo ribbon diagram of thimet oligopeptidase. 

Phrase: "A,"

Phrase: "stereo ribbon diagram of thimet oligopeptidase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681494:Diagram [Intellectual Product]
Processing 00000000.tx.68: Individual helices and strands are numbered, and the region structurally similar to other zinc metallopeptidases is in gold. 

Phrase: "Individual helices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1017315:helices [Eukaryote]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "and"

Phrase: "strands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1704972:Strand [Spatial Concept]
   966   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "numbered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbered [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "structurally similar to other zinc metallopeptidases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "is in gold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C1304897:Gold [Functional Concept]
Processing 00000000.tx.69: The active site zinc is shown as a blue sphere. 

Phrase: "The active site zinc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C2348288:Zinc [Element, Ion, or Isotope]
   734   C0205681:Active Site [Functional Concept]

Phrase: "is"

Phrase: "shown as a blue sphere."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332501:Sphere [Spatial Concept]
   760   C0946401:Sphere [Organism Attribute]
   760   C1260957:Blue [Qualitative Concept]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.70: All molecular figures were created using RIBBONS (71) unless otherwise indicated. 

Phrase: "All molecular figures"

Phrase: "were"

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RIBBONS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709956:Ribbon [Medical Device]
   966   C3541837:ribbon [Cell Component]

Phrase: "(71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: "unless"

Phrase: "otherwise"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.71: B, active site of thimet oligopeptidase. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "active site of thimet oligopeptidase."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0205681:Active Site [Functional Concept]
   806   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C0205177:Active [Functional Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
Processing 00000000.tx.72: Density (2 Fo - Fc) is shown in wire-frame representation at a contour level of 0.8 r.m.s.d. of the map. 

Phrase: "Density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "(2 Fo - Fc)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2983605:FC [Activity]

Phrase: "is"

Phrase: "shown in wire-frame representation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0005978:Wire [Medical Device]
   760   C0080089:Frame [Nucleotide Sequence]
   760   C0180979:Frame [Medical Device]
   760   C1514861:Representation [Conceptual Entity]
   760   C1705105:Wire [Manufactured Object]
   760   C1705858:Frame [Manufactured Object]
   760   C1882932:Representation [Activity]
   726   C1547282:Show [Intellectual Product]

Phrase: "at a contour level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "of 0.8 r.m.s.d."

Phrase: "of the map."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.73: Key residues of the HEXXH sequence motif are marked along with the third zinc ligand from the protein, Glu-502. 

Phrase: "Key residues of the HEXXH sequence motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "are"

Phrase: "marked along with the third zinc ligand"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0023688:Ligand [Chemical]
   748   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0205437:Third [Quantitative Concept]
   748   C0522501:Marked [Qualitative Concept]
   748   C1706089:Marked [Qualitative Concept]
   748   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "from the protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Glu-502."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.74: The active site zinc ion and catalytic water molecule are shown as blue and red spheres, respectively. 

Phrase: "The active site zinc ion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022023:Ion [Element, Ion, or Isotope]
   812   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "catalytic water molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "are"

Phrase: "shown as blue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1260957:Blue [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "red spheres,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0946401:spheres [Organism Attribute]
   827 E C0332501:Sphere [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.75: The image was produced with Swiss-PDBViewer (72).  

Phrase: "The image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1704254:Image [Intellectual Product]
  1000   C1704922:Image [Entity]
  1000   C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "produced with Swiss-PDBViewer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0241315:Swiss [Population Group]

Phrase: "(72"

Phrase: ")."
Processing 00000000.tx.76: The active site of TOP contains an HEXXH sequence motif characteristic of a large class of zinc metallopeptidases (2). 

Phrase: "The active site of TOP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0205681:Active Site [Functional Concept]
   790   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C0205177:Active [Functional Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an HEXXH sequence motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "characteristic of a large class of zinc metallopeptidases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1521970:Characteristic [Qualitative Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.77: As in other metallopeptidases of this type, the two histidines (residues 473 and 477) in the TOP sequence coordinate the zinc ion cofactor (Fig. 1B). 

Phrase: "As in other metallopeptidases of this type,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025543:Metallopeptidases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "the two histidines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(residues 473"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "477"

Phrase: ")"

Phrase: "in the TOP sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]
   734   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "coordinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0427184:coordinate [Finding]
  1000   C0700114:coordinate [Functional Concept]
  1000   C1707511:Coordinate [Spatial Concept]

Phrase: "the zinc ion cofactor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0178555:Cofactor [Biologically Active Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.78: The side chain of a downstream glutamate (Glu-502) from helix 16 serves as the third zinc ligand contributed by the protein, a characteristic of enzymes grouped into metallopeptidase clan MA (2). 

Phrase: "The side chain of a downstream glutamate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0337112:Chain [Manufactured Object]
   748   C0441987:Side [Spatial Concept]
   748   C1524075:Chain [Idea or Concept]

Phrase: "(Glu-502"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "from helix 16"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "serves as the third zinc ligand"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0023688:Ligand [Chemical]
   753   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0205437:Third [Quantitative Concept]
   753   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "contributed by the protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C1880177:Contribute [Activity]

Phrase: "a characteristic of enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristic [Qualitative Concept]

Phrase: "grouped into metallopeptidase clan MA (2"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   790   C0612672:MA-2 [Organic Chemical]
   767   C0441865:Group 2 [Intellectual Product]
   753   C0025543:Metallopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439745:Grouped [Spatial Concept]
   753   C1826433:CLAN [Gene or Genome]
   719 E C0441833:Group [Idea or Concept]
   719 E C0687744:group [Population Group]
   719 E C1257890:Group [Population Group]
   719 E C1552516:Group [Health Care Related Organization]
   719 E C1705428:Group [Conceptual Entity]
   719 E C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.79: The glutamate residue of the HEXXH motif is believed to play an important role in the reaction mechanism, polarizing and orienting a zinc-coordinating water molecule that is the attacking nucleophile (59). 

Phrase: "The glutamate residue of the HEXXH motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the reaction mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "polarizing"

Phrase: "and"

Phrase: "orienting"

Phrase: "a zinc-coordinating water molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:Molecule [Substance]
   741 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "the attacking nucleophile"

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.80: In TOP, the water molecule coordinating the zinc is well defined by the density, and the glutamate (Glu-474) makes the expected hydrogen bonds with this water (Fig. 1B). 

Phrase: "In TOP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the water molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "coordinating"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0427184:coordinating [Finding]
  1000   C0700114:Coordinating [Functional Concept]
   966 E C1707511:Coordinate [Spatial Concept]

Phrase: "the zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "well defined by the density,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0442825:Well defined [Qualitative Concept]
   760   C0205170:Well [Qualitative Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3146287:Well [Manufactured Object]
   760   C3539106:Defined [Intellectual Product]

Phrase: "and"

Phrase: "the glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Glu-474"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the expected hydrogen bonds with this water"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0020276:bonds hydrogen [Natural Phenomenon or Process]
   748   C0020275:Hydrogen [Element, Ion, or Isotope]
   748   C0523702:HYDROGEN [Laboratory Procedure]
   748   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.81: The active site is contained within a region of the enzyme that has strong structural similarity to the active site regions of other clan MA metallopeptidases (see Fig. 1A), including the prototypical group member thermolysin (60). 

Phrase: "The active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "contained within a region of the enzyme"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C0332256:contained [Functional Concept]
   748   C2700400:Contained [Activity]

Phrase: "that"

Phrase: "has"

Phrase: "strong structural similarity to the active site regions of other clan MA metallopeptidases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C2348205:Similarity [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the prototypical group member thermolysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0039815:Thermolysin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.82: Neurolysin is the closest homolog of thimet oligopeptidase in the M3 metallopeptidase family (Fig. 2), and as noted, TOP and neurolysin (49) adopt the same overall fold. 

Phrase: "Neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "is"

Phrase: "the closest homolog of thimet oligopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1334043:Homolog [Gene or Genome]

Phrase: "in the M3 metallopeptidase family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "as"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "(49"

Phrase: ")"

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "the same overall fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.83: Superposition of the two enzymes on C atoms (Fig. 3) yields an overall root mean square deviation (r.m.s.d.) of only 1.19 , indicating a high degree of structural conservation. 

Phrase: "Superposition of the two enzymes"

Phrase: "on C atoms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567415:Atoms [Element, Ion, or Isotope]
   827 E C1706222:Atom [Conceptual Entity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "yields"

Phrase: "an overall root mean square deviation"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   884   C2347976:Root Mean Square [Quantitative Concept]
   853   C1828170:Mean deviation [Clinical Attribute]
   804   C0012727:Deviation [Spatial Concept]
   804   C0040452:Root [Body Part, Organ, or Organ Component]
   804   C0205120:Square [Spatial Concept]
   804   C0205419:Deviation [Qualitative Concept]
   804   C0242726:Root [Plant]
   804   C0444504:Mean [Quantitative Concept]
   804   C1318154:Root [Body Part, Organ, or Organ Component]
   804   C1552595:Square [Intellectual Product]
   804   C1705236:Deviation [Finding]
   804   C1705917:Root [Idea or Concept]
   804   C2347634:Mean [Quantitative Concept]
   804   C2348143:Mean [Quantitative Concept]

Phrase: "(r.m.s.d.)"

Phrase: "of only 1.19 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205171:Only [Quantitative Concept]
   827   C1720467:Only [Intellectual Product]

Phrase: "indicating"

Phrase: "a high degree of structural conservation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.84: The backbones superimpose particularly well in the closed end and the floor of the channel. 

Phrase: "The backbones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037949:backbones [Body Part, Organ, or Organ Component]
   966 E C1267072:Backbone [Body Part, Organ, or Organ Component]

Phrase: "superimpose"

Phrase: "particularly well in the closed end"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205170:Well [Qualitative Concept]
   753   C0444930:End [Spatial Concept]
   753   C0587267:Closed [Functional Concept]
   753   C2746065:End [Temporal Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "the floor of the channel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0016249:Floor [Manufactured Object]
   760   C1547707:Floor [Geographic Area]
Processing 00000000.tx.85: At the open end and near the top of the channel, however, the elements in TOP are displaced outward relative to the corresponding elements in neurolysin (Fig. 3), widening the channel. 

Phrase: "At the open end"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0175566:Open [Spatial Concept]
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]
   789 E C0547049:Openness [Spatial Concept]

Phrase: "and near the top of the channel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439799:Channel [Spatial Concept]
   748   C1515981:And [Idea or Concept]
   748   C1704458:Top [Spatial Concept]
   748   C1706095:Channel [Conceptual Entity]

Phrase: "however,"

Phrase: "the elements in TOP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0013879:Elements [Element, Ion, or Isotope]
   726 E C1705248:Element [Conceptual Entity]

Phrase: "are"

Phrase: "displaced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012727:Displaced [Spatial Concept]

Phrase: "outward relative to the corresponding elements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "in neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "widening"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332464:Widening [Spatial Concept]

Phrase: "the channel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.86: To some extent, this difference results from a hinge-like motion of the two domains about an axis located in the floor of the channel and running parallel to the long axis of the molecule. 

Phrase: "To some extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]

Phrase: "this difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "results from a hinge-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0457406:Hinge [Medical Device]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1706053:Hinge [Medical Device]
   770   C2825142:Result [Finding]

Phrase: "like motion"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0026597:Motion [Natural Phenomenon or Process]
   944 E C0022702:kinetic [Natural Phenomenon or Process]
   916 E C0687704:Motions [Functional Concept]
   907 E C0022699:Kineses [Individual Behavior]

Phrase: "of the two domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "about an axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0004457:Axis [Body Part, Organ, or Organ Component]
  1000   C0999597:Axis [Mammal]
  1000   C1522496:Axis [Spatial Concept]

Phrase: "located in the floor of the channel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0016249:Floor [Manufactured Object]
   748   C0439799:Channel [Spatial Concept]
   748   C1547707:Floor [Geographic Area]
   748   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "running parallel to the long axis of the molecule."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C2348042:Parallel [Qualitative Concept]
   742   C2826345:PARALLEL [Research Activity]
Processing 00000000.tx.87: We have observed this hinge-like motion when comparing different crystal packings of neurolysin,2 and it is likely that here it also reflects the effect of packing environment on the relatively flexible channel walls in the two molecules. 

Phrase: "We"

Phrase: "have"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "this hinge-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0457406:Hinge [Medical Device]
  1000   C1706053:Hinge [Medical Device]

Phrase: "like motion"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0026597:Motion [Natural Phenomenon or Process]
   944 E C0022702:kinetic [Natural Phenomenon or Process]
   916 E C0687704:Motions [Functional Concept]
   907 E C0022699:Kineses [Individual Behavior]

Phrase: "when"

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "different crystal packings of neurolysin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0184967:Packing [Therapeutic or Preventive Procedure]
   726   C1289829:Packing [Medical Device]
   726   C2828395:Packing [Activity]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that here"

Phrase: "it also"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the effect of packing environment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0871974:environmental effect [Natural Phenomenon or Process]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the relatively flexible channel walls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0677535:Walls [Manufactured Object]

Phrase: "in the two molecules."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.88: Elements near the open end of the channel (from the C terminus of 6 through strands 1 and 2 to the N terminus of 8 in domain I and the extended loop between 10 and 15 in domain II), however, show differences beyond the hinge-like motion, and the outward movement of these elements in TOP reflects a true conformational difference from neurolysin. 

Phrase: "Elements near the open end of the channel"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0013879:Elements [Element, Ion, or Isotope]
   711 E C1705248:Element [Conceptual Entity]

Phrase: "("

Phrase: "from the C terminus"

Phrase: "of 6"

Phrase: "through strands 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704972:Strand [Spatial Concept]
   827   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "2 to the N terminus of 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0740116:+2 [Quantitative Concept]
   748   C2827735:2+ [Quantitative Concept]
   748   C2981700:2+ [Classification]

Phrase: "in domain I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "the extended loop between 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0419518:Loop [Medical Device]
   760   C0445022:Loop [Spatial Concept]

Phrase: "and"

Phrase: "15 in domain II"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1880389:Domain [Functional Concept]
   770   C1883221:Domain [Conceptual Entity]
   770   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "however,"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "differences beyond the hinge-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "like motion,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0026597:Motion [Natural Phenomenon or Process]
   944 E C0022702:kinetic [Natural Phenomenon or Process]
   916 E C0687704:Motions [Functional Concept]
   907 E C0022699:Kineses [Individual Behavior]

Phrase: "and"

Phrase: "the outward movement of these elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0026649:Movement [Organism Function]

Phrase: "in TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a true conformational difference from neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.89: These changes would be unlikely to affect substrate specificity or catalytic activity given their location near the top of the channel. 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "substrate specificity"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0038592:Substrate Specificity [Quantitative Concept]
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   861   C1710236:Substrate [Manufactured Object]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "or"

Phrase: "catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "their location near the top of the channel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0450429:Location [Spatial Concept]
   744   C1515974:Location [Body Location or Region]
Processing 00000000.tx.90: View larger version (83K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(83K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.91: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.92: Sequence alignment of human TOP and neurolysin. 

Phrase: "Sequence alignment of human TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0080143:Sequence Alignment [Molecular Biology Research Technique]
   753   C1706765:Alignment [Quantitative Concept]

Phrase: "and"

Phrase: "neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.93: Sequence differences are highlighted in green. 

Phrase: "Sequence differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "are"

Phrase: "highlighted in green."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.94: Structural elements of TOP are shown schematically above the TOP sequence. 

Phrase: "Structural elements of TOP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0013879:Elements [Element, Ion, or Isotope]
   726 E C1705248:Element [Conceptual Entity]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "schematically above the TOP sequence."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.95: Accessible cysteines in TOP are indicated with red triangles, and a key residue difference that affects an active site loop is indicated by a red star.  

Phrase: "Accessible cysteines in TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "indicated with red triangles,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205119:triangles [Conceptual Entity]
   770   C0332575:Red [Finding]
   770   C1260956:Red [Qualitative Concept]
   770   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "a key residue difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   755 E C0443199:Differential [Qualitative Concept]

Phrase: "that"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "an active site loop"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
   734   C0205681:Active Site [Functional Concept]

Phrase: "is"

Phrase: "indicated by a red star."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0332575:Red [Finding]
   760   C1260956:Red [Qualitative Concept]
   760   C1444656:Indicated [Finding]
   704   C0995242:Stella [Bacterium]
   704   C1426084:Stella [Gene or Genome]
   704   C2986872:Stella [Gene or Genome]
Processing 00000000.tx.96: View larger version (52K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(52K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.97: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.98: Backbone superposition of TOP and neurolysin. 

Phrase: "Backbone superposition of TOP"

Phrase: "and"

Phrase: "neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.99: Stereo view of superimposed thimet oligopeptidase (blue/red) and neurolysin (gold) C traces. 

Phrase: "Stereo view of superimposed thimet oligopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449911:View [Spatial Concept]

Phrase: "(blue/red"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]
   861   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "(gold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1304897:Gold [Functional Concept]

Phrase: ")"

Phrase: "C traces."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0442822:Trace [Quantitative Concept]
   827   C1524031:Trace [Qualitative Concept]
   827   C1883002:Trace [Functional Concept]
Processing 00000000.tx.100: Elements near the open end of the channel that show the greatest conformational differences are colored red in the TOP backbone representation.  

Phrase: "Elements near the open end of the channel"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0013879:Elements [Element, Ion, or Isotope]
   711 E C1705248:Element [Conceptual Entity]

Phrase: "that"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the greatest conformational differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]

Phrase: "are"

Phrase: "colored"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0522507:colored [Qualitative Concept]
   966 E C0009393:Color [Natural Phenomenon or Process]
   966 E C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   966 E C1705245:Color [Pharmacologic Substance]

Phrase: "red in the TOP backbone representation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332575:Red [Finding]
   748   C1260956:Red [Qualitative Concept]
Processing 00000000.tx.101: Model for Substrate BindingAs in neurolysin (49), the shielding elements erected over the active site of TOP clearly account for its inability to hydrolyze large, folded substrates. 

Phrase: "Model for Substrate BindingAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: "in neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "(49"

Phrase: ")"

Phrase: ","

Phrase: "the shielding elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "erected over the active site of TOP clearly"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0205681:Active Site [Functional Concept]
   764   C2945843:Site of [Qualitative Concept]
   742   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205145:Site [Spatial Concept]
   742   C0205177:Active [Functional Concept]
   742   C0522014:erected [Functional Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "account for its inability to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1551359:account [Idea or Concept]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]

Phrase: "hydrolyze"

Phrase: "large, folded substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.102: The small oligopeptides hydrolyzed by TOP are known to be largely unstructured in solution (61, 62), and the long narrow channel leading to its active site suggests that these substrates bind in an extended conformation consistent with the known binding of peptide analogs to other metallopeptidases (63, 64). 

Phrase: "The small oligopeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028954:Oligopeptides [Amino Acid, Peptide, or Protein]

Phrase: "hydrolyzed by TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "largely unstructured in solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(61,"

Phrase: "62"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the long narrow channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "leading to its active site"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0205681:Active Site [Functional Concept]
   760   C0205145:Site [Spatial Concept]
   760   C0205177:Active [Functional Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C1515974:Site [Body Location or Region]
   760   C1522538:Leading [Functional Concept]
   760   C2825164:Site [Spatial Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "bind in an extended conformation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0026377:Conformation [Spatial Concept]
   760   C0231448:Extended [Functional Concept]
   760   C0231449:Extended [Spatial Concept]
   760   C0439792:extended [Spatial Concept]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]

Phrase: "consistent with the known binding of peptide analogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "to other metallopeptidases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metallopeptidases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(63,"

Phrase: "64"

Phrase: ")."
Processing 00000000.tx.103: We modeled the 13 residue peptide neurotensin into the TOP channel in a manner similar to our previous work on neurolysin (49, 50). 

Phrase: "We"

Phrase: "modeled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3161035:Model [Intellectual Product]

Phrase: "the 13 residue peptide neurotensin into the TOP channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   739   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "in a manner"

Phrase: "similar to our previous work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "on neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "(49,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.104: Because TOP cleaves neurotensin between Arg-8 and Arg-9, we positioned the carbonyl carbon of Arg-8 to coordinate with the active site zinc, and the N terminus of the peptide was oriented toward the closed end of the channel based on the binding orientation seen in other metallopeptidases with structurally similar active sites (63, 64). 

Phrase: "Because"

Phrase: "TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaves"

Phrase: "neurotensin between Arg-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   770   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "and"

Phrase: "Arg-9,"

Phrase: "we"

Phrase: "positioned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0733755:Position [Spatial Concept]

Phrase: "the carbonyl carbon of Arg-8 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0007009:Carbon [Element, Ion, or Isotope]

Phrase: "coordinate with the active site zinc,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0205681:Active Site [Functional Concept]
   753   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0205145:Site [Spatial Concept]
   753   C0205177:Active [Functional Concept]
   753   C0427184:coordinate [Finding]
   753   C0700114:coordinate [Functional Concept]
   753   C1515974:Site [Body Location or Region]
   753   C1707511:Coordinate [Spatial Concept]
   753   C2348288:Zinc [Element, Ion, or Isotope]
   753   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "the N terminus of the peptide"

Phrase: "was"

Phrase: "oriented toward the closed end of the channel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0439799:Channel [Spatial Concept]
   744   C0444930:End [Spatial Concept]
   744   C0587267:Closed [Functional Concept]
   744   C1704322:Oriented [Spatial Concept]
   744   C1706095:Channel [Conceptual Entity]
   744   C2746065:End [Temporal Concept]

Phrase: "based on the binding orientation"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0029266:Orientation [Mental Process]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1527178:Based [Functional Concept]
   760   C1704322:orientation [Spatial Concept]
   760   C1704972:Orientation [Spatial Concept]
   760   C1705938:Based [Idea or Concept]
   760   C3539923:Orientation [Intellectual Product]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "seen in other metallopeptidases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0025543:Metallopeptidases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "with structurally similar active sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0205681:Sites, Active [Functional Concept]
   812   C0205145:Sites [Spatial Concept]
   812   C0205177:Active [Functional Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "(63,"

Phrase: "64"

Phrase: ")."
Processing 00000000.tx.105: The peptide was adjusted to lie along strand 7, making antiparallel sheet-like interactions with the main chain, and individual residues were placed to make plausible interactions with the protein surface. 

Phrase: "The peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lie along strand 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704972:Strand [Spatial Concept]
   770   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "antiparallel sheet-like interactions with the main chain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "individual residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "placed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0442504:Place [Spatial Concept]
   966   C1704765:Place [Functional Concept]
   966   C1882509:Place [Activity]
   966   C3496241:place [Disease or Syndrome]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "plausible interactions with the protein surface."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0872079:interactions protein [Molecular Function]
   719   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.106: After manual fitting, the modeled complex was subjected to energy minimization using a CHARMM force field (65). 

Phrase: "After manual fitting,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036572:Fitting [Sign or Symptom]
   861   C0441548:Fitting [Health Care Activity]

Phrase: "the modeled complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "subjected to energy minimization"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0424589:Energy [Finding]
   770   C0542479:Energy [Natural Phenomenon or Process]
   770   C1442080:Energy [Quantitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a CHARMM force field"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C2349184:Force Field [Conceptual Entity]
           Field
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C3539073:FIELD [Spatial Concept]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.107: We used the modeled peptide simply as a ruler to analyze the features of the binding site and to gauge the possible modes of peptide binding. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the modeled peptide simply as a ruler to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "analyze"

Phrase: "the features of the binding site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gauge"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456564:Gauge [Spatial Concept]
  1000   C1521879:GAGE [Immunologic Factor]

Phrase: "the possible modes of peptide binding."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1513371:Mode [Functional Concept]
   719   C1705738:Mode [Quantitative Concept]
   719   C2347637:Mode [Quantitative Concept]
   719   C2348146:Mode [Quantitative Concept]
Processing 00000000.tx.108: The fact that the peptide in extended conformation fits entirely within the binding site (Fig. 4) suggests that the relatively basic peptide substrates could extend along the floor of the channel, maximizing contact with its negatively charged surface. 

Phrase: "The fact"

Phrase: "that"

Phrase: "the peptide in extended conformation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1518960:Peptide Conformation [Spatial Concept]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "fits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "entirely within the binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0005456:Binding Site [Receptor]
   806   C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Site [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the relatively basic peptide substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710236:Substrate [Manufactured Object]

Phrase: "could"

Phrase: "extend along the floor of the channel,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0016249:Floor [Manufactured Object]
   748   C0231448:Extend [Functional Concept]
   748   C0439792:extend [Spatial Concept]
   748   C0439799:Channel [Spatial Concept]
   748   C1547707:Floor [Geographic Area]
   748   C1706095:Channel [Conceptual Entity]

Phrase: "maximizing contact with its negatively charged surface."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0332158:Contact with [Functional Concept]
           contact
   748   C0337611:Contact [Population Group]
   748   C1705415:Contact [Idea or Concept]
Processing 00000000.tx.109: The N terminus extends near but not to the closed end of the channel, and additional residues could be accommodated N-terminal to the cleavage site. 

Phrase: "The N terminus"

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "near"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475806:Near [Finding]
  1000   C1706276:Near [Qualitative Concept]

Phrase: "but"

Phrase: "not to the closed end of the channel,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0439799:Channel [Spatial Concept]
   744   C0444930:End [Spatial Concept]
   744   C0587267:Closed [Functional Concept]
   744   C1518422:Not [Functional Concept]
   744   C1706095:Channel [Conceptual Entity]
   744   C2746065:End [Temporal Concept]

Phrase: "and"

Phrase: "additional residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "accommodated"

Phrase: "N-terminal to the cleavage site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.110: As in neurolysin, however, it is unlikely that more than a few additional residues could be added to the N terminus without substantially altering the peptide conformation. 

Phrase: "As in neurolysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "however,"

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that more than a few additional residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1524062:Additional [Functional Concept]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "could"

Phrase: "be"

Phrase: "added to the N terminus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "without substantially"

Phrase: "altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the peptide conformation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1518960:Peptide Conformation [Spatial Concept]
   861   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.111: This limitation on the number of N-terminal residues is consistent with limitations on the activity of another M3 family member, mitochondrial intermediate peptidase, which can only cleave at its preferred site in N-terminal mitochondrial-targeting sequences if the sequence is first trimmed by another enzyme (66, 67). 

Phrase: "This limitation on the number of N-terminal residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449295:Limitation [Functional Concept]

Phrase: "is"

Phrase: "consistent with limitations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "on the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "of another M3 family member,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0086282:Family member [Family Group]
   901   C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:member [Population Group]
   827   C1704727:Family [Conceptual Entity]
   827   C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "mitochondrial intermediate peptidase,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0128577:mitochondrial intermediate peptidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417171:MITOCHONDRIAL INTERMEDIATE PEPTIDASE [Gene or Genome]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0205103:Intermediate [Spatial Concept]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C1947941:Peptidase [Enzyme]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "which"

Phrase: "can"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "cleave at its preferred site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205145:Site [Spatial Concept]
   760   C0558295:Preferred [Idea or Concept]
   760   C1515974:Site [Body Location or Region]
   760   C1548789:Preferred [Qualitative Concept]
   760   C2825164:Site [Spatial Concept]
   760   C3543840:Preferred [Qualitative Concept]

Phrase: "in N-terminal mitochondrial-targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1521840:Targeting [Functional Concept]
   779 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "if"

Phrase: "the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "trimmed by another enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014442:Enzyme [Enzyme,Organic Chemical]
   737   C0146783:trim [Biomedical or Dental Material,Organic Chemical]

Phrase: "(66,"

Phrase: "67"

Phrase: ")."
Processing 00000000.tx.112: View larger version (50K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(50K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.113: 4. 

Phrase: "4."
Processing 00000000.tx.114: Model of substrate peptide binding. 

Phrase: "Model of substrate peptide binding."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.115: A stereo view of the molecular surface representation of thimet oligopeptidase sectioned to show the floor of the active site channel is shown with the 13-residue substrate neurotensin modeled as described under "Model for Substrate Binding." 

Phrase: "A stereo view of the molecular surface representation of thimet oligopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0449911:View [Spatial Concept]

Phrase: "sectioned"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the floor of the active site channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0016249:Floor [Manufactured Object]
   748   C1547707:Floor [Geographic Area]

Phrase: "is"

Phrase: "shown with the 13-residue substrate neurotensin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   748   C1417869:NEUROTENSIN [Gene or Genome]
   748   C1709915:Residue [Conceptual Entity]
   748   C1710236:Substrate [Manufactured Object]
   748   C1882936:RESIDUE [Phenomenon or Process]
   714   C1547282:Show [Intellectual Product]

Phrase: "modeled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3161035:Model [Intellectual Product]

Phrase: "as"

Phrase: "described under ""Model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   790   C3161035:Model [Intellectual Product]

Phrase: "for Substrate Binding."""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
Processing 00000000.tx.116: The overall orientation is similar to Fig. 

Phrase: "The overall orientation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0029266:Orientation [Mental Process]
   861   C1704322:orientation [Spatial Concept]
   861   C1704972:Orientation [Spatial Concept]
   861   C3539923:Orientation [Intellectual Product]

Phrase: "is"

Phrase: "similar to Fig."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.117: 1A, and the N terminus of neurotensin is at the top of the figure. 

Phrase: "1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "the N terminus of neurotensin"

Phrase: "is at the top of the figure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704458:Top [Spatial Concept]
Processing 00000000.tx.118: The image was produced with GRASP (73).  

Phrase: "The image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1704254:Image [Intellectual Product]
  1000   C1704922:Image [Entity]
  1000   C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "produced with GRASP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0220843:grasp [Organism Function]
   790   C1425726:GRASP [Gene or Genome]

Phrase: "(73"

Phrase: ")."
Processing 00000000.tx.119: Differential Substrate Recognition by TOP and NeurolysinTOP and neurolysin cleave many bioactive peptides at the same site or sites, a consequence of their nearly identical structures and the high degree of sequence identity in the residues that line their substrate binding channels (50). 

Phrase: "Differential Substrate Recognition by TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524637:Recognition [Mental Process]

Phrase: "and"

Phrase: "NeurolysinTOP"

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "cleave"

Phrase: "many bioactive peptides at the same site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "a consequence of their nearly identical structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "and"

Phrase: "the high degree of sequence identity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]

Phrase: "in the residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "that line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "their substrate binding channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.120: Indeed the current structure confirms our earlier modeling study, which suggested that only 11% of the sequence differences between TOP and neurolysin map to the walls and floor of the channel, which accounts for more than 23% of the total molecular surface. 

Phrase: "Indeed"

Phrase: "the current structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "our earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "modeling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870071:Modeling [Intellectual Product,Research Activity]
   966 E C3161035:Model [Intellectual Product]

Phrase: "study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "which"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that only 11% of the sequence differences"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0205171:Only [Quantitative Concept]
   748   C1519249:Sequence [Functional Concept]
   748   C1720467:Only [Intellectual Product]
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "between TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin map to the walls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0024779:Map [Manufactured Object]
   760   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "floor of the channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0016249:Floor [Manufactured Object]
   770   C1547707:Floor [Geographic Area]

Phrase: "which"

Phrase: "accounts for more"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1551359:account [Idea or Concept]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]

Phrase: "than 23%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "of the total molecular surface."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205148:Surface [Spatial Concept]
   827   C1521991:Molecular [Qualitative Concept]
   755 E C0567416:Molecule [Substance]
Processing 00000000.tx.121: The two enzymes are known to cleave some peptides at different positions, however, and understanding the determinants of this specificity should provide insight into the mechanism of broad sequence recognition. 

Phrase: "The two enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "some peptides at different positions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "however,"

Phrase: "and"

Phrase: "understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the determinants of this specificity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1521761:Determinant [Functional Concept]

Phrase: "should"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insight into the mechanism of broad sequence recognition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:Insight [Mental Process]
Processing 00000000.tx.122: As noted above, TOP cleaves the 13-residue peptide neurotensin at Arg-8-Arg-9, whereas neurolysin cleaves the peptide at between Pro-10 and Tyr-11. 

Phrase: "As"

Phrase: "noted above, TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaves"

Phrase: "the 13-residue peptide neurotensin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   812   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "at Arg-8-Arg-9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C0653858:Arg-Arg [Amino Acid, Peptide, or Protein]

Phrase: "whereas"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "cleaves"

Phrase: "the peptide at"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "between Pro-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2987124:PRO [Intellectual Product]

Phrase: "and"

Phrase: "Tyr-11."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]
Processing 00000000.tx.123: A possible reason for this sequence specificity is evident when comparing the electrostatic potentials at the channel floors of the two enzymes (Fig. 5A). 

Phrase: "A possible reason for this sequence specificity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392360:Reason [Idea or Concept]

Phrase: "is"

Phrase: "evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "when"

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "the electrostatic potentials at the channel floors of the two enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C3245505:potentials [Qualitative Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.124: In TOP, the surface of the floor near the open end of the channel is strongly electronegative, whereas the corresponding surface in neurolysin has several basic patches. 

Phrase: "In TOP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the surface of the floor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205148:Surface [Spatial Concept]

Phrase: "near the open end"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0175566:Open [Spatial Concept]
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]
   789 E C0547049:Openness [Spatial Concept]

Phrase: "of the channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "is"

Phrase: "strongly electronegative,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0678604:electronegativity [Natural Phenomenon or Process]

Phrase: "whereas"

Phrase: "the corresponding surface in neurolysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205148:Surface [Spatial Concept]

Phrase: "has"

Phrase: "several basic patches."
Meta Candidates (Total=9; Excluded=8; Pruned=0; Remaining=1)
   827   C0994894:Patches [Medical Device]
   793 E C0332461:Patch [Finding]
   793 E C0445403:Patch [Biomedical or Dental Material]
   793 E C0991556:Patch [Medical Device]
   793 E C1305400:Patch [Medical Device]
   793 E C1533128:Patch [Biomedical or Dental Material]
   793 E C1706366:{Patch} [Quantitative Concept]
   793 E C1707974:Patch [Biomedical or Dental Material]
   743 E C0205413:Patchy [Qualitative Concept]
Processing 00000000.tx.125: The large acidic patch in TOP may cause neurotensin to bind with its two adjacent arginines shifted toward the open end of the channel to optimize electrostatic interactions. 

Phrase: "The large acidic patch in TOP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0332461:Patch [Finding]
   748   C0445403:Patch [Biomedical or Dental Material]
   748   C0991556:Patch [Medical Device]
   748   C1305400:Patch [Medical Device]
   748   C1533128:Patch [Biomedical or Dental Material]
   748   C1706366:{Patch} [Quantitative Concept]
   748   C1707974:Patch [Biomedical or Dental Material]

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neurotensin to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "bind with its two adjacent arginines"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205117:Adjacent [Spatial Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   719   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "shifted toward the open end of the channel to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   742   C0175566:Open [Spatial Concept]
   742   C0333051:shifted [Functional Concept]
   742   C0439799:Channel [Spatial Concept]
   742   C0444930:End [Spatial Concept]
   742   C1706095:Channel [Conceptual Entity]
   742   C2746065:End [Temporal Concept]
   708 E C2347509:Shift [Phenomenon or Process]

Phrase: "optimize"

Phrase: "electrostatic interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.126: The basic patches in neurolysin may have the opposite influence, causing neurotensin to shift its binding site toward the closed end of the channel to minimize electrostatic repulsion between the enzyme and the basic residues in the peptide. 

Phrase: "The basic patches in neurolysin"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   760   C0994894:Patches [Medical Device]
   726 E C0332461:Patch [Finding]
   726 E C0445403:Patch [Biomedical or Dental Material]
   726 E C0991556:Patch [Medical Device]
   726 E C1305400:Patch [Medical Device]
   726 E C1533128:Patch [Biomedical or Dental Material]
   726 E C1706366:{Patch} [Quantitative Concept]
   726 E C1707974:Patch [Biomedical or Dental Material]

Phrase: "may"

Phrase: "have"

Phrase: "the opposite influence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0021399:influential [Idea or Concept]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "neurotensin to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "shift"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333051:Shift [Functional Concept]
  1000   C2347509:Shift [Phenomenon or Process]

Phrase: "its binding site toward the closed end of the channel to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C0005456:Binding Site [Receptor]
   756   C0682969:Binding Site [Amino Acid Sequence]
   754   C2945843:Site of [Qualitative Concept]
   738   C0205145:Site [Spatial Concept]
   738   C0243122:binding [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1515974:Site [Body Location or Region]
   738   C2825164:Site [Spatial Concept]

Phrase: "minimize"

Phrase: "electrostatic repulsion between the enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0683283:repulsion [Mental Process]

Phrase: "and"

Phrase: "the basic residues in the peptide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.127: View larger version (78K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(78K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.128: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.129: Determinants of cleavage site differences between TOP and neurolysin. 

Phrase: "Determinants of cleavage site differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1521761:Determinant [Functional Concept]

Phrase: "between TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.130: A, surface electrostatic potential in the substrate binding channels of unliganded TOP and neurolysin (49). 

Phrase: "A,"

Phrase: "surface electrostatic potential in the substrate binding channels of unliganded TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C2986841:Binding Potential [Phenomenon or Process]
   736   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.131: Standard colors are used to indicate electrostatic potential (blue for positive and red for negative), and the neurotensin sequences shown are offset to represent the different binding positions in the two enzymes. 

Phrase: "Standard colors"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009393:Colors [Natural Phenomenon or Process]
   827 E C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   827 E C1705245:Color [Pharmacologic Substance]
   777 E C0522507:colored [Qualitative Concept]

Phrase: "are"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "indicate"

Phrase: "electrostatic potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "(blue for positive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1260957:Blue [Qualitative Concept]

Phrase: "and"

Phrase: "red for negative"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332575:Red [Finding]
   790   C1260956:Red [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the neurotensin sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "offset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711330:Offset [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the different binding positions in the two enzymes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0733755:positions [Spatial Concept]
Processing 00000000.tx.132: Molecular surfaces and electrostatic potentials were calculated using GRASP (73). 

Phrase: "Molecular surfaces"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1521991:Molecular [Qualitative Concept]
   827   C0205148:Surface [Spatial Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "electrostatic potentials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:potentials [Qualitative Concept]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GRASP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220843:grasp [Organism Function]
  1000   C1425726:GRASP [Gene or Genome]

Phrase: "(73"

Phrase: ")."
Processing 00000000.tx.133: pGlu, cyclic Glu. 

Phrase: "pGlu,"

Phrase: "cyclic Glu."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.134: B, key enzyme residues likely to mediate differences in substrate specificity. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "key enzyme residues likely to"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0332148:Likely [Qualitative Concept]
   804   C0750492:Likely [Idea or Concept]
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C0014445:enzymes [Functional Concept]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "differences in substrate specificity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.135: The TOP backbone structure and key residue side chains are shown with the side chains from neurolysin superimposed. 

Phrase: "The TOP backbone structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "key residue side chains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0337112:chains [Manufactured Object]
   812   C0441987:Side [Spatial Concept]
   812   C1524075:Chains [Idea or Concept]

Phrase: "are"

Phrase: "shown with the side chains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0337112:chains [Manufactured Object]
   760   C0441987:Side [Spatial Concept]
   760   C1524075:Chains [Idea or Concept]
   726   C1547282:Show [Intellectual Product]

Phrase: "from neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "superimposed."
Processing 00000000.tx.136: Residues shown for TOP/neurolysin are Glu-469/Arg-470, Met-490/Arg-491, His-495/Asn-496, and Arg-498/Thr-499. 

Phrase: "Residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "shown for TOP/neurolysin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1423943:NEUROLYSIN [Gene or Genome]
   726   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "Glu-469/Arg-470,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Met-490/Arg-491,"

Phrase: "His-495/Asn-496,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003995:Asn [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Arg-498/Thr-499."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.137: The residue positions of the substrate peptide neurotensin are indicated by numbers next to the C positions, and the active site zinc and conserved residues from the active site sequence motif are shown for reference. 

Phrase: "The residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "positions of the substrate peptide neurotensin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0733755:Position [Spatial Concept]
   753   C1417869:NEUROTENSIN [Gene or Genome]
   753   C1710236:Substrate [Manufactured Object]

Phrase: "are"

Phrase: "indicated by numbers next to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0205117:Next to [Spatial Concept]
           next
   760   C0237753:*Number [Quantitative Concept]
   760   C0332282:Next [Temporal Concept]
   760   C0449788:Number [Quantitative Concept]
   760   C1444656:Indicated [Finding]
   760   C1883708:Next [Temporal Concept]

Phrase: "the C positions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "the active site zinc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C2348288:Zinc [Element, Ion, or Isotope]
   734   C0205681:Active Site [Functional Concept]

Phrase: "and"

Phrase: "conserved residues from the active site sequence motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "are"

Phrase: "shown for reference."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1514811:Reference [Idea or Concept]
   790   C1706462:Reference [Conceptual Entity]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.138: Images were produced with Swiss-PDBViewer (72). 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "produced with Swiss-PDBViewer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0241315:Swiss [Population Group]

Phrase: "(72"

Phrase: ")."
Processing 00000000.tx.139: NT, neurotensin. 

Phrase: "NT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332126:NT [Qualitative Concept]
  1000   C1449832:NT [Diagnostic Procedure]

Phrase: "neurotensin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1417869:NEUROTENSIN [Gene or Genome]
Processing 00000000.tx.140: C, summary of neurotensin binding in thimet oligopeptidase and neurolysin relative to the four key residue differences between the two enzymes. 

Phrase: "C,"

Phrase: "summary of neurotensin binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552616:summary [Intellectual Product]
   770   C1706244:Summary [Intellectual Product]

Phrase: "in thimet oligopeptidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "relative to the four key residue differences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "between the two enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.141: Sequences of neurotensin in the modeled registration for TOP and neurolysin binding are shown on the top and bottom, respectively, with color coding for residue type. 

Phrase: "Sequences of neurotensin"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C0162326:Sequences [Nucleotide Sequence]
   756 E C0004793:Sequence [Nucleotide Sequence]
   756 E C0162327:Sequence [Nucleotide Sequence]
   756 E C1519249:Sequence [Functional Concept]
   706 E C1548958:Sequential [Idea or Concept]
   706 E C1705294:Sequential [Qualitative Concept]

Phrase: "in the modeled registration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514821:Registration [Health Care Activity]
   861   C1553384:registration [Idea or Concept]
   861   C2697663:Registration [Machine Activity]

Phrase: "for TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "are"

Phrase: "shown on the top"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704458:Top [Spatial Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "bottom,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: "respectively,"

Phrase: "with color coding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009219:Coding [Occupational Activity]

Phrase: "for residue type."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.142: The key residue differences between TOP and neurolysin are shown in the center with the position numbers in each enzyme. 

Phrase: "The key residue differences between TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "are"

Phrase: "shown in the center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205099:Center [Spatial Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "with the position numbers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2985830:Position Number [Quantitative Concept]
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "in each enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.143: Enzyme residues are aligned relative to the substrate peptide sequences based on models of substrate binding described under "Model for Substrate Binding," with the primary cleavage position indicated by the vertical line. 

Phrase: "Enzyme residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "aligned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706765:Aligned [Quantitative Concept]
   966 E C2369992:Align [Pharmacologic Substance]

Phrase: "relative to the substrate peptide sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "based on models of substrate binding"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C1710236:Substrate [Manufactured Object]
   753   C3161035:Models [Intellectual Product]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "described under ""Model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   790   C3161035:Model [Intellectual Product]

Phrase: "for Substrate Binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: """"

Phrase: "with the primary cleavage position"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0444508:Primary position [Spatial Concept]
   827   C0733755:Position [Spatial Concept]
   755 E C0240795:POSITIONAL [Finding]

Phrase: "indicated by the vertical line."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205128:Vertical [Spatial Concept]
   760   C0205132:Line [Spatial Concept]
   760   C1444656:Indicated [Finding]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.144: D, schematic representation of residue preferences in TOP and neurolysin relative to the four key residue differences between the enzymes. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "schematic representation of residue preferences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514861:Representation [Conceptual Entity]
   760   C1882932:Representation [Activity]

Phrase: "in TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "relative to the four key residue differences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "between the enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.145: The residue preferences were derived by systematic variation at each residue position of the fluorogenic substrate ortho-aminobenzoyl-Gly-Phe-Ser-Pro-Phe-Arg-Gln- N-[2,4-dinitrophenyl]-ethylenediamine in a study by Juliano and co-workers (48). 

Phrase: "The residue preferences"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0558295:Preferences [Idea or Concept]
   827 E C1549513:Preference [Idea or Concept]

Phrase: "were"

Phrase: "derived by systematic variation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205419:Variation [Qualitative Concept]
   770   C0220922:systematic [Functional Concept]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "at each residue position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "of the fluorogenic substrate ortho-aminobenzoyl-Gly-Phe-Ser-Pro-Phe-Arg-Gln- N-[2,4-dinitrophenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   785   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: "]-ethylenediamine in a study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]

Phrase: "by Juliano"

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.146: Residue preferences, reflected by low Km values, in positions near the cleavage site (heavy vertical line) are indicated for TOP (above) and neurolysin (below). 

Phrase: "Residue preferences,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0558295:Preferences [Idea or Concept]
   827 E C1549513:Preference [Idea or Concept]

Phrase: "reflected by low Km values,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0042295:Values [Qualitative Concept]
   760   C0205251:low [Qualitative Concept]
   760   C0558058:reflected [Mental Process]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "in positions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:positions [Spatial Concept]
   916 E C0240795:POSITIONAL [Finding]

Phrase: "near the cleavage site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(heavy vertical line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "indicated for TOP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1444656:Indicated [Finding]

Phrase: "(above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "("

Phrase: "below"

Phrase: ")."
Processing 00000000.tx.147: Key differences in TOP and neurolysin are shown in the center, aligned according to models of substrate binding.  

Phrase: "Key differences in TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "are"

Phrase: "shown in the center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205099:Center [Spatial Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "aligned according to models of substrate binding."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0243122:binding [Functional Concept]
   748   C0680240:according [Social Behavior]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1706765:Aligned [Quantitative Concept]
   748   C1710236:Substrate [Manufactured Object]
   748   C3161035:Models [Intellectual Product]
   714 E C2369992:Align [Pharmacologic Substance]
Processing 00000000.tx.148: The differences in electrostatic potential near the open end of the channel floor are due in large part to a single residue change in the region, Glu-469 in TOP converting to an arginine in neurolysin (Fig. 5B). 

Phrase: "The differences in electrostatic potential"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "near the open end"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0175566:Open [Spatial Concept]
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]
   789 E C0547049:Openness [Spatial Concept]

Phrase: "of the channel floor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016249:Floor [Manufactured Object]
   861   C1547707:Floor [Geographic Area]

Phrase: "are"

Phrase: "due in large part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0678226:due [Functional Concept]
   770   C3146286:Due [Idea or Concept]

Phrase: "to a single residue change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0392747:Change [Functional Concept]
   827   C0443172:change [Quantitative Concept]
   827   C1705241:Change [Quantitative Concept]

Phrase: "in the region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "Glu-469 in TOP converting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to an arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.149: Arg-9 in the model of bound neurotensin could hydrogen-bond to Glu-469 of TOP, suggesting that this specific contact, in addition to general electrostatic complementarity, may contribute to differences in substrate recognition. 

Phrase: "Arg-9 in the model of bound neurotensin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C0621953:neurotensin, Arg(9)- [Amino Acid, Peptide, or Protein]
   744   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   744   C0332297:bound [Spatial Concept]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1417869:NEUROTENSIN [Gene or Genome]
   744   C1689898:% bound [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]
   744   C3161035:Model [Intellectual Product]

Phrase: "could"

Phrase: "hydrogen-bond to Glu-469 of TOP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020276:hydrogen bond [Natural Phenomenon or Process]
   744   C0020275:Hydrogen [Element, Ion, or Isotope]
   744   C0523702:HYDROGEN [Laboratory Procedure]
   744   C0885426:hydrogen [Inorganic Chemical]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this specific contact,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332158:contact [Functional Concept]
   861   C0337611:Contact [Population Group]
   861   C1705415:Contact [Idea or Concept]

Phrase: "in addition to general electrostatic complementarity,"

Phrase: "may"

Phrase: "contribute to differences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1880177:Contribute [Activity]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in substrate recognition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524637:Recognition [Mental Process]
Processing 00000000.tx.150: In fact, the TOP structure supports earlier work (50) that identified four key positions, including 469/470, which likely determine the specificity differences between TOP and neurolysin. 

Phrase: "In fact,"

Phrase: "the TOP structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0678594:Structure [Spatial Concept]
   734   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "earlier work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "(50"

Phrase: ")"

Phrase: "that identified four key positions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0733755:positions [Spatial Concept]
   729 E C0240795:POSITIONAL [Finding]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "469/470,"

Phrase: "which likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "determine"

Phrase: "the specificity differences between TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.151: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.152: 5B, the three other key residue changes are Met-490/Arg-491, His-495/Asn-496, and Arg-498/Thr-499 in TOP and neurolysin. 

Phrase: "5B,"

Phrase: "the three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "other key residue changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "Met-490/Arg-491,"

Phrase: "His-495/Asn-496,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003995:Asn [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Arg-498/Thr-499 in TOP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.153: These three positions all arise from the extended turn between helices 15 and 16, the helices that contribute the zinc coordinating residues in the active site. 

Phrase: "These three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "positions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]

Phrase: "all"

Phrase: "arise from the extended turn"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0231448:Extended [Functional Concept]
   760   C0231449:Extended [Spatial Concept]
   760   C0439792:extended [Spatial Concept]
   760   C0541749:turn [Finding]
   760   C1709743:Turn [Spatial Concept]

Phrase: "between helices 15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1017315:helices [Eukaryote]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "and"

Phrase: "16,"

Phrase: "the helices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018882:Helix [Eukaryote]
  1000   C0229304:Helix [Body Part, Organ, or Organ Component]
  1000   C1017315:helices [Eukaryote]
  1000   C1704821:Helix [Spatial Concept]
  1000   C1705682:Helix [Anatomical Structure]

Phrase: "that"

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "the zinc coordinating residues in the active site."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.154: The extended turn spans most of that region of the channel floor that runs from the active site to the closed end of the channel, and a substrate peptide like neurotensin, with a relatively large number of residues N-terminal to the cleavage site, could potentially interact with the enzyme at all of the key positions. 

Phrase: "The extended turn spans most of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1711300:Span [Conceptual Entity]
   719   C2700613:Span [Quantitative Concept]

Phrase: "that region of the channel floor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "that runs from the active site"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0600140:Runs [Finding]
   719 E C0035953:run [Daily or Recreational Activity]
   719 E C1704688:Run [Functional Concept]
   719 E C2346414:Run [Finding]

Phrase: "to the closed end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "of the channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "a substrate peptide like neurotensin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   812   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "with a relatively large number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]

Phrase: "of residues N-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "to the cleavage site,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "could"

Phrase: "potentially"

Phrase: "interact with the enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "at all"

Phrase: "of the key positions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.155: In particular, Met-490 of TOP is positioned to favorably interact with Leu-2 (at position P7 using the standard nomenclature for peptidase substrates) of neurotensin in the current model, and His-495 could make a salt bridge to Glu-4 (P5) of the peptide. 

Phrase: "In particular, Met-490"

Phrase: "of TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "positioned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0733755:Position [Spatial Concept]

Phrase: "to favorably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "interact with Leu-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "("

Phrase: "at position P7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424742:p7 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the standard nomenclature for peptidase substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0600281:Nomenclature [Intellectual Product]
   753   C1524067:Nomenclature [Intellectual Product]

Phrase: ")"

Phrase: "of neurotensin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "in the current model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "His-495"

Phrase: "could"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "a salt bridge to Glu-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0036140:Salt [Chemical Viewed Structurally]
   753   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0206136:Salt [Food,Inorganic Chemical]
   753   C0456378:Bridge [Medical Device]

Phrase: "(P5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1538611:P5 [Gene or Genome]
  1000   C1539371:p5 [Gene or Genome]

Phrase: ")"

Phrase: "of the peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.156: Also, the peptide registration places the strongly electropositive adjacent arginines at positions 8 (P1) and 9 (P1') of the peptide, away from Arg-498, reducing any unfavorable interaction. 

Phrase: "Also,"

Phrase: "the peptide registration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514821:Registration [Health Care Activity]
   861   C1553384:registration [Idea or Concept]
   861   C2697663:Registration [Machine Activity]

Phrase: "places"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "the strongly electropositive adjacent arginines at positions 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(P1)"

Phrase: "and"

Phrase: "9"

Phrase: "(P1') of the peptide,"

Phrase: "away from Arg-498,"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "any unfavorable interaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.157: In neurotensin, on the other hand, where the peptide shifts toward the closed end of the channel, changes in these key residues appear complementary to the altered peptide position. 

Phrase: "In neurotensin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "where"

Phrase: "the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "shifts toward the closed end of the channel,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0333051:Shift [Functional Concept]
   744   C0439799:Channel [Spatial Concept]
   744   C0444930:End [Spatial Concept]
   744   C0587267:Closed [Functional Concept]
   744   C1706095:Channel [Conceptual Entity]
   744   C2347509:Shift [Phenomenon or Process]
   744   C2746065:End [Temporal Concept]

Phrase: "changes in these key residues"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "complementary to the altered peptide position."
Processing 00000000.tx.158: Instead of Met-490, Arg-491 at the equivalent neurolysin position can now make a salt bridge to Glu-4 (P7) of neurotensin. 

Phrase: "Instead of Met-490,"

Phrase: "Arg-491 at the equivalent neurolysin position"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205163:Equivalent [Qualitative Concept]
   748   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439185:equivalent [Quantitative Concept]
   748   C0733755:Position [Spatial Concept]
   748   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "can"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "a salt bridge to Glu-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0036140:Salt [Chemical Viewed Structurally]
   753   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0206136:Salt [Food,Inorganic Chemical]
   753   C0456378:Bridge [Medical Device]

Phrase: "(P7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424742:p7 [Gene or Genome]

Phrase: ")"

Phrase: "of neurotensin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1417869:NEUROTENSIN [Gene or Genome]
Processing 00000000.tx.159: And the equivalent residue to His-495 in TOP is now an asparagine, a change that avoids an electrostatic clash with Lys-6 (P5) of the peptide and makes possible hydrogen-bond interactions with that residue or possibly Asn-5 (P6). 

Phrase: "And"

Phrase: "the equivalent residue to His-495"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1709915:Residue [Conceptual Entity]
   753   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "in TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "an asparagine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003995:Asparagine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "avoids"

Phrase: "an electrostatic clash with Lys-6"

Phrase: "(P5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1538611:P5 [Gene or Genome]
  1000   C1539371:p5 [Gene or Genome]

Phrase: ")"

Phrase: "of the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "possible hydrogen-bond interactions with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "that residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "or"

Phrase: "possibly Asn-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003995:Asn [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2362652:Possibly [Qualitative Concept]

Phrase: "(P6"

Phrase: ")."
Processing 00000000.tx.160: Finally, Arg498 of TOP is a threonine in neurolysin (Thr-499), and this change avoids an electrostatic clash with the electropositive region of the peptide, which is now near this position, and possibly allows a direct interaction with one of the arginine side chains. 

Phrase: "Finally,"

Phrase: "Arg498 of TOP"

Phrase: "is"

Phrase: "a threonine in neurolysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Thr-499"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "this change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "avoids"

Phrase: "an electrostatic clash with the electropositive region of the peptide,"

Phrase: "which"

Phrase: "is"

Phrase: "now near this position,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0733755:Position [Spatial Concept]
   770   C1948052:Now [Temporal Concept]

Phrase: "and"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "a direct interaction with one of the arginine side chains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.161: The model for difference in neurotensin specificity is summarized in Fig. 

Phrase: "The model for difference"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: "in neurotensin specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "is"

Phrase: "summarized in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.162: 5C. 

Phrase: "5C."
Processing 00000000.tx.163: This relatively simple picture of differential substrate specificity appears to hold for a systematic series of sequence variants studied by Juliano and co-workers (48). 

Phrase: "This relatively simple picture of differential substrate specificity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441468:picture [Manufactured Object]
   744   C0441469:Picture [Manufactured Object]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "hold for a systematic series of sequence variants"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0205419:variants [Qualitative Concept]
   744   C0205549:Series [Quantitative Concept]
   744   C0220922:systematic [Functional Concept]
   744   C1519249:Sequence [Functional Concept]
   744   C1553387:Hold [Idea or Concept]
   744   C1948035:Hold [Activity]
   744   C2348044:Series [Intellectual Product]

Phrase: "studied by Juliano"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.164: Substitution of every possible amino acid except glycine at each position in the fluorogenic substrate ortho-aminobenzoyl-Gly-Phe-Ser-Pro-Phe-Arg-Gln- N-[2,4-dinitrophenyl]-ethylenediamine identified preferred residues at each position. 

Phrase: "Substitution of every possible amino acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C0525038:Amino Acid Substitution [Genetic Function,Molecular Biology Research Technique]
   753   C1555721:Substitution [Idea or Concept]
   753   C1706204:Substitution [Activity]

Phrase: "except glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: "at each position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]
   928 E C0240795:POSITIONAL [Finding]

Phrase: "in the fluorogenic substrate ortho-aminobenzoyl-Gly-Phe-Ser-Pro-Phe-Arg-Gln- N-[2,4-dinitrophenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   785   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: "]-ethylenediamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "preferred residues at each position."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.165: For this short peptide, the 490/491 sites on the two enzymes are not close enough to interact with substrate in our model. 

Phrase: "For this short peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "the 490/491 sites on the two enzymes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0205145:Sites [Spatial Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "close"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0587267:Close [Functional Concept]

Phrase: "enough to"

Phrase: "interact with substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1710236:Substrate [Manufactured Object]

Phrase: "in our model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]
Processing 00000000.tx.166: The other three key positions, however, are largely consistent with the observed substrate Km values, the most relevant parameter for this analysis (Fig. 5D). 

Phrase: "The"

Phrase: "other three key positions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0733755:positions [Spatial Concept]
   743 E C0240795:POSITIONAL [Finding]

Phrase: "however,"

Phrase: "are"

Phrase: "largely consistent with the observed substrate Km values,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "the most relevant parameter for this analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0549193:Parameter [Spatial Concept]
   748   C1704769:Parameter [Conceptual Entity]
   748   C2350001:Parameter [Quantitative Concept]

Phrase: "(Fig. 5D"

Phrase: ")."
Processing 00000000.tx.167: On the C-terminal side of the scissile bond, neurolysin shows a strong preference for aspartate at P2', which could interact with the Arg-470 of the enzyme. 

Phrase: "On the C-terminal side"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441987:Side [Spatial Concept]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "of the scissile bond,"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a strong preference for aspartate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0558295:preference [Idea or Concept]
   760   C1549513:Preference [Idea or Concept]

Phrase: "at P2',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "which"

Phrase: "could"

Phrase: "interact with the Arg-470 of the enzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
Processing 00000000.tx.168: TOP on the other hand, does not show a strong preference at P2'. 

Phrase: "TOP on the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a strong preference at P2'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0558295:preference [Idea or Concept]
   760   C1549513:Preference [Idea or Concept]
Processing 00000000.tx.169: Instead, Glu-469, which replaces Arg-470 or neurolysin, could interact with the preferred positive residues at P1' or possibly P3'. 

Phrase: "Instead,"

Phrase: "Glu-469,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "replaces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550539:replaces [Idea or Concept]
  1000   C1553396:replaces [Idea or Concept]
  1000   C1554078:Replace [Idea or Concept]

Phrase: "Arg-470"

Phrase: "or"

Phrase: "neurolysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "could"

Phrase: "interact with the preferred positive residues"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0439178:% Positive [Quantitative Concept]
   753   C0558295:Preferred [Idea or Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C1548789:Preferred [Qualitative Concept]
   753   C2825490:Positive [Qualitative Concept]
   753   C3543840:Preferred [Qualitative Concept]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "at P1'"

Phrase: "or"

Phrase: "possibly P3'."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412751:P3 [Gene or Genome]
   861   C1427831:P3 [Gene or Genome]
   861   C1539372:p3 [Gene or Genome]
Processing 00000000.tx.170: On the other side of the scissile bond, TOP preference for negatively charged residues at P3 is consistent with the positively charged residues present at positions 495 and 498 of the enzyme, both of which could interact with the P3 residue in our model. 

Phrase: "On the"

Phrase: "other side of the scissile bond,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441987:Side [Spatial Concept]

Phrase: "TOP preference for negatively charged residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0558295:preference [Idea or Concept]
   748   C1549513:Preference [Idea or Concept]

Phrase: "at P3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412751:P3 [Gene or Genome]
  1000   C1427831:P3 [Gene or Genome]
  1000   C1539372:p3 [Gene or Genome]

Phrase: "is"

Phrase: "consistent with the positively charged residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "present at positions 495"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C0733755:positions [Spatial Concept]

Phrase: "and"

Phrase: "498 of the enzyme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "both of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "could"

Phrase: "interact with the P3 residue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1412751:P3 [Gene or Genome]
   760   C1427831:P3 [Gene or Genome]
   760   C1539372:p3 [Gene or Genome]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "in our model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]
Processing 00000000.tx.171: Arg-498 is also in position to interact with the preferred asparagine at P2 of the substrate or possibly the preferred phenylalanine at P1. 

Phrase: "Arg-498"

Phrase: "is"

Phrase: "also in position to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0733755:Position [Spatial Concept]

Phrase: "interact with the preferred asparagine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003995:Asparagine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0558295:Preferred [Idea or Concept]
   760   C1548789:Preferred [Qualitative Concept]
   760   C3543840:Preferred [Qualitative Concept]

Phrase: "at P2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "of the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "or"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "the preferred phenylalanine at P1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.172: The polar residues at the corresponding two positions in neurolysin are compatible with the preference for positively charged residues at P4 and the ability to accommodate a positively charged residue at P1. 

Phrase: "The polar residues at the corresponding two positions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "in neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "are"

Phrase: "compatible with the preference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:compatible [Idea or Concept]
   770   C1524057:Compatible [Qualitative Concept]

Phrase: "for positively charged residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "at P4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1539372:p4 [Gene or Genome]

Phrase: "and"

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "accommodate"

Phrase: "a positively charged residue at P1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1709915:Residue [Conceptual Entity]
   753   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.173: Also, the preferred phenylalanine at P3 might interact with either Asn-496 or Thr-499. 

Phrase: "Also,"

Phrase: "the preferred phenylalanine at P3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "might"

Phrase: "interact with either Asn-496"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003995:Asn [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "Thr-499."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.174: The preference of neurolysin for hydrophobic residues at positions P1 and P2 is more difficult to rationalize with this model, and an understanding will likely require visualization by structure determination of substrate-enzyme complexes. 

Phrase: "The preference of neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0558295:preference [Idea or Concept]
   770   C1549513:Preference [Idea or Concept]

Phrase: "for hydrophobic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "at positions P1"

Phrase: "and"

Phrase: "P2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "is"

Phrase: "more difficult to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205172:More [Functional Concept]
   827   C0332218:Difficult [Qualitative Concept]
   755 E C1299586:Difficulty [Finding]

Phrase: "rationalize with this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "an understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "will"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "require"

Phrase: "visualization by structure determination of substrate-enzyme complexes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0175631:Visualization [Mental Process]
   744   C2827662:Visualization [Occupation or Discipline]
Processing 00000000.tx.175: Possible Role of an Active Site Loop in Differential Substrate RecognitionWe proposed in earlier work that at least some of the many loop and open coil segments lining the active site channel of neurolysin might rearrange when binding different substrate peptides, a possible mechanism for the ability of the enzyme to recognize a range of peptide sequences (49). 

Phrase: "Possible Role of an Active Site Loop"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C2347795:Site Role [Idea or Concept]
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in Differential Substrate RecognitionWe"

Phrase: "proposed in earlier"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1441414:PROPOSED [Idea or Concept]
   790   C1553874:Proposed [Qualitative Concept]
   790   C1578820:Proposed [Idea or Concept]
   756   C1279919:Early [Temporal Concept]

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "that at least"

Phrase: "some of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "many loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "and"

Phrase: "open coil segments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0441635:Segment [Spatial Concept]
   743 E C0205122:Segmental [Spatial Concept]

Phrase: "lining"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lining [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "the active site channel of neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439799:Channel [Spatial Concept]
   753   C1706095:Channel [Conceptual Entity]

Phrase: "might"

Phrase: "rearrange"

Phrase: "when"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "different substrate peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "a possible mechanism for the ability of the enzyme to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0596524:enzyme mechanism [Molecular Function]
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]

Phrase: "recognize"

Phrase: "a range of peptide sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.176: One loop in particular (residues 600-612) contains five potentially flexible glycine residues and is partially disordered in the neurolysin crystal structure, suggesting high mobility. 

Phrase: "One loop in particular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0419518:Loop [Medical Device]
   770   C0445022:Loop [Spatial Concept]

Phrase: "(residues 600-612"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "five potentially flexible glycine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "partially"

Phrase: "disordered in the neurolysin crystal structure,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   753   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0427896:Crystal [Body Substance]
   753   C0678594:Structure [Spatial Concept]
   753   C1423943:NEUROLYSIN [Gene or Genome]
   753   C1533132:Crystal [Body Substance]
   753   C1704641:Crystal [Manufactured Object]
   719   C0012634:Disorder [Disease or Syndrome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "high mobility."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0425245:Mobility [Finding]
   861   C0449580:Mobility [Qualitative Concept]
   789 E C0231435:Mobile [Functional Concept]
   789 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.177: In TOP, the corresponding loop (residues 599-611) has only four glycine residues, and the change from glycine to alanine at position 607 might be expected to affect the conformation and mobility of this segment. 

Phrase: "In TOP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the corresponding loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "(residues 599-611"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "has"

Phrase: "only four glycine residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "the change from glycine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0025320:The change [Physiologic Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "to alanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at position 607"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "might"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "and"

Phrase: "mobility of this segment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0425245:Mobility [Finding]
   770   C0449580:Mobility [Qualitative Concept]
Processing 00000000.tx.178: The loop is in close proximity to the active site (Fig. 6A) and would likely interact with bound substrate. 

Phrase: "The loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "is in close proximity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0587267:Close [Functional Concept]
   770   C1514583:Proximity [Spatial Concept]

Phrase: "to the active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "would"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "interact with bound substrate."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C1710236:Substrate [Manufactured Object]
   770   C2349209:Bound [Conceptual Entity]
Processing 00000000.tx.179: Mutating Tyr-606 at the tip of the neurolysin segment differentially affects the substrate recognition of the enzyme, supporting a role for this loop in substrate binding.2 It is possible, therefore, that in addition to the key residue differences in the floor of the channel, changes in this loop segment may contribute to differences in cleavage site specificity between TOP and neurolysin. 

Phrase: "Mutating Tyr-606 at the tip of the neurolysin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1421250:TYR [Gene or Genome]
   742   C1423943:NEUROLYSIN [Gene or Genome]
   742   C1710425:Tip [Medical Device]
   742   C3282898:Tip [Qualitative Concept]
   708   C1513776:Mutate [Genetic Function]

Phrase: "segment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441635:Segment [Spatial Concept]

Phrase: "differentially"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the substrate recognition of the enzyme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524637:Recognition [Mental Process]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "a role for this loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in substrate binding.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1710236:Substrate [Manufactured Object]

Phrase: "It"

Phrase: "is"

Phrase: "possible, therefore,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that in addition to the key residue differences"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C1709915:Residue [Conceptual Entity]
   744   C1882936:RESIDUE [Phenomenon or Process]
   744   C1883712:Addition [Functional Concept]
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "in the floor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016249:Floor [Manufactured Object]
  1000   C1547707:Floor [Geographic Area]

Phrase: "of the channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "changes in this loop segment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0392747:Change [Functional Concept]
   760   C0419518:Loop [Medical Device]
   760   C0441635:Segment [Spatial Concept]
   760   C0443172:change [Quantitative Concept]
   760   C0445022:Loop [Spatial Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "may"

Phrase: "contribute to differences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1880177:Contribute [Activity]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in cleavage site specificity"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   865   C0449604:site specific [Spatial Concept]
   827   C0037791:Specificity [Quantitative Concept]
   827   C0205145:Site [Spatial Concept]
   827   C1511884:Specificity [Quantitative Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "between TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.180: View larger version (26K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.181: 6. 

Phrase: "6."
Processing 00000000.tx.182: Changes in the loop just opposite the active site in TOP and neurolysin. 

Phrase: "Changes in the loop"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "just opposite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521805:Opposite [Spatial Concept]

Phrase: "the active site in TOP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205681:Active Site [Functional Concept]
   753   C0205145:Site [Spatial Concept]
   753   C0205177:Active [Functional Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.183: A, conformations of the loops. 

Phrase: "A,"

Phrase: "conformations of the loops."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.184: The backbone trace of the TOP loop (residues 599-611) together with the adjacent Tyr-612 is in gray with the conformations of large side chains indicated in atom colors. 

Phrase: "The backbone trace of the TOP loop"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0442822:Trace [Quantitative Concept]
   744   C1524031:Trace [Qualitative Concept]
   744   C1883002:Trace [Functional Concept]

Phrase: "(residues 599-611"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "together with the adjacent Tyr-612"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0205117:Adjacent [Spatial Concept]
   827   C1421250:TYR [Gene or Genome]
   755 E C3242705:adjacency [Idea or Concept]

Phrase: "is in gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0556636:gray [Quantitative Concept]
   790   C1269776:Gray [Qualitative Concept]

Phrase: "with the conformations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0026377:Conformation [Spatial Concept]

Phrase: "of large side chains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0337112:chains [Manufactured Object]
   827   C0441987:Side [Spatial Concept]
   827   C1524075:Chains [Idea or Concept]

Phrase: "indicated in atom colors."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0009393:Colors [Natural Phenomenon or Process]
   770   C0567415:Atom [Element, Ion, or Isotope]
   770   C1444656:Indicated [Finding]
   770   C1706222:Atom [Conceptual Entity]
   737 E C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   737 E C1705245:Color [Pharmacologic Substance]
Processing 00000000.tx.185: The corresponding side chains from superimposed neurolysin are in yellow, and the position the alanine substitution in the TOP loop is indicated. 

Phrase: "The corresponding side chains from superimposed neurolysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0337112:chains [Manufactured Object]
   748   C0441987:Side [Spatial Concept]
   748   C1524075:Chains [Idea or Concept]

Phrase: "are in yellow,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0221205:Yellow [Qualitative Concept]
   790   C1551058:Are [Quantitative Concept]

Phrase: "and"

Phrase: "the position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]
   928 E C0240795:POSITIONAL [Finding]

Phrase: "the alanine substitution in the TOP loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1555721:Substitution [Idea or Concept]
   744   C1706204:Substitution [Activity]

Phrase: "is"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.186: The TOP active site residues and zinc ion are shown for reference. 

Phrase: "The TOP active site residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "zinc ion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022023:Ion [Element, Ion, or Isotope]
   861   C1700702:ION [Functional Concept]

Phrase: "are"

Phrase: "shown for reference."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1514811:Reference [Idea or Concept]
   790   C1706462:Reference [Conceptual Entity]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.187: B, active site loop order in TOP and neurolysin. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "active site loop order in TOP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C1705175:Order [Intellectual Product]
   748   C1705176:Order [Qualitative Concept]
   748   C1705177:Order [Classification]
   748   C1705178:Order [Activity]
   748   C1882348:Order [Qualitative Concept]

Phrase: "and"

Phrase: "neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.188: Backbone traces of the loops opposite the active site in the two enzymes are colored according to the thermal factors of main chain atoms in the loop residues. 

Phrase: "Backbone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037949:Backbone [Body Part, Organ, or Organ Component]
  1000   C1267072:Backbone [Body Part, Organ, or Organ Component]

Phrase: "traces of the loops opposite"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0181687:loops [Medical Device]
   760   C0442822:Trace [Quantitative Concept]
   760   C1521805:Opposite [Spatial Concept]
   760   C1524031:Trace [Qualitative Concept]
   760   C1883002:Trace [Functional Concept]
   726 E C0419518:Loop [Medical Device]
   726 E C0445022:Loop [Spatial Concept]

Phrase: "the active site in the two enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0205681:Active Site [Functional Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0205177:Active [Functional Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "colored according to the thermal factors of main chain atoms"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   739   C0205225:Main [Qualitative Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C0522507:colored [Qualitative Concept]
   739   C0567415:Atoms [Element, Ion, or Isotope]
   739   C0680240:according [Social Behavior]
   739   C1524075:Chain [Idea or Concept]
   739   C1542147:Main [Qualitative Concept]
   706 E C0009393:Color [Natural Phenomenon or Process]
   706   C1521761:Factor [Functional Concept]
   706 E C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   706 E C1705245:Color [Pharmacologic Substance]
   706 E C1706222:Atom [Conceptual Entity]
   706   C2827422:Factor [Conceptual Entity]

Phrase: "in the loop residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.189: The key indicates the color coding scheme, with yellow representing the highest thermal factor (66 2) and dark blue representing the lowest thermal factor (9 2). 

Phrase: "The key"

Phrase: "indicates"

Phrase: "the color coding scheme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519193:Scheme [Intellectual Product]

Phrase: "with yellow representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882932:Represent [Activity]

Phrase: "the highest thermal factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(66 2"

Phrase: ")"

Phrase: "and"

Phrase: "dark blue representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1882932:Represent [Activity]

Phrase: "the lowest thermal factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(9 2"

Phrase: ")."
Processing 00000000.tx.190: The arrow indicates the alanine residue in TOP (Ala-607) that is changed to a glycine in neurolysin.  

Phrase: "The arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "indicates"

Phrase: "the alanine residue in TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1709915:Residue [Conceptual Entity]
   753   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(Ala-607"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   789   C0702172:Alar [Hazardous or Poisonous Substance,Organic Chemical]
   768 E C0043189:Wing [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "that"

Phrase: "is"

Phrase: "changed to a glycine"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0392747:Changed [Functional Concept]
   770   C0443172:Changed [Quantitative Concept]
   770   C0522461:Glycine [Plant]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.191: Changes in loop conformation and mobility are indeed found in the TOP crystal structure (Fig. 6). 

Phrase: "Changes in loop conformation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   767   C0301641:Conformational change [Molecular Function]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "mobility"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0425245:Mobility [Finding]
  1000   C0449580:Mobility [Qualitative Concept]
   928 E C0231435:Mobile [Functional Concept]
   928 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "are"

Phrase: "indeed"

Phrase: "found in the TOP crystal structure"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   748   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0150312:Found [Quantitative Concept]
   748   C0427896:Crystal [Body Substance]
   748   C0678594:Structure [Spatial Concept]
   748   C1533132:Crystal [Body Substance]
   748   C1704641:Crystal [Manufactured Object]
   714 E C0243095:Find [Finding]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.192: Backbone and side chain rearrangements result in different placement of residues that might interact with substrate, including His-600 and Tyr-605 as well as Tyr-612, which is immediately C-terminal to the loop. 

Phrase: "Backbone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037949:Backbone [Body Part, Organ, or Organ Component]
  1000   C1267072:Backbone [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "side chain rearrangements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511695:Rearrangements [Genetic Function]

Phrase: "result in different placement of residues"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0441587:Placement [Health Care Activity]
   753   C1274040:Result [Functional Concept]
   753   C1524072:Placement [Qualitative Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C2825142:Result [Finding]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "that"

Phrase: "might"

Phrase: "interact with substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1710236:Substrate [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "His-600"

Phrase: "and"

Phrase: "Tyr-605"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "as well as"

Phrase: "Tyr-612,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "immediately C-terminal to the loop."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   783   C3548406:terminal loop [Cell Component]
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.193: His-600 adopts a different side chain rotomer conformation, pointing toward the active site in TOP and away from it in neurolysin. 

Phrase: "His-600"

Phrase: "adopts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a different side chain rotomer conformation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0026377:Conformation [Spatial Concept]

Phrase: "pointing toward the active site"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0205681:Active Site [Functional Concept]
   760   C0205145:Site [Spatial Concept]
   760   C0205177:Active [Functional Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]

Phrase: "in TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and away from it"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "in neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.194: Tyr-605 shifts position by 2.1  in C position and also adopts a different side chain rotomer conformation in the two enzymes but in both cases still points in toward the active site. 

Phrase: "Tyr-605"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "shifts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333051:Shift [Functional Concept]
  1000   C2347509:Shift [Phenomenon or Process]

Phrase: "position by 2.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0733755:Position [Spatial Concept]

Phrase: "in C position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "also"

Phrase: "adopts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a different side chain rotomer conformation in the two enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0026377:Conformation [Spatial Concept]

Phrase: "but in both cases still"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "points in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1552961:Point [Quantitative Concept]
   833   C2347617:point [Quantitative Concept]

Phrase: "toward the active site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.195: Interestingly, Tyr-612 rotates away from the active site. 

Phrase: "Interestingly,"

Phrase: "Tyr-612"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "rotates away from the active site."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0205681:Active Site [Functional Concept]
   753   C0205145:Site [Spatial Concept]
   753   C0205177:Active [Functional Concept]
   753   C0231458:rotate [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
Processing 00000000.tx.196: Mutations at this position affect catalysis in both TOP and neurolysin (68), suggesting that it may play a role by contributing a hydrogen bond to the oxyanion transition state intermediate (49, 68). 

Phrase: "Mutations at this position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "catalysis in both TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0007382:Catalysis [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role by contributing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "a hydrogen bond to the oxyanion transition state"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020276:hydrogen bond [Natural Phenomenon or Process]
   744   C0020275:Hydrogen [Element, Ion, or Isotope]
   744   C0523702:HYDROGEN [Laboratory Procedure]
   744   C0885426:hydrogen [Inorganic Chemical]

Phrase: "intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "(49,"

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.197: The tyrosine in neurolysin is well positioned to serve in this function, but the TOP loop would need to change main chain conformation upon substrate binding to place the Tyr-612 within hydrogen bonding distance of the substrate carbonyl oxygen. 

Phrase: "The tyrosine in neurolysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "well positioned to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   793   C0733755:Position [Spatial Concept]

Phrase: "serve in this function,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "but"

Phrase: "the TOP loop"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
   734   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "would"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "main chain conformation upon substrate binding to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0026377:Conformation [Spatial Concept]
   748   C0205225:Main [Qualitative Concept]
   748   C0337112:Chain [Manufactured Object]
   748   C1524075:Chain [Idea or Concept]
   748   C1542147:Main [Qualitative Concept]

Phrase: "place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "the Tyr-612 within hydrogen bonding distance of the substrate carbonyl oxygen."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0020276:Hydrogen Bonding [Natural Phenomenon or Process]
   736   C0012751:Distance [Quantitative Concept]
   736   C0020275:Hydrogen [Element, Ion, or Isotope]
   736   C0028758:BONDING [Mental Process]
   736   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   736   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0523702:HYDROGEN [Laboratory Procedure]
   736   C0885426:hydrogen [Inorganic Chemical]
   736   C1421250:TYR [Gene or Genome]
   736   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.198: The differences in loop conformation between the two enzymes are accompanied by an overall increase in order of the TOP loop relative to the same segment in neurolysin (Fig. 6B). 

Phrase: "The differences in loop conformation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "between the two enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "accompanied by an overall increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0282416:Overall [Intellectual Product]
   760   C0442805:Increase [Functional Concept]
   760   C1561607:Overall [Qualitative Concept]

Phrase: "in order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "of the TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "relative to the same segment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "in neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.199: The average backbone thermal factors for the 12 residues in the TOP loop is 19 2 compared with a much larger value of 45 2 in neurolysin. 

Phrase: "The average backbone thermal factors for the 12 residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1521761:Factor [Functional Concept]
   708   C2827422:Factor [Conceptual Entity]

Phrase: "in the TOP loop"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
   734   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "19 2"

Phrase: "compared with a much larger value of 45 2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0443228:larger [Quantitative Concept]
   742   C0549177:Larger [Quantitative Concept]
   742   C1522609:Value [Quantitative Concept]
   742   C1704243:Larger [Quantitative Concept]
   742   C1707455:Compared [Activity]

Phrase: "in neurolysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]
Processing 00000000.tx.200: Clearly the loss of one glycine has a considerable effect on both mobility as well as conformation. 

Phrase: "Clearly"

Phrase: "the loss of one glycine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "has"

Phrase: "a considerable effect on both mobility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "as well as"

Phrase: "conformation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.201: Given the differences between the loops in the two crystal structures, it seems likely that this single residue change plays a role in creating specificity differences. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the differences between the loops"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "in the two crystal structures,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   827   C0427896:Crystal [Body Substance]
   827   C0678594:structures [Spatial Concept]
   827   C1533132:Crystal [Body Substance]
   827   C1704641:Crystal [Manufactured Object]

Phrase: "it"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "this single residue change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0392747:Change [Functional Concept]
   827   C0443172:change [Quantitative Concept]
   827   C1705241:Change [Quantitative Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in creating specificity differences."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.202: Recently, the glycine at position 607 in TOP was mutated to the alanine found in neurolysin (68), and the altered TOP has kinetic parameters more like neurolysin for hydrolysis of a peptide that is not normally a good TOP substrate. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the glycine at position 607"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0522461:Glycine [Plant]

Phrase: "in TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "mutated to the alanine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1705285:Mutated [Cell or Molecular Dysfunction]
   737 E C1513776:Mutate [Genetic Function]

Phrase: "found in neurolysin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0150312:Found [Quantitative Concept]
   790   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1423943:NEUROLYSIN [Gene or Genome]
   756 E C0243095:Find [Finding]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the altered TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "kinetic parameters more like neurolysin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0449381:Parameters [Finding]
   726 E C0549193:Parameter [Spatial Concept]
   726 E C1704769:Parameter [Conceptual Entity]
   726 E C2350001:Parameter [Quantitative Concept]

Phrase: "for hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "of a peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "is"

Phrase: "not normally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "a good TOP substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.203: Additional mutagenesis and characterization will be necessary to fully test the model for differences in cleavage site selection. 

Phrase: "Additional mutagenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079866:Mutagenesis [Molecular Function]
   861   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "and"

Phrase: "characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterization [Activity]

Phrase: "will"

Phrase: "be"

Phrase: "necessary to fully"

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the model for differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: "in cleavage site selection."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0010813:cleavage [Cell Function]
   827   C0036576:selection [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.204: Modification and Subcellular LocalizationTOP activity can be modulated by posttranslational covalent modification (3). 

Phrase: "Modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "Subcellular LocalizationTOP activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "modulated by posttranslational covalent modification"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0033666:Post-Translational Modification [Molecular Function]
   760   C0392747:Modification [Functional Concept]
   760   C0443264:Modulated [Spatial Concept]
   760   C1511539:Covalent [Molecular Function]
   760   C1554963:modification [Qualitative Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.205: The enzyme loses activity in the absence of reducing agents, and this inactivation occurs in part by the formation of disulfide-linked multimers, which appear to lose affinity for substrate (35, 37). 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "loses"

Phrase: "activity in the absence of reducing agents,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "this inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "occurs in part"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0449719:Part [Spatial Concept]
   790   C1709305:Occur [Activity]
   790   C1709471:Part [Quantitative Concept]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "by the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of disulfide-linked multimers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1979934:Multimers [Chemical Viewed Structurally]

Phrase: "which"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lose"

Phrase: "affinity for substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "(35,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.206: Shrimpton et al. 

Phrase: "Shrimpton et al."
Processing 00000000.tx.207: (35) suggest that polymerization may provide a mechanism for modulating TOP activity based on the redox characteristics of its environment. 

Phrase: "(35"

Phrase: ")"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that polymerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a mechanism for modulating TOP activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "based on the redox characteristics of its environment."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0014406:Environment [Spatial Concept]
   744   C0030012:Redox [Molecular Function]
   744   C1521970:Characteristics [Qualitative Concept]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.208: Recently, an apparently proteinaceous component of cerebrospinal fluid has been shown to affect the multimerization state of TOP, indicating another possible level of regulation for the secreted pool of the enzyme (36). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "an apparently proteinaceous component of cerebrospinal fluid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the multimerization state of TOP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]

Phrase: "indicating"

Phrase: "another possible level of regulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "for the secreted pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337051:Pool [Geographic Area]
   861   C1509144:pool [Clinical Attribute]
   861   C2349200:Pool [Functional Concept]

Phrase: "of the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.209: Of the 14 cysteines in human TOP, 7 are solvent-accessible in the crystal structure, and 6 of those 7 are on the outside of the enzyme where they could participate in intermolecular disulfide links (Fig. 7). 

Phrase: "Of the 14 cysteines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in human TOP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "7"

Phrase: "are"

Phrase: "solvent-accessible in the crystal structure,"

Phrase: "and"

Phrase: "6 of those 7"

Phrase: "are on the outside of the enzyme where"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0205101:Outside [Spatial Concept]
   744   C1551058:Are [Quantitative Concept]

Phrase: "they"

Phrase: "could"

Phrase: "participate in intermolecular disulfide links"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0012771:disulfide [Chemical Viewed Structurally]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.210: In addition, Cys-18 and Cys-682 are located in the disordered N and C termini, respectively (not included in the crystal structure), and are, therefore, also likely to be solvent-accessible. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "Cys-18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Cys-682"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "located in the disordered N"

Phrase: "and"

Phrase: "C termini,"

Phrase: "respectively"

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "included in the crystal structure"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   760   C0332257:included [Functional Concept]
   760   C0427896:Crystal [Body Substance]
   760   C0678594:Structure [Spatial Concept]
   760   C1533132:Crystal [Body Substance]
   760   C1704641:Crystal [Manufactured Object]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "are"

Phrase: ","

Phrase: "therefore,"

Phrase: "also likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "solvent-accessible."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0814423:accessibility [Qualitative Concept]
Processing 00000000.tx.211: In the rat ortholog, cysteines 246, 248, 253, and 682 have been implicated in multimer formation (35, 37), and all are among the surface-accessible residues in the crystal structure of the human enzyme. 

Phrase: "In the rat ortholog,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1335144:Ortholog [Gene or Genome]
   789 E C1709346:Orthologous [Qualitative Concept]

Phrase: "cysteines 246,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "248,"

Phrase: "253,"

Phrase: "and"

Phrase: "682"

Phrase: "have"

Phrase: "been"

Phrase: "implicated in multimer formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "(35,"

Phrase: "37"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "all"

Phrase: "are among the surface-accessible residues"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205148:Surface [Spatial Concept]
   753   C1551058:Are [Quantitative Concept]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "in the crystal structure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   861   C0427896:Crystal [Body Substance]
   861   C0678594:Structure [Spatial Concept]
   861   C1533132:Crystal [Body Substance]
   861   C1704641:Crystal [Manufactured Object]

Phrase: "of the human enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.212: Cysteines at positions 46 and 687 in rat TOP are also thought to be involved in multimer formation. 

Phrase: "Cysteines at positions 46"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "687 in rat TOP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "also"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in multimer formation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1522492:Formation [Functional Concept]
Processing 00000000.tx.213: Human TOP has an arginine at position 46. 

Phrase: "Human TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "an arginine at position 46."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.214: This residue is in an exterior portion of 1, and it is likely that the S of a cysteine at this position would be accessible and in a good position to mediate dimer contacts. 

Phrase: "This residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "is in an exterior portion of 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449719:Portion [Spatial Concept]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the S of a cysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at this position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]
   928 E C0240795:POSITIONAL [Finding]

Phrase: "would"

Phrase: "be"

Phrase: "accessible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0814423:accessibility [Qualitative Concept]

Phrase: "and in a good position to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205170:Good [Qualitative Concept]
   753   C0733755:Position [Spatial Concept]
   753   C1515981:And [Idea or Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "dimer contacts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332158:contact [Functional Concept]
   827   C0337611:Contact [Population Group]
   827   C1705415:Contact [Idea or Concept]
Processing 00000000.tx.215: Position 687 (glutamine in human TOP) is in the disordered C terminus of the crystal structure and would likely also be available for intermolecular disulfide bond formation. 

Phrase: "Position 687"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "(glutamine in human TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "is in the disordered C terminus of the crystal structure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   739   C0427896:Crystal [Body Substance]
   739   C0678594:Structure [Spatial Concept]
   739   C1533132:Crystal [Body Substance]
   739   C1704641:Crystal [Manufactured Object]

Phrase: "and"

Phrase: "would"

Phrase: "likely also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "available for intermolecular disulfide bond formation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0470187:Available [Functional Concept]
Processing 00000000.tx.216: Interestingly, the other accessible cysteine residues outside the channel, positions 321, 350, and 644, are not present in the rat homolog and might be additional sites of covalent linkage in human TOP. 

Phrase: "Interestingly,"

Phrase: "the"

Phrase: "other accessible cysteine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "positions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]

Phrase: "321,"

Phrase: "350,"

Phrase: "and"

Phrase: "644,"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in the rat homolog"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C1334043:Homolog [Gene or Genome]

Phrase: "and"

Phrase: "might"

Phrase: "be"

Phrase: "additional sites of covalent linkage"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C2945843:Site of [Qualitative Concept]
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "in human TOP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.217: As noted previously based on a TOP model (50), cysteines 246, 248, and 253, which appear particularly important in disulfide bond formation, cluster tightly on the molecular surface and could themselves mediate only dimer formation. 

Phrase: "As"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "previously"

Phrase: "based on a TOP model"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C3161035:Model [Intellectual Product]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "cysteines 246,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "248,"

Phrase: "and"

Phrase: "253,"

Phrase: "which"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "particularly important in disulfide bond formation,"

Phrase: "cluster"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1555715:Cluster [Idea or Concept]
  1000   C1704332:Cluster [Quantitative Concept]

Phrase: "tightly on the molecular surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205148:Surface [Spatial Concept]
   760   C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "could"

Phrase: "themselves"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "only dimer formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.218: In fact, these three cysteines are located in a strongly electronegative region of the TOP surface (Fig. 7, lower right panel), suggesting that dimerization via only these residues may be rare. 

Phrase: "In fact,"

Phrase: "these three cysteines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "located in a strongly electronegative region of the TOP surface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   754   C1268222:Surface region [Body Location or Region]
   738   C0017446:Region [Geographic Area]
   738   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205147:Region [Spatial Concept]
   738   C0205148:Surface [Spatial Concept]

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that dimerization via only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0376525:Dimerization [Natural Phenomenon or Process]

Phrase: "these residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "rare."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]
Processing 00000000.tx.219: Multimer formation, particularly the formation of aggregates larger than dimers, must therefore involve cysteines other than this tightly clustered set. 

Phrase: "Multimer formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "particularly"

Phrase: "the formation of aggregates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "larger than dimers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0443228:larger [Quantitative Concept]
   790   C0549177:Larger [Quantitative Concept]
   790   C1704243:Larger [Quantitative Concept]

Phrase: "must"

Phrase: "therefore"

Phrase: "involve"

Phrase: "cysteines other than this tightly clustered set."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.220: View larger version (96K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(96K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.221: 7. 

Phrase: "7."
Processing 00000000.tx.222: Covalent modification of TOP. 

Phrase: "Covalent modification of TOP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392747:Modification [Functional Concept]
   760   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.223: Surface-accessible cysteine residues. 

Phrase: "Surface-accessible cysteine residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.224: Cysteines that form part of the molecular surface of the TOP crystal structure are indicated by pink patches for three different orientations of the molecule in the upper and lower left panels. 

Phrase: "Cysteines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that form part of the molecular surface of the TOP crystal structure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C1292711:Part of [Spatial Concept]
   749   C0442052:Part structure [Spatial Concept]
   735   C0449719:Part [Spatial Concept]
   735   C1709471:Part [Quantitative Concept]

Phrase: "are"

Phrase: "indicated by pink patches"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   770   C0332585:Pink [Qualitative Concept]
   770   C0994894:Patches [Medical Device]
   770   C1444656:Indicated [Finding]
   737 E C0332461:Patch [Finding]
   737 E C0445403:Patch [Biomedical or Dental Material]
   737 E C0991556:Patch [Medical Device]
   737 E C1305400:Patch [Medical Device]
   737 E C1533128:Patch [Biomedical or Dental Material]
   737 E C1706366:{Patch} [Quantitative Concept]
   737 E C1707974:Patch [Biomedical or Dental Material]

Phrase: "for three different orientations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0029266:Orientations [Mental Process]
   793 E C1704322:orientation [Spatial Concept]
   793 E C1704972:Orientation [Spatial Concept]
   793 E C3539923:Orientation [Intellectual Product]

Phrase: "of the molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "in the upper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282910:Upper [Spatial Concept]

Phrase: "and"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "left panels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.225: Residue numbers for each cysteine are given. 

Phrase: "Residue numbers for each cysteine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "given."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]
Processing 00000000.tx.226: In the lower right panel, the surface electrostatic potential near cysteines (246, 248, 253) known to be involved in the disulfide mediated polymerization of TOP (35) is shown in the same molecular orientation as the lower left panel. 

Phrase: "In the lower right panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: "the surface electrostatic potential near cysteines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(246,"

Phrase: "248,"

Phrase: "253"

Phrase: ")"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in the disulfide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012771:disulfide [Chemical Viewed Structurally]
   770   C1314939:Involved [Functional Concept]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "polymerization of TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "(35"

Phrase: ")"

Phrase: "is"

Phrase: "shown in the same molecular orientation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0029266:Orientation [Mental Process]
   753   C0445247:Same [Qualitative Concept]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1704322:orientation [Spatial Concept]
   753   C1704972:Orientation [Spatial Concept]
   753   C3539923:Orientation [Intellectual Product]
   719   C1547282:Show [Intellectual Product]

Phrase: "as the lower left panel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.227: The images in this figure were created with GRASP (73).  

Phrase: "The images in this figure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "created with GRASP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0220843:grasp [Organism Function]
   790   C1425726:GRASP [Gene or Genome]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "(73"

Phrase: ")."
Processing 00000000.tx.228: Given the locations of the accessible cysteines, it is not immediately clear why multimerization inhibits the enzyme, since covalent linkage would be unlikely to prevent substrate entry into the active site channel. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the locations of the accessible cysteines,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0450429:locations [Spatial Concept]
   719 E C1515974:Location [Body Location or Region]

Phrase: "it"

Phrase: "is"

Phrase: "not immediately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205548:Immediately [Temporal Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "why multimerization"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "since"

Phrase: "covalent linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023745:linkage [Molecular Function]

Phrase: "would"

Phrase: "be"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "substrate entry into the active site channel."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705654:Entry [Intellectual Product]
Processing 00000000.tx.229: The decrease in activity has only been shown with the rat homolog, and it is possible that multimer formation involving Cys-46, which is located at the top of one channel wall, restricts substrate access to the active site. 

Phrase: "The decrease in activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "has"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "been"

Phrase: "shown with the rat homolog,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C1334043:Homolog [Gene or Genome]
   726   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that multimer formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "Cys-46,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "is"

Phrase: "located at the top of one channel wall,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0205447:One [Quantitative Concept]
   744   C0439799:Channel [Spatial Concept]
   744   C0677535:Wall [Manufactured Object]
   744   C1704458:Top [Spatial Concept]
   744   C1706095:Channel [Conceptual Entity]

Phrase: "restricts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:restrict [Functional Concept]

Phrase: "substrate access to the active site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0589360:access site [Spatial Concept]
   753   C0444454:Access [Spatial Concept]
   753   C1554204:access [Idea or Concept]
Processing 00000000.tx.230: Indeed, mutation of this position improves activity under oxidizing condition (37). 

Phrase: "Indeed,"

Phrase: "mutation of this position"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "improves"

Phrase: "activity under oxidizing condition"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C1292728:Condition activity [Functional Concept]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.231: Mutation of Cys-682 and Cys-687, on the other hand, does not improve activity, consistent with their location on the backside of the enzyme far away from the channel opening. 

Phrase: "Mutation of Cys-682"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "Cys-687,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "improve"

Phrase: "activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "consistent with their location"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "on the backside"

Phrase: "of the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "far away from the channel opening."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205108:far [Spatial Concept]
Processing 00000000.tx.232: Mutating Cys-46 is not sufficient to prevent all loss of activity, and it seems clear that other cysteines, most prominently cysteines 246, 248, and 253, also mediate inactivation by multimerization (35, 37). 

Phrase: "Mutating Cys-46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1513776:Mutate [Genetic Function]

Phrase: "is"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "all loss of activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "it"

Phrase: "seems"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "other cysteines,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "most prominently cysteines 246,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0205393:Most [Quantitative Concept]

Phrase: "248,"

Phrase: "and"

Phrase: "253,"

Phrase: "also"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "inactivation by multimerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "(35,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.233: It is difficult to imagine how multimerization involving these residues and any of the other surface cysteines would occlude the active site channel, and determining if loss of activity is a steric or a conformational effect awaits further experimentation. 

Phrase: "It"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "imagine"

Phrase: "how multimerization"

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "these residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "any of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552551:Any [Qualitative Concept]
   790   C3272371:ANY [Intellectual Product]

Phrase: "other surface cysteines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "would"

Phrase: "occlude"

Phrase: "the active site channel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
   734   C0205681:Active Site [Functional Concept]

Phrase: "and"

Phrase: "determining"

Phrase: "if"

Phrase: "loss of activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "a steric"

Phrase: "or"

Phrase: "a conformational effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "awaits"

Phrase: "further experimentation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678323:experimentation [Research Activity]
Processing 00000000.tx.234: Both TOP and neurolysin are inactivated by thiol-modifying reagents, and a conserved cysteine at the base of the channel near the active site, Cys-427 in TOP, would almost certainly affect substrate binding if modified by a bulky reagent (50). 

Phrase: "Both TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neurolysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0286406:neurolysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1423943:NEUROLYSIN [Gene or Genome]

Phrase: "are"

Phrase: "inactivated by thiol-modifying reagents,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0038738:Thiol Reagents [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   760   C0038734:thiol [Organic Chemical]
   726   C0392747:MODIFY [Functional Concept]

Phrase: "and"

Phrase: "a conserved cysteine at the base of the channel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "near the active site,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "Cys-427 in TOP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "would"

Phrase: "almost certainly"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "substrate binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "if"

Phrase: "modified by a bulky reagent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0205349:Modified By [Qualitative Concept]
   760   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   760   C0392747:Modified [Functional Concept]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.235: This cysteine is not surface-accessible in the TOP crystal structure, however, and the only solvent-exposed cysteine inside the channel, Cys-175, is located high up on one channel wall where modification is unlikely to affect activity. 

Phrase: "This cysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not surface-accessible in the TOP crystal structure,"

Phrase: "however,"

Phrase: "and"

Phrase: "the only solvent-exposed cysteine inside the channel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Cys-175,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "located"

Phrase: "high up"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0205250:High [Qualitative Concept]
   833   C1299351:High [Qualitative Concept]
   833   C2700149:HIGH [Intellectual Product]

Phrase: "on one channel wall where modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0392747:Modification [Functional Concept]
   804   C1554963:modification [Qualitative Concept]

Phrase: "is"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.236: It appears then that either local dynamics allows transient access to Cys-427 or modification of another cysteine causes a conformational change that affects activity. 

Phrase: "It"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "that either local dynamics"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "transient access to Cys-427"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444454:Access [Spatial Concept]
   760   C1554204:access [Idea or Concept]

Phrase: "or"

Phrase: "modification of another cysteine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392747:Modification [Functional Concept]
   770   C1554963:modification [Qualitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a conformational change"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0301641:Conformational change [Molecular Function]
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.237: The early suggestion (69) that thiol-modifying reagents or high concentrations of reductant might disrupt intramolecular disulfide bonds is incorrect since there are no disulfide bonds or appropriately positioned cysteine pairs in the crystal structure. 

Phrase: "The early suggestion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038659:Suggestion [Idea or Concept]
   861   C1705535:suggestion [Idea or Concept]

Phrase: "(69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")"

Phrase: "that thiol-modifying reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0038738:Thiol Reagents [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "high concentrations of reductant"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "might"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "intramolecular disulfide bonds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C1511997:Disulfide Bond [Amino Acid Sequence]
   827   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "incorrect"

Phrase: "since"

Phrase: "there"

Phrase: "are"

Phrase: "no disulfide bonds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1511997:Disulfide Bond [Amino Acid Sequence]
   861   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "or"

Phrase: "appropriately positioned cysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "pairs in the crystal structure."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   760   C0427896:Crystal [Body Substance]
   760   C0678594:Structure [Spatial Concept]
   760   C1533132:Crystal [Body Substance]
   760   C1704641:Crystal [Manufactured Object]
   760   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.238: The rat homolog of TOP is a substrate for protein kinase A, and phosphorylation at Ser-644 affects activity on at least one substrate peptide (38). 

Phrase: "The rat homolog of TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1334043:Homolog [Gene or Genome]

Phrase: "is"

Phrase: "a substrate for protein kinase A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "phosphorylation at Ser-644"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "activity on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0205177:Activity [Functional Concept]
   833   C0439167:% activity [Quantitative Concept]
   833   C0441655:Activity [Activity]
   833   C1561536:*Activity [Idea or Concept]

Phrase: "at least one substrate peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.239: In addition, rat TOP expressed in cultured cells is phosphorylated, suggesting that this modification may be an additional form of TOP regulation. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "rat TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "expressed in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "is"

Phrase: "phosphorylated"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "an additional form of TOP regulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]
Processing 00000000.tx.240: The serine at position 644 is a cysteine in the human form of the enzyme, so this regulatory mechanism is not completely conserved. 

Phrase: "The serine at position 644"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "a cysteine in the human form of the enzyme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "so"

Phrase: "this regulatory mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "conserved."
Processing 00000000.tx.241: In any case, whereas Cys-644 is solvent-accessible in the crystal structure, it is located in 22 on the side of the enzyme opposite the channel opening, more than 20  from the active site (see Fig. 7). 

Phrase: "In any case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "whereas"

Phrase: "Cys-644"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "solvent-accessible in the crystal structure,"

Phrase: "it"

Phrase: "is"

Phrase: "located in 22"

Phrase: "on the side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441987:Side [Spatial Concept]

Phrase: "of the enzyme opposite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521805:Opposite [Spatial Concept]

Phrase: "the channel opening,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0175566:Opening [Spatial Concept]
   861   C1882151:Opening [Spatial Concept]

Phrase: "more than 20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205172:More [Functional Concept]

Phrase: "from the active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.242: The remote location of this residue might explain the modest and inconsistent effect of modification in the rat enzyme (38). 

Phrase: "The remote location of this residue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1550013:location - remote [Idea or Concept]
   753   C0450429:Location [Spatial Concept]
   753   C1515974:Location [Body Location or Region]

Phrase: "might"

Phrase: "explain"

Phrase: "the modest"

Phrase: "and"

Phrase: "inconsistent effect of modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "in the rat enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.243: Interestingly, the residue at position 643 in human TOP is a serine, but it is not known if this residue can be phosphorylated. 

Phrase: "Interestingly,"

Phrase: "the residue at position 643"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "in human TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a serine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "if"

Phrase: "this residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "phosphorylated."
Processing 00000000.tx.244: A key remaining question about TOP is the mechanism by which it is localized to different compartments despite the absence of known signal sequences. 

Phrase: "A key remaining question about TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1522634:Question [Intellectual Product]

Phrase: "is"

Phrase: "the mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "it"

Phrase: "is"

Phrase: "localized to different compartments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0392752:Localized [Spatial Concept]
   770   C1185625:Compartments [Body Space or Junction]
   770   C1382196:Compartments [Natural Phenomenon or Process]
   770   C1705242:Different [Qualitative Concept]
   737 E C2986730:Compartment [Spatial Concept]

Phrase: "despite the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of known signal sequences."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   901   C0037081:Signal Sequences [Amino Acid Sequence]
   827   C0162326:Sequences [Nucleotide Sequence]
   827   C1710082:Signal [Phenomenon or Process]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.245: In this regard, our finding that the N terminus is disordered as far back as residue 25 in the crystal structure suggests that it may play a role in localization by one or more yet unrecognized sequence motifs. 

Phrase: "In this regard,"

Phrase: "our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the N terminus"

Phrase: "is"

Phrase: "disordered as far back"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   802   C0263888:Back disorder [Disease or Syndrome]
   770   C0004600:Back [Body Location or Region]
   770   C0205095:Back [Spatial Concept]
   770   C0205108:far [Spatial Concept]
   770   C0460009:Back [Body Location or Region]
   770   C1995000:Back [Body Location or Region]
   737   C0012634:Disorder [Disease or Syndrome]

Phrase: "as"

Phrase: "residue 25 in the crystal structure"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   753   C0427896:Crystal [Body Substance]
   753   C0678594:Structure [Spatial Concept]
   753   C1533132:Crystal [Body Substance]
   753   C1704641:Crystal [Manufactured Object]
   753   C1709915:Residue [Conceptual Entity]
   753   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "by one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more yet unrecognized sequence motifs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.246: TOP has been reported to be primarily nuclear in rat brain neuronal cells, in apparent contradiction with its proposed functions, and residues 234-240 (PETRRKV) were identified as a possible nuclear localization sequence (12-14). 

Phrase: "TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "primarily nuclear in rat brain neuronal cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1441012:Neuronal nuclear [Immunologic Factor]
   748   C0521447:Nuclear [Spatial Concept]

Phrase: "in apparent contradiction"

Phrase: "with its proposed functions,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "residues 234-240"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "(PETRRKV"

Phrase: ")"

Phrase: "were"

Phrase: "identified as a possible nuclear localization sequence"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0205396:Identified [Qualitative Concept]
   748   C0332149:Possible [Qualitative Concept]
   748   C0475264:Localisation [Functional Concept]
   748   C0521447:Nuclear [Spatial Concept]
   748   C1519249:Sequence [Functional Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1705910:Possible [Qualitative Concept]
   748   C1744691:localisation [Biologic Function]
   748   C2362652:Possible [Qualitative Concept]

Phrase: "(12-14"

Phrase: ")."
Processing 00000000.tx.247: This sequence forms the N-terminal segment of helix 8 in one channel wall of the enzyme, however, and a major rearrangement would be required for it to adopt the extended conformation recognized by nuclear import carrier molecules (70). 

Phrase: "This sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the N-terminal segment of helix 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0441635:Segment [Spatial Concept]

Phrase: "in one channel wall"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0677535:Wall [Manufactured Object]

Phrase: "of the enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "however,"

Phrase: "and"

Phrase: "a major rearrangement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511695:Rearrangement [Genetic Function]

Phrase: "would"

Phrase: "be"

Phrase: "required for it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Required [Functional Concept]

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "the extended conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]

Phrase: "recognized by nuclear import carrier molecules"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0887839:Nuclear Import [Cell Function]
   753   C0007294:Carrier [Finding]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0560175:Carrier [Finding]
   753   C0567416:molecules [Substance]
   753   C0699788:Import [Occupational Activity]
   753   C1706209:Carrier [Medical Device]
   753   C3273162:Carrier [Intellectual Product]

Phrase: "(70"

Phrase: ")."
Processing 00000000.tx.248: Several reports have also suggested that TOP associates with membranes of the secretory apparatus and the plasma membrane, perhaps even the specialized substructures known as lipid rafts (5-7, 12, 13, 17, 18). 

Phrase: "Several reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "also"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that TOP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "associates with membranes of the secretory apparatus"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0025255:Membranes [Tissue]
   748   C0243111:apparatus [Manufactured Object]
   748   C0750490:Associate [Idea or Concept]
   748   C1327616:Secretory [Cell Function]
   748   C1706221:Associate [Professional or Occupational Group]
   748   C1947951:Apparatus [Anatomical Structure]
   714 E C0596901:Membrane [Cell Component]
   714 E C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "the plasma membrane,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "perhaps even"

Phrase: "the specialized substructures"

Phrase: "known as lipid rafts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1167250:lipid rafts [Cell Component]
   770   C0023779:Lipid [Lipid]
   770   C0205309:Known [Qualitative Concept]
   737   C0336849:Raft [Manufactured Object]

Phrase: "(5-7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "12,"

Phrase: "13,"

Phrase: "17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.249: There are no basic regions of the molecular surface that might mediate direct electrostatic association. 

Phrase: "There"

Phrase: "are"

Phrase: "no basic regions of the molecular surface"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1268222:Surface region [Body Location or Region]
   714   C0017446:Region [Geographic Area]
   714   C0205147:Region [Spatial Concept]

Phrase: "that"

Phrase: "might"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "direct electrostatic association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
Processing 00000000.tx.250: The one prominent surface electrostatic feature, the large acidic patch (Fig. 7), might mediate membrane association by interaction with another protein, a possibility that could be tested by site-directed mutagenesis.  

Phrase: "The one prominent surface electrostatic feature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1521970:Feature [Qualitative Concept]
   804   C1706388:Feature [Conceptual Entity]
   804   C2346469:Feature [Qualitative Concept]
   804   C2348519:Feature [Qualitative Concept]

Phrase: "the large acidic patch"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0332461:Patch [Finding]
   827   C0445403:Patch [Biomedical or Dental Material]
   827   C0991556:Patch [Medical Device]
   827   C1305400:Patch [Medical Device]
   827   C1533128:Patch [Biomedical or Dental Material]
   827   C1706366:{Patch} [Quantitative Concept]
   827   C1707974:Patch [Biomedical or Dental Material]
   755 E C0205413:Patchy [Qualitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "might"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "membrane association by interaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with another protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "tested by site-directed mutagenesis."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   760   C0079866:Mutagenesis [Molecular Function]
   760   C0205145:Site [Spatial Concept]
   760   C0392366:tested [Intellectual Product]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   760   C3146302:Mutagenesis [Laboratory Procedure]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.251: FOOTNOTES  The atomic coordinates and structure factors (code 1S4B) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "The atomic coordinates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0427184:coordinates [Finding]
   861   C0700114:coordinates [Functional Concept]
   861   C1707511:Coordinates [Spatial Concept]

Phrase: "and"

Phrase: "structure factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678594:Structure [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(code 1S4B"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "deposited in the Protein Data Bank,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1705318:Protein Data Bank [Intellectual Product]
   790   C0242356:Data Bank [Intellectual Product]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0333562:deposited [Functional Concept]
   753   C0442598:Bank [Manufactured Object]
   753   C0872261:Bank [Manufactured Object]
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "Research Collaboratory for Structural Bioinformatics,"

Phrase: "Rutgers University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "New Brunswick,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027963:New Brunswick [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.rcsb.org/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.252: * This work was supported by United States Public Health Service Grant NS38041 (to D. W. R.), National Science Foundation Grant MCB-9904886 (to D. W. R.), and American Chemical Society Petroleum Research Fund 37135-AC4 (to D. W. R.). 

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by United States Public Health Service Grant NS38041"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   849   C0041734:United States Public Health Service [Health Care Related Organization]
           Public Health Service
   790   C0699943:Public health service [Health Care Activity]
           public health
   764   C0018747:Service, Health [Health Care Activity]
   764   C0034019:Public Health [Biomedical Occupation or Discipline]
   764   C0041703:United States [Geographic Area]
   764   C3244304:public health [Intellectual Product]
   762   C0683314:health states [Finding]
   742   C0018173:Grant [Quantitative Concept]
   742   C0018684:Health [Idea or Concept]
   742   C0557854:Service [Occupational Activity]
   742   C1301808:states [Geographic Area]
   742   C1521721:Supported [Conceptual Entity]
   742   C1548284:Grant [Idea or Concept]
   742   C2825316:Service [Manufactured Object]
   742   C3245478:service [Idea or Concept]
   708   C0166872:unite [Biomedical or Dental Material]
   708 E C0183683:Support [Medical Device]
   708 E C1442792:State [Functional Concept]
   708 E C3148680:State [Geographic Area]

Phrase: "("

Phrase: "to D. W. R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "National Science Foundation Grant MCB-9904886"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   799   C0016617:Foundation [Organization]
   799   C0018173:Grant [Quantitative Concept]
   799   C0036397:Science [Occupation or Discipline]
   799   C1548284:Grant [Idea or Concept]
   799   C3245503:national [Intellectual Product]
   716 E C0002055:base [Inorganic Chemical]
   716 E C0178499:Base [Chemical Viewed Functionally]
   716 E C1626935:Bases [Quantitative Concept]
   716 E C1880279:Base [Biomedical or Dental Material]

Phrase: "("

Phrase: "to D. W. R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "American Chemical Society Petroleum Research Fund 37135-AC4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1412223:AC4 [Gene or Genome]

Phrase: "("

Phrase: "to D. W. R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.253: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.254: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.255: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.256: A predoctoral fellow of the American Heart Association Ohio Valley Affiliate. 

Phrase: "A predoctoral fellow of the American Heart Association Ohio Valley Affiliate."
Processing 00000000.tx.257: A fellow of the National Institute on Drug Abuse (Grant DA14596).  

Phrase: "A fellow of the National Institute on Drug Abuse"

Phrase: "(Grant DA14596"

Phrase: ")."
Processing 00000000.tx.258: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.259: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.260: 859-257-5205; 

Phrase: "859-257-5205"

Phrase: ";"
Processing 00000000.tx.261: Fax: 859-323-1037; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "859-323-1037"

Phrase: ";"
Processing 00000000.tx.262: E-mail: david.rodgers{at}uky.edu . 1 The abbreviations used are: TOP, thimet oligopeptidase; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "david.rodgers{at}uky.edu . 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "TOP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "thimet oligopeptidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145620:thimet oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.263: r.m.s.d., root mean square deviation. 

Phrase: "r.m.s.d.,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   875   C1512018:M.D. [Intellectual Product]
   861   C0439493:m/s [Quantitative Concept]
   861   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C1513009:M.S. [Intellectual Product]
   812   C0205090:R- [Spatial Concept]
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: "root mean square deviation."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   923   C2347976:Root Mean Square [Quantitative Concept]
   875   C1828170:Mean deviation [Clinical Attribute]
   812   C0012727:Deviation [Spatial Concept]
   812   C0040452:Root [Body Part, Organ, or Organ Component]
   812   C0205120:Square [Spatial Concept]
   812   C0205419:Deviation [Qualitative Concept]
   812   C0242726:Root [Plant]
   812   C0444504:Mean [Quantitative Concept]
   812   C1318154:Root [Body Part, Organ, or Organ Component]
   812   C1552595:Square [Intellectual Product]
   812   C1705236:Deviation [Finding]
   812   C1705917:Root [Idea or Concept]
   812   C2347634:Mean [Quantitative Concept]
   812   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.264: 2 K. 

Phrase: "2 K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.265: Ray, C. 

Phrase: "Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "C."
Processing 00000000.tx.266: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.267: Hines, J. 

Phrase: "Hines,"

Phrase: "J."
Processing 00000000.tx.268: Coll-Rodriguez, D. 

Phrase: "Coll-Rodriguez,"

Phrase: "D."
Processing 00000000.tx.269: W. 

Phrase: "W."
Processing 00000000.tx.270: Rodgers, unpublished observations.  

Phrase: "Rodgers,"

Phrase: "unpublished observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.271: ACKNOWLEDGMENTS  We thank the staffs of Advanced Photon Source beamlines 22ID (SER-CAT), 19ID (SBC), and 14-BMC (BioCARS) for help with data collection. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the staffs of Advanced Photon Source beamlines 22ID"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0851286:Staff [Professional or Occupational Group]
   744   C1947908:Staff [Professional or Occupational Group]

Phrase: "(SER-CAT"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0007450:Cat [Mammal]
   861   C0325090:Cat [Mammal]
   861   C0524517:Cat [Mammal]
   805 E C0325089:feline [Mammal]
   777 E C1825121:CATS [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "19ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552189:19id [Medical Device]

Phrase: "(SBC"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "14-BMC (BioCARS"

Phrase: ")"

Phrase: "for"

Phrase: "help with data collection."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0010995:Data Collection [Research Activity]
   770   C0018896:Help [Social Behavior]
   770   C1511726:Data [Idea or Concept]
   770   C1516698:Collection [Functional Concept]
   770   C1552861:help [Idea or Concept]
   770   C1704814:Collection [Idea or Concept]
   770   C3245479:data [Medical Device]
Processing 00000000.tx.272: Use of the Advanced Photon Source is supported by the United States Department of Energy.  

Phrase: "Use of the Advanced Photon Source"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "is"

Phrase: "supported by the United States Department of Energy."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   800   C1511776:Department of Energy [Professional or Occupational Group]
   770   C0041703:United States [Geographic Area]
   744   C0424589:Energy [Finding]
   744   C0542479:Energy [Natural Phenomenon or Process]
   744   C1301808:states [Geographic Area]
   744   C1442080:Energy [Quantitative Concept]
   744   C1521721:Supported [Conceptual Entity]
   744   C1704729:Department [Organization]
   711   C0166872:unite [Biomedical or Dental Material]
   711 E C0183683:Support [Medical Device]
   711 E C1442792:State [Functional Concept]
   711 E C3148680:State [Geographic Area]
Processing 00000000.tx.273: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES  Barrett, A. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   813   C2825142:Experimental Result [Finding]
           Result
   762   C1274040:Result [Functional Concept]
   762   C1546471:Result [Idea or Concept]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Barrett,"

Phrase: "A."
Processing 00000000.tx.274: J., Brown, M. 

Phrase: "J.,"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.275: A., Dando, P. 

Phrase: "A.,"

Phrase: "Dando,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.276: M., Knight, C. 

Phrase: "M."

Phrase: ","

Phrase: "Knight,"

Phrase: "C."
Processing 00000000.tx.277: G., McKie, N., Rawlings, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "McKie,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Rawlings,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.278: D., and Serizawa, A. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Serizawa,"

Phrase: "A."
Processing 00000000.tx.279: (1995) Methods Enzymol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.280: 248, 529-556[Medline] [OrderarticleviaInfotrieve] Rawlings, N. 

Phrase: "248,"

Phrase: "529-556"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rawlings,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.281: D., and Barrett, A. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Barrett,"

Phrase: "A."
Processing 00000000.tx.282: J. 

Phrase: "J."
Processing 00000000.tx.283: (1995) Methods Enzymol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.284: 248, 183-228[Medline] [OrderarticleviaInfotrieve] Shrimpton, C. 

Phrase: "248,"

Phrase: "183-228"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shrimpton,"

Phrase: "C."
Processing 00000000.tx.285: N., Smith, A. 

Phrase: "N., Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.286: I., and Lew, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Lew,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.287: A. 

Phrase: "A."
Processing 00000000.tx.288: (2002) Endocr. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Endocr."
Processing 00000000.tx.289: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.290: 23, 647-664[Abstract/Free FullText] Dando, P. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "647-664"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dando,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.291: M., Brown, M. 

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.292: A., and Barrett, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Barrett,"

Phrase: "A."
Processing 00000000.tx.293: J. 

Phrase: "J."
Processing 00000000.tx.294: (1993) Biochem. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.295: J. 

Phrase: "J."
Processing 00000000.tx.296: 294, 451-457[Medline] [OrderarticleviaInfotrieve] Acker, G. 

Phrase: "294,"

Phrase: "451-457"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Acker,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.297: R., Molineaux, C., and Orlowski, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Molineaux,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Orlowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.298: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.299: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.300: 48, 284-292[Medline] [OrderarticleviaInfotrieve] Chu, T. 

Phrase: "48,"

Phrase: "284-292"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chu,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.301: G., and Orlowski, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Orlowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.302: (1985) Endocrinology 116, 1418-1425[Abstract] Healy, D. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Endocrinology 116,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "1418-1425"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Healy,"

Phrase: "D."
Processing 00000000.tx.303: P., and Orlowski, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Orlowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.304: (1992) Brain Res. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.305: 571, 121-128[CrossRef][Medline] [OrderarticleviaInfotrieve] Pierotti, A., Dong, K. 

Phrase: "571,"

Phrase: "121-128"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pierotti,"

Phrase: "A.,"

Phrase: "Dong,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.306: W., Glucksman, M. 

Phrase: "W., Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.307: J., Orlowski, M., and Roberts, J. 

Phrase: "J.,"

Phrase: "Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.308: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.309: (1990) Biochemistry 29, 10323-10329[Medline] [OrderarticleviaInfotrieve] Wu, T. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Biochemistry 29,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "10323-10329"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.310: J., Pierotti, A. 

Phrase: "J.,"

Phrase: "Pierotti,"

Phrase: "A."
Processing 00000000.tx.311: R., Jakubowski, M., Sheward, W. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jakubowski,"

Phrase: "M."

Phrase: ","

Phrase: "Sheward,"

Phrase: "W."
Processing 00000000.tx.312: J., Glucksman, M. 

Phrase: "J.,"

Phrase: "Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.313: J., Smith, A. 

Phrase: "J.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.314: I., King, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "King,"

Phrase: "J."
Processing 00000000.tx.315: C., Fink, G., and Roberts, J. 

Phrase: "C., Fink,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.316: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.317: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.318: Neuroendocrinol. 

Phrase: "Neuroendocrinol."
Processing 00000000.tx.319: 9, 813-822[Medline] [OrderarticleviaInfotrieve] Ferro, E. 

Phrase: "9,"

Phrase: "813-822"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.320: S., Tambourgy, D. 

Phrase: "S."

Phrase: ","

Phrase: "Tambourgy,"

Phrase: "D."
Processing 00000000.tx.321: V., Abreu, P. 

Phrase: "V., Abreu,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.322: A., Camargo, A. 

Phrase: "A.,"

Phrase: "Camargo,"

Phrase: "A."
Processing 00000000.tx.323: C., Raw, I., and Ho, P. 

Phrase: "C., Raw, I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1547546:C-I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.324: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.325: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.326: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.327: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.328: 57, 311-320[Medline] [OrderarticleviaInfotrieve] Ferro, E. 

Phrase: "57,"

Phrase: "311-320"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.329: S., Tullai, J. 

Phrase: "S."

Phrase: ","

Phrase: "Tullai,"

Phrase: "J."
Processing 00000000.tx.330: W., Glucksman, M. 

Phrase: "W., Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.331: J., and Roberts, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.332: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.333: (1999) DNA Cell Biol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "DNA Cell Biol."
Processing 00000000.tx.334: 18, 781-789[CrossRef][Medline] [OrderarticleviaInfotrieve] Fontenele-Neto, J. 

Phrase: "18,"

Phrase: "781-789"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Fontenele-Neto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1657233:NETO [Cell Function]

Phrase: "J."
Processing 00000000.tx.335: D., Massarelli, E. 

Phrase: "D."

Phrase: ","

Phrase: "Massarelli,"

Phrase: "E."
Processing 00000000.tx.336: E., Gurgel Garrido, P. 

Phrase: "E.,"

Phrase: "Gurgel Garrido,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.337: A., Beaudet, A., and Ferro, E. 

Phrase: "A.,"

Phrase: "Beaudet,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.338: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.339: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.340: Comp. 

Phrase: "Comp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056167:COMP [Therapeutic or Preventive Procedure]
  1000   C1456376:COMP [Gene or Genome]
Processing 00000000.tx.341: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.342: 438, 399-410[CrossRef][Medline] [OrderarticleviaInfotrieve] Garrido, P. 

Phrase: "438,"

Phrase: "399-410"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Garrido,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.343: A., Vandenbulcke, F., Ramjaun, A. 

Phrase: "A.,"

Phrase: "Vandenbulcke,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ramjaun,"

Phrase: "A."
Processing 00000000.tx.344: R., Vincent, B., Checler, F., Ferro, E., and Beaudet, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vincent,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Checler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E.,"

Phrase: "and"

Phrase: "Beaudet,"

Phrase: "A."
Processing 00000000.tx.345: (1999) DNA Cell Biol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "DNA Cell Biol."
Processing 00000000.tx.346: 18, 323-331[CrossRef][Medline] [OrderarticleviaInfotrieve] Massarelli, E. 

Phrase: "18,"

Phrase: "323-331"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Massarelli,"

Phrase: "E."
Processing 00000000.tx.347: E., Casatti, C. 

Phrase: "E.,"

Phrase: "Casatti,"

Phrase: "C."
Processing 00000000.tx.348: A., Kato, A., Camargo, A. 

Phrase: "A.,"

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "A.,"

Phrase: "Camargo,"

Phrase: "A."
Processing 00000000.tx.349: C., Bauer, J. 

Phrase: "C., Bauer,"

Phrase: "J."
Processing 00000000.tx.350: A., Glucksman, M. 

Phrase: "A.,"

Phrase: "Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.351: J., Roberts, J. 

Phrase: "J.,"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.352: L., Hirose, S., and Ferro, E. 

Phrase: "L., Hirose,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.353: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.354: (1999) Brain Res. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.355: 851, 261-265[CrossRef][Medline] [OrderarticleviaInfotrieve] Oliveira, V., Ferro, E. 

Phrase: "851,"

Phrase: "261-265"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Oliveira,"

Phrase: "V.,"

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.356: S., Gomes, M. 

Phrase: "S."

Phrase: ","

Phrase: "Gomes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.357: D., Oshiro, M. 

Phrase: "D."

Phrase: ","

Phrase: "Oshiro,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.358: E., Almeida, P. 

Phrase: "E.,"

Phrase: "Almeida,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3463949:Almeida [Eukaryote]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.359: C., Juliano, M. 

Phrase: "C., Juliano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.360: A., and Juliano, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Juliano,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.361: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.362: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.363: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.364: 76, 478-488[CrossRef][Medline] [OrderarticleviaInfotrieve] Orlowski, M., Michaud, C., and Chu, T. 

Phrase: "76,"

Phrase: "478-488"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "Michaud,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Chu,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.365: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.366: (1983) Eur. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.367: J. 

Phrase: "J."
Processing 00000000.tx.368: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.369: 135, 81-88[Abstract] Crack, P. 

Phrase: "135,"

Phrase: "81-88"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Crack,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706353:Crack [Finding]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.370: J., Wu, T. 

Phrase: "J.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.371: J., Cummins, P. 

Phrase: "J.,"

Phrase: "Cummins,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.372: M., Ferro, E. 

Phrase: "M."

Phrase: ","

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.373: S., Tullai, J. 

Phrase: "S."

Phrase: ","

Phrase: "Tullai,"

Phrase: "J."
Processing 00000000.tx.374: W., Glucksman, M. 

Phrase: "W., Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.375: J., and Roberts, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.376: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.377: (1999) Brain Res. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.378: 835, 113-124[CrossRef][Medline] [OrderarticleviaInfotrieve] Chen, J. 

Phrase: "835,"

Phrase: "113-124"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J."
Processing 00000000.tx.379: M., Changco, A., Brown, M. 

Phrase: "M."

Phrase: ","

Phrase: "Changco,"

Phrase: "A.,"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.380: A., and Barrett, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Barrett,"

Phrase: "A."
Processing 00000000.tx.381: J. 

Phrase: "J."
Processing 00000000.tx.382: (1995) Exp. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.383: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.384: 216, 80-85[CrossRef][Medline] [OrderarticleviaInfotrieve] Dahms, P., and Mentlein, R. 

Phrase: "216,"

Phrase: "80-85"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dahms,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Mentlein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.385: (1992) Eur. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.386: J. 

Phrase: "J."
Processing 00000000.tx.387: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.388: 208, 145-154[Abstract] Mentlein, R., and Dahms, P. 

Phrase: "208,"

Phrase: "145-154"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mentlein,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Dahms,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.389: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.390: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.391: 64, 27-37 Barrett, A. 

Phrase: "64,"

Phrase: "27-37 Barrett,"

Phrase: "A."
Processing 00000000.tx.392: J., and Brown, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.393: A. 

Phrase: "A."
Processing 00000000.tx.394: (1990) Biochem. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.395: J. 

Phrase: "J."
Processing 00000000.tx.396: 271, 701-706[Medline] [OrderarticleviaInfotrieve] Vincent, B., Jiracek, J., Noble, F., Loog, M., Roques, B., Dive, V., Vincent, J. 

Phrase: "271,"

Phrase: "701-706"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vincent,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jiracek,"

Phrase: "J.,"

Phrase: "Noble,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Loog,"

Phrase: "M."

Phrase: ","

Phrase: "Roques,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Dive,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0012823:dive [Daily or Recreational Activity]
  1000   C0325913:dive [Bird]
   966 E C1412762:Diva [Gene or Genome]
   966 E C2700407:DIVA [Gene or Genome]

Phrase: "V.,"

Phrase: "Vincent,"

Phrase: "J."
Processing 00000000.tx.397: P., and Checler, F. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.398: (1997) Eur. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.399: J. 

Phrase: "J."
Processing 00000000.tx.400: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.401: 334, 49-53[CrossRef][Medline] [OrderarticleviaInfotrieve] Orlowski, M., Reznik, S., Ayala, J., and Pierotti, A. 

Phrase: "334,"

Phrase: "49-53"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "Reznik,"

Phrase: "S."

Phrase: ","

Phrase: "Ayala,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Pierotti,"

Phrase: "A."
Processing 00000000.tx.402: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.403: (1989) Biochem. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.404: J. 

Phrase: "J."
Processing 00000000.tx.405: 261, 951-958[Medline] [OrderarticleviaInfotrieve] Dendorfer, A., Vordermark, D., and Dominiak, P. 

Phrase: "261,"

Phrase: "951-958"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dendorfer,"

Phrase: "A.,"

Phrase: "Vordermark,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Dominiak,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.406: (1997) Br. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.407: J. 

Phrase: "J."
Processing 00000000.tx.408: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.409: 120, 121-129[Abstract] Lew, R. 

Phrase: "120,"

Phrase: "121-129"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lew,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.410: A., Cowley, M., Clarke, I. 

Phrase: "A.,"

Phrase: "Cowley,"

Phrase: "M."

Phrase: ","

Phrase: "Clarke,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.411: J., and Smith, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.412: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.413: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.414: Neuroendocrinol. 

Phrase: "Neuroendocrinol."
Processing 00000000.tx.415: 9, 707-712[Medline] [OrderarticleviaInfotrieve] Yang, X. 

Phrase: "9,"

Phrase: "707-712"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "X."
Processing 00000000.tx.416: P., Saitoh, S., Scicli, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Saitoh,"

Phrase: "S."

Phrase: ","

Phrase: "Scicli,"

Phrase: "A."
Processing 00000000.tx.417: G., Mascha, E., Orlowski, M., and Carretero, O. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mascha,"

Phrase: "E.,"

Phrase: "Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Carretero,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.418: A. 

Phrase: "A."
Processing 00000000.tx.419: (1994) Hypertension 23, 1235-1239 Saric, T., Beninga, J., Graef, C. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Hypertension 23,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C0450348:23 [Quantitative Concept]
   861   C1963138:Hypertension [Finding]

Phrase: "1235-1239 Saric,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Beninga,"

Phrase: "J.,"

Phrase: "Graef,"

Phrase: "C."
Processing 00000000.tx.420: I., Akopian, T. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Akopian,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.421: N., Rock, K. 

Phrase: "N., Rock,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.422: L., and Goldberg, A. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Goldberg,"

Phrase: "A."
Processing 00000000.tx.423: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.424: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.425: Biol. 

Phrase: "Biol."
Processing 00000000.tx.426: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.427: 276, 36474-36481[Abstract/Free FullText] York, I. 

Phrase: "276,"

Phrase: "36474-36481"

Phrase: "[Abstract/Free FullText"

Phrase: "] York,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.428: A., Mo, A. 

Phrase: "A.,"

Phrase: "Mo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "A."
Processing 00000000.tx.429: X., Lemerise, K., Zeng, W., Shen, Y., Abraham, C. 

Phrase: "X.,"

Phrase: "Lemerise,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zeng,"

Phrase: "W.,"

Phrase: "Shen,"

Phrase: "Y.,"

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.430: R., Saric, T., Goldberg, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Saric,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Goldberg,"

Phrase: "A."
Processing 00000000.tx.431: L., and Rock, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Rock,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.432: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.433: (2003) Immunity 18, 429-440[Medline] [OrderarticleviaInfotrieve] Kim, S. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Immunity 18,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: "429-440"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.434: I., Pabon, A., Swanson, T. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pabon,"

Phrase: "A.,"

Phrase: "Swanson,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.435: A., and Glucksman, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.436: J. 

Phrase: "J."
Processing 00000000.tx.437: (2003) Biochem. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.438: J. 

Phrase: "J."
Processing 00000000.tx.439: 375, 111-120[CrossRef][Medline] [OrderarticleviaInfotrieve] Koike, H., Seki, H., Kouchi, Z., Ito, M., Kinouchi, T., Tomioka, S., Sorimachi, H., Saido, T. 

Phrase: "375,"

Phrase: "111-120"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Koike,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Seki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272348:Seki [Organic Chemical,Pharmacologic Substance]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kouchi,"

Phrase: "Z.,"

Phrase: "Ito,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415618:ITO [Gene or Genome]

Phrase: "M."

Phrase: ","

Phrase: "Kinouchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tomioka,"

Phrase: "S."

Phrase: ","

Phrase: "Sorimachi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.440: C., Maruyama, K., Suzuki, K., and Ishiura, S. 

Phrase: "C., Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ishiura,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.441: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.442: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.443: (Tokyo) 126, 235-242[Abstract] Yamin, R., Malgeri, E. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "126,"

Phrase: "235-242"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yamin,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Malgeri,"

Phrase: "E."
Processing 00000000.tx.444: G., Sloane, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sloane,"

Phrase: "J."
Processing 00000000.tx.445: A., McGraw, W. 

Phrase: "A.,"

Phrase: "McGraw,"

Phrase: "W."
Processing 00000000.tx.446: T., and Abraham, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.447: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.448: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.449: Biol. 

Phrase: "Biol."
Processing 00000000.tx.450: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.451: 274, 18777-18784[Abstract/Free FullText] McCool, S., and Pierotti, A. 

Phrase: "274,"

Phrase: "18777-18784"

Phrase: "[Abstract/Free FullText"

Phrase: "] McCool,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Pierotti,"

Phrase: "A."
Processing 00000000.tx.452: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.453: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.454: Soc. 

Phrase: "Soc."
Processing 00000000.tx.455: Trans. 

Phrase: "Trans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826298:TRANS [Idea or Concept]
Processing 00000000.tx.456: 26, S15[Medline] [OrderarticleviaInfotrieve] McCool, S., and Pierotti, A. 

Phrase: "26,"

Phrase: "S15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419704:S15 [Gene or Genome]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McCool,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Pierotti,"

Phrase: "A."
Processing 00000000.tx.457: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.458: (2000) DNA Cell Biol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "DNA Cell Biol."
Processing 00000000.tx.459: 19, 729-738[CrossRef][Medline] [OrderarticleviaInfotrieve] Morrison, L. 

Phrase: "19,"

Phrase: "729-738"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Morrison,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.460: S., and Pierotti, A. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Pierotti,"

Phrase: "A."
Processing 00000000.tx.461: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.462: (2003) Biochem. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.463: J. 

Phrase: "J."
Processing 00000000.tx.464: 376, 189-197[CrossRef][Medline] [OrderarticleviaInfotrieve] Shrimpton, C. 

Phrase: "376,"

Phrase: "189-197"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shrimpton,"

Phrase: "C."
Processing 00000000.tx.465: N., Glucksman, M. 

Phrase: "N., Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.466: J., Lew, R. 

Phrase: "J.,"

Phrase: "Lew,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.467: A., Tullai, J. 

Phrase: "A.,"

Phrase: "Tullai,"

Phrase: "J."
Processing 00000000.tx.468: W., Margulies, E. 

Phrase: "W., Margulies,"

Phrase: "E."
Processing 00000000.tx.469: H., Roberts, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.470: L., and Smith, A. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.471: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.472: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.473: Biol. 

Phrase: "Biol."
Processing 00000000.tx.474: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.475: 272, 17395-17399[Abstract/Free FullText] Shrimpton, C. 

Phrase: "272,"

Phrase: "17395-17399"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shrimpton,"

Phrase: "C."
Processing 00000000.tx.476: N., Wolfson, A. 

Phrase: "N., Wolfson,"

Phrase: "A."
Processing 00000000.tx.477: J., Smith, A. 

Phrase: "J.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.478: I., and Lew, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Lew,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.479: A. 

Phrase: "A."
Processing 00000000.tx.480: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.481: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.482: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.483: 74, 474-478[CrossRef][Medline] [OrderarticleviaInfotrieve] Sigman, J. 

Phrase: "74,"

Phrase: "474-478"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sigman,"

Phrase: "J."
Processing 00000000.tx.484: A., Sharky, M. 

Phrase: "A.,"

Phrase: "Sharky,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: L., Walsh, S. 

Phrase: "L., Walsh,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.486: T., Pabon, A., Glucksman, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pabon,"

Phrase: "A.,"

Phrase: "Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.487: J., and Wolfson, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Wolfson,"

Phrase: "A."
Processing 00000000.tx.488: J. 

Phrase: "J."
Processing 00000000.tx.489: (2003) Protein Eng. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Protein Eng."
Processing 00000000.tx.490: 16, 623-628[CrossRef][Medline] [OrderarticleviaInfotrieve] Tullai, J. 

Phrase: "16,"

Phrase: "623-628"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tullai,"

Phrase: "J."
Processing 00000000.tx.491: W., Cummins, P. 

Phrase: "W., Cummins,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.492: M., Pabon, A., Roberts, J. 

Phrase: "M."

Phrase: ","

Phrase: "Pabon,"

Phrase: "A.,"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.493: L., Lopingco, M. 

Phrase: "L., Lopingco,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.494: C., Shrimpton, C. 

Phrase: "C., Shrimpton,"

Phrase: "C."
Processing 00000000.tx.495: N., Smith, A. 

Phrase: "N., Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.496: I., Martignetti, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Martignetti,"

Phrase: "J."
Processing 00000000.tx.497: A., Ferro, E. 

Phrase: "A.,"

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.498: S., and Glucksman, M. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.499: J. 

Phrase: "J."
Processing 00000000.tx.500: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.501: Biol. 

Phrase: "Biol."
Processing 00000000.tx.502: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.503: 275, 36514-36522[Abstract/Free FullText] Portaro, F. 

Phrase: "275,"

Phrase: "36514-36522"

Phrase: "[Abstract/Free FullText"

Phrase: "] Portaro,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.504: C., Hayashi, M. 

Phrase: "C., Hayashi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.505: A., Silva, C. 

Phrase: "A.,"

Phrase: "Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   928   C0144237:Silvan [Organic Chemical]
   907 E C0043217:Wood [Substance]
   907 E C0442548:Woods [Geographic Area]

Phrase: "C."
Processing 00000000.tx.506: L., and de Camargo, A. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "de Camargo,"

Phrase: "A."
Processing 00000000.tx.507: C. 

Phrase: "C."
Processing 00000000.tx.508: (2001) Eur. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.509: J. 

Phrase: "J."
Processing 00000000.tx.510: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.511: 268, 887-894[Abstract/Free FullText] Checler, F., Barelli, H., Dauch, P., Dive, V., Vincent, B., and Vincent, J. 

Phrase: "268,"

Phrase: "887-894"

Phrase: "[Abstract/Free FullText"

Phrase: "] Checler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Barelli,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dauch,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Dive,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0012823:dive [Daily or Recreational Activity]
  1000   C0325913:dive [Bird]
   966 E C1412762:Diva [Gene or Genome]
   966 E C2700407:DIVA [Gene or Genome]

Phrase: "V.,"

Phrase: "Vincent,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Vincent,"

Phrase: "J."
Processing 00000000.tx.512: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.513: (1995) Methods Enzymol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.514: 248, 593-614[Medline] [OrderarticleviaInfotrieve] Dauch, P., Vincent, J. 

Phrase: "248,"

Phrase: "593-614"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dauch,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vincent,"

Phrase: "J."
Processing 00000000.tx.515: P., and Checler, F. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.516: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.517: Biol. 

Phrase: "Biol."
Processing 00000000.tx.518: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.519: 270, 27266-27271[Abstract/Free FullText] Checler, F. 

Phrase: "270,"

Phrase: "27266-27271"

Phrase: "[Abstract/Free FullText"

Phrase: "] Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.520: (1993) in Methods in Neurotransmitter and Neuropeptide Research (Nagatsu, T., Parvez, H., Naoi, M., and Parvez, S., eds) Vol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "in Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "in Neurotransmitter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027908:Neurotransmitter [Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "Neuropeptide Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "(Nagatsu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Parvez,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Naoi,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Parvez,"

Phrase: "S."

Phrase: ","

Phrase: "eds) Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449468:VOL [Quantitative Concept]
   861   C0560268:vol% [Quantitative Concept]
   861   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.521: 2, pp. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "pp."
Processing 00000000.tx.522: 375-418, Elsevier Science Publishers B. 

Phrase: "375-418,"

Phrase: "Elsevier Science Publishers B."
Processing 00000000.tx.523: V., Amsterdam Jiracek, J., Yiotakis, A., Vincent, B., Checler, F., and Dive, V. 

Phrase: "V., Amsterdam Jiracek,"

Phrase: "J.,"

Phrase: "Yiotakis,"

Phrase: "A.,"

Phrase: "Vincent,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Checler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Dive,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0012823:dive [Daily or Recreational Activity]
  1000   C0325913:dive [Bird]
   966 E C1412762:Diva [Gene or Genome]
   966 E C2700407:DIVA [Gene or Genome]

Phrase: "V."
Processing 00000000.tx.524: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.525: Biol. 

Phrase: "Biol."
Processing 00000000.tx.526: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.527: 271, 19606-19611[Abstract/Free FullText] Rioli, V., Kato, A., Portaro, F. 

Phrase: "271,"

Phrase: "19606-19611"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rioli,"

Phrase: "V.,"

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "A.,"

Phrase: "Portaro,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.528: C., Cury, G. 

Phrase: "C., Cury,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.529: K., te Kaat, K., Vincent, B., Checler, F., Camargo, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "te Kaat,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vincent,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Checler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Camargo,"

Phrase: "A."
Processing 00000000.tx.530: C., Glucksman, M. 

Phrase: "C., Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.531: J., Roberts, J. 

Phrase: "J.,"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.532: L., Hirose, S., and Ferro, E. 

Phrase: "L., Hirose,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.533: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.534: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.535: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.536: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.537: Commun. 

Phrase: "Commun."
Processing 00000000.tx.538: 250, 5-11[CrossRef][Medline] [OrderarticleviaInfotrieve] Vincent, B., Dive, V., Yiotakis, A., Smadja, C., Maldonado, R., Vincent, J.-P., and Checler, F. 

Phrase: "250,"

Phrase: "5-11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vincent,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Dive,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0012823:dive [Daily or Recreational Activity]
  1000   C0325913:dive [Bird]
   966 E C1412762:Diva [Gene or Genome]
   966 E C2700407:DIVA [Gene or Genome]

Phrase: "V.,"

Phrase: "Yiotakis,"

Phrase: "A.,"

Phrase: "Smadja,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Maldonado,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vincent,"

Phrase: "J.-P.,"

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.539: (1995) Br. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.540: J. 

Phrase: "J."
Processing 00000000.tx.541: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.542: 115, 1053-1063[Abstract] Camargo, A. 

Phrase: "115,"

Phrase: "1053-1063"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Camargo,"

Phrase: "A."
Processing 00000000.tx.543: C. 

Phrase: "C."
Processing 00000000.tx.544: M., Gomes, M. 

Phrase: "M."

Phrase: ","

Phrase: "Gomes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.545: D., Reichl, A. 

Phrase: "D."

Phrase: ","

Phrase: "Reichl,"

Phrase: "A."
Processing 00000000.tx.546: P., Ferro, E. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.547: S., Jacchieri, S., Hirata, I. 

Phrase: "S."

Phrase: ","

Phrase: "Jacchieri,"

Phrase: "S."

Phrase: ","

Phrase: "Hirata,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.548: Y., and Juliano, L. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Juliano,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.549: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.550: J. 

Phrase: "J."
Processing 00000000.tx.551: 324, 517-522[Medline] [OrderarticleviaInfotrieve] Oliveira, V., Campos, M., Hemerly, J. 

Phrase: "324,"

Phrase: "517-522"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Oliveira,"

Phrase: "V.,"

Phrase: "Campos,"

Phrase: "M."

Phrase: ","

Phrase: "Hemerly,"

Phrase: "J."
Processing 00000000.tx.552: P., Ferro, E. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.553: S., Camargo, A. 

Phrase: "S."

Phrase: ","

Phrase: "Camargo,"

Phrase: "A."
Processing 00000000.tx.554: C., Juliano, M. 

Phrase: "C., Juliano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.555: A., and Juliano, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Juliano,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.556: (2001) Anal. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.557: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.558: 292, 257-265[CrossRef][Medline] [OrderarticleviaInfotrieve] Oliveira, V., Campos, M., Melo, R. 

Phrase: "292,"

Phrase: "257-265"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Oliveira,"

Phrase: "V.,"

Phrase: "Campos,"

Phrase: "M."

Phrase: ","

Phrase: "Melo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3098072:Melo [Eukaryote]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.559: L., Ferro, E. 

Phrase: "L., Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.560: S., Carmago, A. 

Phrase: "S."

Phrase: ","

Phrase: "Carmago,"

Phrase: "A."
Processing 00000000.tx.561: C. 

Phrase: "C."
Processing 00000000.tx.562: M., Juliano, M. 

Phrase: "M."

Phrase: ","

Phrase: "Juliano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.563: A., and Julinan, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Julinan,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.564: (2001) Biochemistry 40, 4417-4425[CrossRef][Medline] [OrderarticleviaInfotrieve] Brown, C. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Biochemistry 40,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005477:Biochemistry [Occupation or Discipline]
   861   C0439509:/40 [Temporal Concept]

Phrase: "4417-4425"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "C."
Processing 00000000.tx.565: K., Madauss, K., Lian, W., Beck, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Madauss,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lian,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330941:lian [Plant]

Phrase: "W.,"

Phrase: "Beck,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.566: R., Tolbert, W. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tolbert,"

Phrase: "W."
Processing 00000000.tx.567: D., and Rodgers, D. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Rodgers,"

Phrase: "D."
Processing 00000000.tx.568: W. 

Phrase: "W."
Processing 00000000.tx.569: (2001) Proc. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.570: Natl. 

Phrase: "Natl."
Processing 00000000.tx.571: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.572: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.573: U. 

Phrase: "U."
Processing 00000000.tx.574: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.575: A. 

Phrase: "A."
Processing 00000000.tx.576: 98, 3127-3132[Abstract/Free FullText] Ray, K., Hines, C. 

Phrase: "98,"

Phrase: "3127-3132"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hines,"

Phrase: "C."
Processing 00000000.tx.577: S., and Rodgers, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Rodgers,"

Phrase: "D."
Processing 00000000.tx.578: W. 

Phrase: "W."
Processing 00000000.tx.579: (2002) Protein Sci. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Protein Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.580: 11, 2237-2246[Abstract/Free FullText] McPherson, A. 

Phrase: "11,"

Phrase: "2237-2246"

Phrase: "[Abstract/Free FullText"

Phrase: "] McPherson,"

Phrase: "A."
Processing 00000000.tx.581: (1999) Crystallization of Biological Macromolecules, pp. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Crystallization of Biological Macromolecules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010423:Crystallization [Natural Phenomenon or Process]

Phrase: "pp."
Processing 00000000.tx.582: 188-192, Cold Spring Harbor Press, New York Rodgers, D. 

Phrase: "188-192,"

Phrase: "Cold Spring Harbor Press,"

Phrase: "New York Rodgers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "D."
Processing 00000000.tx.583: W. 

Phrase: "W."
Processing 00000000.tx.584: (1997) Methods Enzymol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.585: 276, 183-203 Otwinowski, Z., and Minor, W. 

Phrase: "276,"

Phrase: "183-203 Otwinowski,"

Phrase: "Z.,"

Phrase: "and"

Phrase: "Minor, W."
Processing 00000000.tx.586: (1997) Methods Enzymol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.587: 276, 307-326 Brnger, A. 

Phrase: "276,"

Phrase: "307-326 Brnger,"

Phrase: "A."
Processing 00000000.tx.588: T., Adams, P. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.589: D., Clore, G. 

Phrase: "D."

Phrase: ","

Phrase: "Clore,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.590: M., Delano, W. 

Phrase: "M."

Phrase: ","

Phrase: "Delano,"

Phrase: "W."
Processing 00000000.tx.591: L., Gros, P., Grosse-Kunstleve, R. 

Phrase: "L., Gros,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1332652:GRO [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1705593:GRO [Gene or Genome]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Grosse-Kunstleve,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.592: W., Jiang, J. 

Phrase: "W., Jiang,"

Phrase: "J."
Processing 00000000.tx.593: S., Kuszewski, J. 

Phrase: "S."

Phrase: ","

Phrase: "Kuszewski,"

Phrase: "J."
Processing 00000000.tx.594: N., Pannu, N. 

Phrase: "N., Pannu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.595: S., Reed, R. 

Phrase: "S."

Phrase: ","

Phrase: "Reed,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.596: J., Rice, L. 

Phrase: "J.,"

Phrase: "Rice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035567:Rice [Food]
  1000   C1140671:rice [Plant]
  1000   C1509547:RICE [Organic Chemical,Pharmacologic Substance]
  1000   C3484401:RICE [Pharmacologic Substance]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.597: M., Simonson, T., and Warren, G. 

Phrase: "M."

Phrase: ","

Phrase: "Simonson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Warren,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.598: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.599: (1998) Acta Crystallogr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.600: Sect. 

Phrase: "Sect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0061878:SECT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415380:SECT [Gene or Genome]
  1000   C3538708:SECT [Gene or Genome]
Processing 00000000.tx.601: D 54, 905-921[CrossRef][Medline] [OrderarticleviaInfotrieve] Jones, T. 

Phrase: "D 54,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "905-921"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.602: A., Zou, J. 

Phrase: "A.,"

Phrase: "Zou,"

Phrase: "J."
Processing 00000000.tx.603: Y., Cowan, S. 

Phrase: "Y.,"

Phrase: "Cowan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.604: W., and Kjeldgaard, M. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Kjeldgaard,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.605: (1991) Acta Crystallogr. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Acta Crystallogr."
Processing 00000000.tx.606: Sect. 

Phrase: "Sect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0061878:SECT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415380:SECT [Gene or Genome]
  1000   C3538708:SECT [Gene or Genome]
Processing 00000000.tx.607: A 47, 110-119[CrossRef][Medline] [OrderarticleviaInfotrieve] Natesh, R., Schwager, S. 

Phrase: "A 47,"

Phrase: "110-119"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Natesh,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Schwager,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.608: L., Sturrock, E. 

Phrase: "L., Sturrock,"

Phrase: "E."
Processing 00000000.tx.609: D., and Acharya, K. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Acharya,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.610: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.611: (2003) Nature 421, 551-554[CrossRef][Medline] [OrderarticleviaInfotrieve] Kim, H. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nature 421,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "551-554"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kim,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.612: M., Shin, D. 

Phrase: "M."

Phrase: ","

Phrase: "Shin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230444:Shin [Body Location or Region]

Phrase: "D."
Processing 00000000.tx.613: R., Yoo, O. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Yoo,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.614: J., Lee, H., and Lee, J. 

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lee,"

Phrase: "J."
Processing 00000000.tx.615: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.616: (2003) FEBS Lett. 

Phrase: "(2003"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.617: 538, 65-70[CrossRef][Medline] [OrderarticleviaInfotrieve] Arndt, J. 

Phrase: "538,"

Phrase: "65-70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450385:65 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Arndt,"

Phrase: "J."
Processing 00000000.tx.618: W., Hao, B., Ramakrishnan, V., Cheng, T., Chan, S. 

Phrase: "W., Hao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1324275:HAO [Molecular Function]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ramakrishnan,"

Phrase: "V.,"

Phrase: "Cheng,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.619: I., and Chan, M. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Chan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.620: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.621: (2002) Structure (Camb) 10, 215-224[Medline] [OrderarticleviaInfotrieve] Kester, W. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "(Camb"

Phrase: ")"

Phrase: "10,"

Phrase: "215-224"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kester,"

Phrase: "W."
Processing 00000000.tx.622: R., and Matthews, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Matthews,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.623: W. 

Phrase: "W."
Processing 00000000.tx.624: (1977) Biochemistry 16, 2506-2516[Medline] [OrderarticleviaInfotrieve] Matthews, B. 

Phrase: "(1977"

Phrase: ")"

Phrase: "Biochemistry 16,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "2506-2516"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Matthews,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.625: W., Weaver, L. 

Phrase: "W., Weaver,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0326812:Weaver [Bird]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.626: H., and Kester, W. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kester,"

Phrase: "W."
Processing 00000000.tx.627: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.628: (1974) J. 

Phrase: "(1974"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.629: Biol. 

Phrase: "Biol."
Processing 00000000.tx.630: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.631: 249, 8030-8044[Abstract/Free FullText] Xu, G. 

Phrase: "249,"

Phrase: "8030-8044"

Phrase: "[Abstract/Free FullText"

Phrase: "] Xu,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.632: Y., and Deber, C. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Deber,"

Phrase: "C."
Processing 00000000.tx.633: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.634: (1991) Int. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.635: J. 

Phrase: "J."
Processing 00000000.tx.636: Pept. 

Phrase: "Pept."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080384:PEPT [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.637: Protein Res. 

Phrase: "Protein Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.638: 37, 528-535[Medline] [OrderarticleviaInfotrieve] Dyson, H. 

Phrase: "37,"

Phrase: "528-535"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dyson,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.639: J., and Write, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Write"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043266:write [Occupation or Discipline]
  1000   C1576875:Write [Finding]
  1000   C2584304:Write [Mental Process]

Phrase: ","

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.640: E. 

Phrase: "E."
Processing 00000000.tx.641: (1991) Annu. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.642: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.643: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.644: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.645: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.646: 20, 519-538[CrossRef][Medline] [OrderarticleviaInfotrieve] Holden, H. 

Phrase: "20,"

Phrase: "519-538"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Holden,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.647: M., Tronrud, D. 

Phrase: "M."

Phrase: ","

Phrase: "Tronrud,"

Phrase: "D."
Processing 00000000.tx.648: E., Monzingo, A. 

Phrase: "E.,"

Phrase: "Monzingo,"

Phrase: "A."
Processing 00000000.tx.649: F., Weaver, L. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Weaver,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326812:Weaver [Bird]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.650: H., and Matthews, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Matthews,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.651: W. 

Phrase: "W."
Processing 00000000.tx.652: (1987) Biochemistry 26, 8542-8553[Medline] [OrderarticleviaInfotrieve] Grams, F., Dive, V., Yiotakis, A., Yiallouros, I., Vassiliou, S., Zwilling, R., Bode, W., and Stocker, W. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Biochemistry 26,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "8542-8553"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Grams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439208:grams [Quantitative Concept]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Dive,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0012823:dive [Daily or Recreational Activity]
  1000   C0325913:dive [Bird]
   966 E C1412762:Diva [Gene or Genome]
   966 E C2700407:DIVA [Gene or Genome]

Phrase: "V.,"

Phrase: "Yiotakis,"

Phrase: "A.,"

Phrase: "Yiallouros,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vassiliou,"

Phrase: "S."

Phrase: ","

Phrase: "Zwilling,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bode"

Phrase: ","

Phrase: "W.,"

Phrase: "and"

Phrase: "Stocker,"

Phrase: "W."
Processing 00000000.tx.653: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.654: Struct. 

Phrase: "Struct."
Processing 00000000.tx.655: Biol. 

Phrase: "Biol."
Processing 00000000.tx.656: 3, 671-675[Medline] [OrderarticleviaInfotrieve] Brooks, B. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "671-675"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Brooks,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.657: R., Bruccoleri, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bruccoleri,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.658: E., Olafson, B. 

Phrase: "E.,"

Phrase: "Olafson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.659: D., States, D. 

Phrase: "D."

Phrase: ","

Phrase: "States,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1301808:states [Geographic Area]
   966 E C1442792:State [Functional Concept]
   966 E C3148680:State [Geographic Area]

Phrase: "D."
Processing 00000000.tx.660: J., Swaminathan, S., and Karplus, M. 

Phrase: "J.,"

Phrase: "Swaminathan,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Karplus,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.661: (1983) J. 

Phrase: "(1983"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.662: Comput. 

Phrase: "Comput."
Processing 00000000.tx.663: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.664: 4, 187-217 Isaya, G., Kalousek, F., Fenton, W. 

Phrase: "4,"

Phrase: "187-217 Isaya,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kalousek,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fenton,"

Phrase: "W."
Processing 00000000.tx.665: A., and Rosenberg, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.666: E. 

Phrase: "E."
Processing 00000000.tx.667: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.668: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.669: 113, 65-76[Abstract] Kalousek, F., Hendrik, J. 

Phrase: "113,"

Phrase: "65-76"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450385:65 [Intellectual Product]

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kalousek,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hendrik,"

Phrase: "J."
Processing 00000000.tx.670: P., and Rosenberg, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.671: E. 

Phrase: "E."
Processing 00000000.tx.672: (1988) Proc. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.673: Natl. 

Phrase: "Natl."
Processing 00000000.tx.674: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.675: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.676: U. 

Phrase: "U."
Processing 00000000.tx.677: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.678: A. 

Phrase: "A."
Processing 00000000.tx.679: 85, 7536-7540[Abstract] Oliveira, V., Araujo, M. 

Phrase: "85,"

Phrase: "7536-7540"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Oliveira,"

Phrase: "V.,"

Phrase: "Araujo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.680: C., Rioli, V., de Camargo, A. 

Phrase: "C., Rioli,"

Phrase: "V.,"

Phrase: "de Camargo,"

Phrase: "A."
Processing 00000000.tx.681: C., Tersariol, I. 

Phrase: "C., Tersariol,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.682: L., Juliano, M. 

Phrase: "L., Juliano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.683: A., Juliano, L., and Ferro, E. 

Phrase: "A.,"

Phrase: "Juliano,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.684: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.685: (2003) FEBS Lett. 

Phrase: "(2003"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.686: 541, 89-92[CrossRef][Medline] [OrderarticleviaInfotrieve] Morales, T. 

Phrase: "541,"

Phrase: "89-92"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Morales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026530:Morales [Individual Behavior]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.687: I., and Woessner, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Woessner,"

Phrase: "J."
Processing 00000000.tx.688: F., Jr. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.689: (1977) J. 

Phrase: "(1977"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.690: Biol. 

Phrase: "Biol."
Processing 00000000.tx.691: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.692: 252, 4855-4860[Abstract] Conti, E., and Kuriyan, J. 

Phrase: "252,"

Phrase: "4855-4860"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Conti,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Kuriyan,"

Phrase: "J."
Processing 00000000.tx.693: (2000) Structure Fold. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "Fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Fold [Spatial Concept]
  1000   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.694: Des. 

Phrase: "Des."
Processing 00000000.tx.695: 8, 329-338[Medline] [OrderarticleviaInfotrieve] Carson, M. 

Phrase: "8,"

Phrase: "329-338"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Carson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551667:Carson [Population Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.696: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.697: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.698: Graph. 

Phrase: "Graph."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]
Processing 00000000.tx.699: 5, 103-106[CrossRef] Guex, N., and Peitsch, M. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "103-106"

Phrase: "[CrossRef"

Phrase: "] Guex,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Peitsch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.700: C. 

Phrase: "C."
Processing 00000000.tx.701: (1997) Electrophoresis 18, 2714-2723[Medline] [OrderarticleviaInfotrieve] Nicholls, A., Sharp, K. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Electrophoresis 18,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "2714-2723"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nicholls,"

Phrase: "A.,"

Phrase: "Sharp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1444775:Sharp [Finding]
  1000   C1539835:SHARP [Gene or Genome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.702: A., and Honig, B. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Honig,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.703: (1991) Proteins Struct. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Proteins Struct."
Processing 00000000.tx.704: Funct. 

Phrase: "Funct."
Processing 00000000.tx.705: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.706: 11, 281-296[Medline] [OrderarticleviaInfotrieve]

Phrase: "11,"

Phrase: "281-296"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

